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In vitro disease models are powerful platforms for the development of drugs and novel therapies. Stem-
cell based approaches have emerged as cutting-edge tools in disease modelling, allowing for deeper 
insights into previously unknown disease mechanisms. Hence the significant role of these disease-in-a-
dish methods in therapeutics and translational medicine.  
Impedance sensing is a non-invasive, quantitative technique that can monitor changes in cellular 
behaviour and morphology in real-time. Bioimpedance measurements can be used to characterize and 
evaluate the establishment of a valid disease model, without the need for invasive end-point biochemical 
assays. In this work, two stem cell-based disease models-on-a-chip are proposed for acute liver failure 
(ALF) and age-related macular degeneration (AMD).  
The ALF disease model-on-a-chip integrates impedance sensing with the highly-differentiated HepaRG 
cell line to monitor in real-time quantitative and dynamic response to various hepatotoxins. 
Bioimpedance analysis and modelling has revealed an unknown mechanism of paracetamol 
hepatotoxicity; a temporal, dose-dependent disruption of tight junctions (TJs) and cell-substrate 
adhesion. This disruption has been validated using ultrastructural imaging and immunostaining of the 
TJ-associated protein ZO-1. 
Age-related macular degeneration (AMD) is the leading cause of blindness in the developed world with 
a need for disease models for its currently incurable forms. Human induced pluripotent stem cells 
(hiPSCs) technology offers a novel approach for disease modelling, with the potential to impact 
translational retinal research and therapy. Recent developments enable the generation of Retinal 
Pigment Epithelial cells from patients (hiPSC-RPE), thus allowing for human retinal disease in vitro 
studies with great clinical and physiological relevance. In the current study, the development of a tissue-
on-a-chip AMD disease model has been established using RPE generated from a patient with an 




A reproducible Electric Cell-substrate Impedance Sensing (ECIS) electrical wounding assay was 
conducted to mimic RPE damage in AMD. First, a robust and reproducible real-time quantitative 
monitoring over a 25-day period demonstrated the establishment and maturation of RPE layers on 
microelectrodes. A spatially-controlled RPE layer damage that mimicked cell loss in AMD was then 
initiated. Post recovery, significant differences in migration rates were found between case and control 
cell lines. Data analysis and modelling suggested this was due to the lower cell-substrate adhesion of 
the control cell line. These findings were confirmed using cell adhesion biochemical assays. Moreover, 
different-sized, individually-addressed square microelectrode arrays with high spatial resolution were 
designed and fabricated in-house. ECIS wounding assays were performed on these chips to study 
immortalized RPE migration. Migration rates comparable to those obtained with ECIS circular 
microelectrodes were determined. 
The two proposed disease-models-on-a-chip were then used to explore the therapeutic potential of the 
antioxidant N-Acetyl-Cysteine (NAC) on hiPSC-RPE and HepaRG cell recovery. Addition of 10 mM 
NAC at the end of a 24h paracetamol challenge caused a slight increase in the measured impedance, 
suggesting partial cell recovery. On the other hand, no effect on case hiPSC-RPE migration has been 
observed. More experiments are needed to examine the effect of different NAC concentrations and 
incubation periods. The therapeutic potential of electrical stimulation has also been explored. A 
preliminary study to evaluate the effect of electrical stimulation on RPE migration has been conducted. 
An externally applied direct current electric field (DC EF) of 300 mV/mm was found to direct the 
migration of the immortalized RPE cell line (hTERT-RPE1) perpendicular to the EF. The cells were 
also observed to elongate and to realign their long axes perpendicular to the applied EF.  
The proposed tissue-on-a-chip disease models are powerful platforms for translational studies. The 
potential of such platforms has been demonstrated through revealing unknown effects of acetaminophen 
on the liver as well as providing deeper insights into the underlying mechanisms of macular 
degeneration. Combining stem cell technology with impedance sensing provides a high throughput 
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1.1. Disease-in-a-dish: A new promise for stem cells 
 
In 1998, James A. Thomson and his colleagues at the University of Wisconsin–Madison 
succeeded in creating human embryonic stem cells (hESCs) in a lab for the first time [1]. These 
cells could renew themselves, providing an unlimited supply, and could differentiate into any 
other cell type. Using these stem cells to create transplants to cure almost all diseases was a 
possibility that intrigued researchers, clinicians and most of all, patients with incurable 
diseases. Unfortunately, these stem cells had to be derived from the inner cell mass of 
developing embryos [2]; an ethical issue that led President George W. Bush to announce in 
2001 that the US would not fund embryonic stem cell research, except for that using already 
existing stem cell lines [3]. In addition to ethical concerns, controlling the stem cell 
differentiation process was not easy with almost all initial trials failing to derive other cell types 
from stem cells [3]. This however changed in 2002 when Hynek Wichterle et al. managed to 
derive motor neurons from embryonic stem cells [4]. This was considered a milestone, allowing 
researchers and clinicians to develop new stem cell-based therapies to treat patients with 
incurable brain or spinal cord conditions. Soon other researchers started to realize that there 
was another promise for the use of stem cells: creating a disease-in-a-dish. It was thought that 
this new role for stem cells in disease modelling would allow for the study of incurable diseases 





 technique in drug discovery [5]. However, the ethical issues surrounding embryonic stem cells 
remained, hindering the progress of such research. 
In 2006, a major breakthrough in stem cell research was achieved when Shinya Yamanaka was 
able to derive embryonic-like stem cells from human adult cells (somatic cells). This process 
of transforming adult cells back into stem cells was called 'reprogramming' and the cells were 
known as induced pluripotent stem cells (iPSCs) [6]. iPSCs shared the self renewal properties 
of ESCs and the ability to differentiate into other cell types,  without the ethical concerns 
surrounding ESCs.  
Recent recognition of the importance of the series of breakthroughs in stem cell research was 
acknowledged with the awarding of the 2012 Nobel prize for medicine and physiology to Sir 
John Gurdon, who first demonstrated the cloning of an adult frog, and Shinya Yamanaka [2]. 
Generating human iPSCs (hiPSCs) from patients is revolutionizing the field of regenerative 
medicine and disease modelling, with the potential to model almost any disease or genetic 
disorder [7].  
1.2. Stem cells and drug development 
The development cost of marketable drugs is continuing to grow reaching billions of pounds, 
with almost 90% of the drugs failing to get approved after clinical trials or are withdrawn from 
the market due to safety concerns [8]. The pharmaceutical industry therefore needs toxicity 
assays that can accurately evaluate the toxic/therapeutic potential of a drug during its 
development phase. Stem cells provide innovative tools for drug high-throughput screening 
(HTS) [8]. The ability to generate patient-specific human induced pluripotent stem cells also 
shows a great potential in individualizing drug testing [9]. However, in such stem cell-based 
toxicity assays, validation is essential in order to establish a reliable platform that can evaluate 





1.3. Impedance sensing and stem cells: Quantifying stem cell 
research 
 
The need for a non-invasive, quantitative technique that can monitor the differentiation process, 
growth kinetics and quality of stem cells is essential for determining the validity of stem cell-
based disease models and drug screening platforms.  Usually biochemical assays, including 
reverse transcription polymerase chain reaction (RT-PCR), western blotting and 
immunofluorescence assays, are used to determine the suitability of stem cells for disease 
modelling and to make sure that the required differentiation path is reached [10, 11]. However, 
these assays are end-point, invasive and time-consuming procedures. There is therefore a need 
for a non-invasive technique that can monitor stem cell-differentiation in real-time and validate 
stem cell-based disease models.  
Electric Cell-substrate Impedance Sensing (ECIS) is a non-invasive method that can 
quantitatively characterize cells and monitor changes in their cellular behaviour/morphology 
in real-time [12]. In this technique, a small alternating current (AC) is driven between a sensing 
(measuring) electrode and a larger counter electrode, and impedance measurements are 
recorded using a lock-in amplifier. As cells grow on top of the sensing electrode, they impede 
current flow resulting in an increase in the measured bioimpedance. Hence, any change in cell 
physiology can be interpreted from the impedance measurements. The impedance can also be 
analyzed and translated into biologically-relevant parameters describing cell-cell junctions, 
cell-electrode adhesion and cell membrane capacitance [13].  
Due to this non-invasive, real-time, quantitative nature, impedance sensing is increasingly 
being used to evaluate and characterize stem cell-based models [14, 15]. Impedance based 





high-throughput screening approach that can monitor cellular response to a test compound in 
real-time [16-18].  
1.4. The proposed disease models-on-a-chip: Aims and objectives 
The main aim of this research is to develop a platform, combining impedance spectroscopy 
with stem cells, to quantitatively model and examine disease kinetics and underlying 
mechanisms; and evaluate the therapeutic potential of drugs and new therapies.                               
In the current study, two stem cell-based disease models are proposed to investigate underlying 
mechanisms of drug-induced acute liver failure (ALF) and age-related macular degeneration 
(AMD). The non-invasive, real-time Electric Cell-substrate Impedance Sensing (ECIS) 
platform formed the basis of these disease models-on-a-chip; providing a quantitative method 
for the characterization of the diseases as well as the evaluation of therapeutic approaches. 
 The first disease model-on-a-chip presented in this work, employs a liver biochip approach 
where HepaRG cells, a bipotent human hepatic progenitor cell line, self-organize for 8 days, 
until they form a liver-like structure, directly on ECIS microelectrodes. The liver biochip has 
been used to monitor in real- time, via impedance measurements, dynamic changes in structural 
tight junctions and cell-substrate adhesions in response to the introduction of drugs and test 
compounds during the conducted hepatotoxicity studies.  
The second disease model-on-a-chip is for age-related macular degeneration. AMD is the main 
cause of blindness in the developed world affecting 500,000 patients in the UK alone [19, 20].  
Hence the need for disease models to fully investigate AMD incurable forms. An hiPSC-based 
disease model has been developed on ECIS microelectrodes. Induced pluripotent cells have 
been successfully derived from a patient with macular degeneration and one unaffected sibling. 
Patient’s fibroblasts were expanded and reprogrammed to a pluripotent state before being 





before being allowed to mature for an additional period of 3 weeks. Final RPE maturation was 
completed on the microelectrode arrays before investigating the regenerative abilities of the 
affected (case) and control cell lines using electrical wound healing assays. Figure 1.1 shows 
the basic steps towards the establishment of the AMD disease model on ECIS chips. 
The therapeutic potential of antioxidants and electrical stimulation on cell recovery has also 
been investigated. Moreover, microelectrode arrays, with different-sized, individually-
addressed electrodes with a higher spatial resolution than that of ECIS commercial electrodes, 
have been designed and fabricated in-house. 
 
Figure 1.1: Establishment of the hiPSC-based AMD model-on-a-chip. Patient’s fibroblasts were expanded 
and reprogrammed with Yamanaka factors to a pluripotent state before being differentiated to RPE. Cells were 
then plated on ECIS microarrays and allowed to mature. Figure modified from [2]. 
 
This thesis is divided into six main chapters and is organized as follows: 
Chapter 2: Literature Review 
This chapter provides the theoretical background behind this work. Advances in stem cell-
based disease models and therapeutic approaches are discussed. A brief description of the two 
diseases modelled in the current study is provided. Moreover, basics of electrical impedance 
spectroscopy and Electric Cell-Substrate Impedance Sensing are explained. Finally, 







Chapter 3:  Materials and Methods 
The methods, materials and culturing protocols used in this work are described. Microelectrode 
designs and fabrication processes are also illustrated. 
Chapter 4: Drug-induced injuries: Acute liver failure disease model-on-a-chip 
This chapter introduces a disease model-on-a-chip for drug-induced acute liver failure. The 
model integrates impedance sensing with the progenitor HepaRG cell line and is used to 
examine the kinetics behind drug-induced hepatotoxicity. Finally, differences between sub-
populations of the hepatic co-culture as reflected by impedance measurements are discussed.  
Chapter 5: Electrically-induced Injuries: An in vitro model-on-a-chip for AMD and 
degenerative diseases 
This chapter focuses on the study of cell migration and regeneration following an electrically-
induced injury. Electrical wound healing assays are employed to mimic the damage of retinal 
pigment epithelial cells in age-related macular degeneration. Electrical wounding is also used 
to investigate the migration abilities of the hepatic cell lines, HepaRG and C3A, in order to 
gain more insight into hepatocytes regeneration. Finally, the use of in-house fabricated 
microelectrode arrays, with different-sized, individually-addressed electrodes for ECIS 
measurements is demonstrated. 
Chapter 6: Towards a new therapy: Stimulation of wound healing 
This chapter examines the potential of two therapeutic approaches; drug-stimulation and 
electrical stimulation, on cell recovery and wound healing. The effect of antioxidants on cell 
recovery in drug-induced acute liver failure is explored. The potential of electrical stimulation 





allowing for radial electrical stimulation and integrating the stimulation platform with 
impedance sensing is proposed. 
Chapter 7: Discussion 
This chapter discusses the results obtained in this work. Some considerations and limitations 
surrounding the measurements are described. 
Chapter 8: Conclusions and Perspectives 
This chapter provides a summary of the current work and describes areas for future 













This chapter provides the theoretical background behind this work. Advances in disease 
modelling and therapeutics are discussed together with a brief description of the two diseases 
modelled in the current study: acute liver failure and age-related macular degeneration. The 
theory of electrical impedance spectroscopy, employed in this thesis to quantitatively monitor 
disease kinetics, is also described. Finally, a few design considerations and microelectrode 
fabrication methods are discussed. 
I. Advances in disease modelling 
 
In the current study, two stem cell-based disease models-on-a-chip are proposed to investigate 
underlying mechanisms of drug-induced acute liver failure (ALF) and age-related macular 
degeneration (AMD). This section describes advances in disease modelling and therapeutics. 
A brief description of ALF and AMD is also provided. 
2.1. Stem cell-based disease models 
 
Disease models have become essential tools for investigating underlying mechanisms of 
diseases, making them a vital platform for drug development and novel therapies [9]. Animal-
based disease models have been widely used for many years. However, many diseases are 
species-specific and animal models cannot fully reflect the human behaviour in these cases [7]. 




has been attributed to this behavioural difference [9]. Ethical issues are also associated with 
animal studies, especially when toxicity assays and drug development are involved. In vitro 
cell-based disease models overcome these problems allowing for relevant models and, with the 
exception of embryonic stem cells, without the surrounding ethical issues [7, 21]. Primary 
human cells are still the preferred cell type for physiologically relevant disease models. 
However, primary cells are limited, expensive and difficult to obtain and culture [2]. For that 
reason, immortalized cell lines have predominated cell-based disease models, despite that in 
many cases they do not accurately reflect the in vivo behaviour [2, 9].  
Due to their self-renewal properties, their ability to differentiate into various physiologically 
relevant cell types and their unlimited proliferation capacity, stem cells play a major role in 
therapeutic and regenerative medicine [2, 22]. Recently, stem cells have been widely used in 
disease modelling as an alternative to primary human cells, animal cells and transformed cells 
[22, 23]. In 2006, a breakthrough in regenerative medicine was achieved when the Nobel 
laureate, Shinya Yamanaka [6], was able to reprogramme somatic (adult) cells, transforming 
them back into stem cells. Generation of patient-specific human induced pluripotent stem cells 
(hiPSCs) offers a new paradigm for disease modelling and for individualizing drug testing [9]. 
In this work, two stem cell based-disease models are proposed for acute liver failure and age-
related macular degeneration. The general mechanisms underlying these two diseases are 
explained in the following sub-sections. 
2.1.1. Acute liver failure 
 
Acute liver failure (ALF) is a rare but life-threatening critical illness that occurs most often in 
patients who do not have a pre-existing liver disease [24]. Drug-induced liver injury (DILI) is 




acetaminophen and acetyl-para-aminophenol (APAP)) toxicity was found to be the leading 
cause of drug induced ALF [25]. Well-described biochemical endpoint assays of APAP 
overdose show various intrinsic pathophysiological mechanisms from the depletion of the 
high-enegry phosphate (Adenosine triphosphate, ATP) that is required for many cellular 
processes, to mitochondrial dysfunction and oxidative stress. This eventually results in an 
unprogrammed (necrotic) cell death through physical disruption of cellular and liver 
architecture [26, 27].  
Normal liver architecture is maintained by establishment of functional hepatic polarity arising 
from spatial structural and functional differences between apical and basolateral membranes as 
illustrated in Figure 2.1 and described in more detail in Appendix A [28, 29]. Cell-cell junctions 
and cell-substrate adhesion play a crucial role in preserving such polarity. Hepatic tight 
junctions (TJs) maintain the structural polarity essential for bile secretion, drug transporters 
and the expression of the detox enzymes cytochrome P450 (CYP450) [30]. Cell adhesion sites 
on the other hand connect the cytoskeleton to the extracellular matrix (ECM), and serve to 
modulate many aspects of cell behaviour including survival/apoptosis, differentiation, and 
polarity [31, 32]. Moreover, chemical disruption of adhesion sites can also have profound 
effects on the functioning of the liver. Cholestatic drugs, which induce leaky TJs, can generate 
toxic mechanisms (similar to APAP) in HepaRG cells [33, 34]. For instance, chlorpromazine 
has been shown to destabilize intercellular TJs; while phorbol-ester is known to disrupt TJ 
integrity and cell polarity in the hepatic cell line HepG2 [35].  Despite of the vital roles played 
by TJs and cell adhesion in sustaining many hepatic functions, temporal and quantitative effects 
of direct APAP toxicity on adhesion structures have not been previously explored, hindered by 





Figure 2.1: Hepatic Polarity. A schematic diagram showing the structural differences between hepatic apical 
and basal membranes. The red lines represent the hepatic cell-cell tight junctions. 
 
Conventional 2D cultures for drug safety testing using rodent or human immortalized hepatic 
cell lines such as HepG2, Fa2N4 or HuH7 lack the functionality of primary human hepatocytes 
(PHHs) and are not representative of normal liver tissue. Although PHHs are still preferred for 
in vitro prediction of drug hepatotoxicity, they rapidly lose polarity and exhibit phenotypic 
instability, besides their limited supply [36].  Human hepatocyte-like cells (HLCs) generated 
using pluripotent stem cell (PSC) technologies have been put forward as potential hepatic 
models for drug discovery [37]. However, current PSC-differentiation protocols produce 
monolayers of HLCs with fetal phenotype. Also, compared with PHHs, HLCs exhibit reduced 
hepatic gene expression and CYP450 enzyme levels [38]. An alternative to PHHs increasingly 
used in hepatotoxicity testing, is the hepatic HepaRG progenitor (tissue-specific stem cells) 
cell line, which is able to differentiate to HLCs and biliary-like epithelial cells (BECs) [31, 39, 
40]. HepaRGs are a uniquely stable, highly-differentiated hepatocyte:cholangiocyte co-culture 
model, which maintain in vivo-like liver-specific functions, including drug metabolism, lipid 
metabolism, and mitochondrial phenotype for several weeks [38, 41]. HepaRGs are used in 





2.1.2. Age-related macular degeneration 
 
Age-related macular degeneration (AMD) is the most common cause of blindness in the 
developed world [19, 42]. The disease usually affects patients in their seventh and eighth 
decades resulting in the loss of functionally important central vision. There are two main forms 
of the disease; wet AMD, in which sub-retinal vascular leakage predominates and dry AMD in 
which the formation of drusen (lipid and fatty protein deposits) and cell degeneration are the 
primary disease processes [42].  Although treatments have recently been developed for wet 
AMD, there is currently no effective treatment for dry AMD.   
The Retinal Pigment Epithelium (RPE) is a pigmented, polygonal monolayer of cells found 
directly below the photoreceptor layer in the retina (for more detail on the retinal structure and 
RPE functions, see Appendix B [43-45]). The primary role of the RPE is in maintaining 
photoreceptor homeostasis. RPE dysfunction, degeneration and reduced repair are implicated 
in the AMD disease process [46, 47].  In normal ageing, RPE cell loss is compensated for by 
increasing cell size and migration of neighbouring RPE [48]. In AMD however, healing is 
hampered leading to problems such as incomplete RPE coverage and the consequent death of 
overlying photoreceptors.  
Late onset retinal macular degeneration (LORMD) is a rare form of macular degeneration. It 
is an autosomal dominant disease in which the abnormal gene dominates, i.e. the patient can 
get the disease even if the abnormal gene is inherited from only one parent [49]. LORMD 
results from a mutation in the gene encoding the protein C1QTNF5 [50].  The complete 
function of C1QTNF5 is currently unknown. However, it is suggested to play a role in cell 
adhesion between the RPE layer and the underlying basement membrane [51]. LORMD shares 
key clinical and pathological features with AMD including dark adaptation delay, drusenoid 




it has been proposed as a good model for AMD [52].  
In vitro RPE models are required to investigate the underlying mechanisms associated with 
AMD. Primary human RPE cell lines will be the cells of choice in many research labs due to 
their physiological behaviour if not for their previously mentioned difficulties to obtain and 
culture. Hence immortalized cell lines are still predominant in AMD research. Recent 
developments enable the generation of RPE cells derived from patients (hiPSC-RPE)  [53, 54], 
thus allowing in vitro studies of human retinal disease that have a great clinical and 
physiological relevance. In the macular degeneration disease model proposed in this work, 
hiPSC-RPE case and control cell lines, used to model RPE loss accompanying the disease, 
have been derived from a patient with LORMD and one of his unaffected siblings respectively 
[55].  
2.2. Automated quantitative assays for disease modelling 
 
While biochemical assays remain the gold standard for detecting, quantifying and studying 
various cellular behaviours, the invasive nature of these assays results in the destruction of the 
sample under investigation. These traditional methods are normally performed at one time 
point, missing any changes in cellular behaviour over time. Impedance sensing overcomes 
these problems. Being a label-free, non-invasive technique allows for measurements to be 
performed on live cells. The measurements are also done in real-time and for long periods. 
Impedance sensing can therefore monitor kinetics of cellular behaviour and changes in 
morphology over time and is in that sense particularly useful to monitor processes like wound 
healing, stem cell differentiation and cytotoxicity assays [56]. Impedance sensing has been 
employed in this study to establish fully automated, quantitative stem cell-based disease models 




drug-induced liver injuries and electrically-induced retinal injuries have been used to model 
the two diseases.  
2.2.1. Drug-induced injuries 
 
Adverse drug reactions (ADRs) are a major issue for the pharmaceutical industry and public 
health, and are a frequent cause of both failure of drug approval and withdrawal. As the liver 
is bound to be the most affected during drug metabolism, drug-induced-liver-injury (DILI) is 
the most prominent reason for a  drug to be withdrawn from the market [17, 18, 57, 58].  
During the drug development process, cell-based assays are a key tool to support the selection 
of safe drug candidates before entering animal testing [57, 59]. Biochemical methods, such as 
the MTT (tetrazolium dye) assay [60], the neutral red uptake assay [61], and ATP (adenosine 
triphosphate) measurement [62], are widely used in hepatotoxicity screening assays. However, 
these traditional biochemical assays are time consuming, requiring complex steps with multiple 
reagents at every prescheduled time point. Moreover, the information provided is usually 
limited to the time points investigated, disregarding the kinetics of the effects [63]. Impedance-
based cellular assays (IBCAs) can overcome this problem. IBCAs are an emerging technology 
in drug discovery due to their high sensitivity, non-invasive and quantitative nature. An 
impedance-based assay could provide a high-throughput screening (HTS) approach that can 
monitor changes in cell morphology and behaviour in response to a test compound in real-time 
[16-18]. Impedance measurements can therefore be used to examine the temporal interaction 
of the tested compounds with cells; creating distinct profiles for drug kinetics and toxicity 
mechanisms [64]. In a study by Kustermann et al. [59], impedance-based time-dependent cell 
response profiles (TCRPs) were used to establish different impedance profiles allowing for the 
differentiation between cytostatic and cytotoxic drugs through recording and analyzing 




Commercial as well as non-commercial impedance-based systems have been employed for 
cytotoxicity assays with many of them focusing on hepatotoxicity studies [65, 66]. Platforms 
like xCELLigence [67] and Electric Cell-Substrate Impedance Sensing (ECIS) [66] have been 
used to investigate the effects of various drugs and compounds on different cell types including 
hepatocytes [17, 57], cardiomycocytes [67], fibroblasts [68, 69] and cancerous cells [70]. 
Further drug effects have been explored using the Bionas platform. Ehret et al. [71] for instance 
demonstrated the effect of APAP on decreasing metabolism, the increase of acidification rates 
and decrease in oxygen consumption in liver cells using the Bionas Discovery device. The 
working principles behind some commercial platforms are described in Section 2.7. 
It has to be mentioned that the majority of impedance-based toxicity studies have not made use 
of the full capability of impedance measurements. A decline in impedance, or cell index as 
measured by the xCELLigence system, is not necessarily a reflection of cell death, but could 
be due to a disruption of tight junctions, cell adhesion or a change in morphology. Using 
mathematical models, similar to the ECIS built-in model (Section 2.7.1.1), to further analyze 
the measurements, allows for a more accurate data interpretation and a deeper insight into the 
mechanisms of drugs/compounds. 
In this study, an impedance-based liver-on-a-chip model has been developed. The highly-
differentiated human hepatic cell line HepaRG has been combined with impedance sensing 
microelectrode arrays to profile real-time changes in the cellular impedance in response to 
model hepatotoxins. Moreover, the impedance measurements were deconvolved into 
parameters defining tight junctions, cell-substrate adhesion and cell membrane capacitance 





2.2.2. Electrically-induced injuries 
 
Degenerative diseases are characterized by loss of cell regenerative abilities leading to a 
deterioration of tissue structure. In macular degeneration for instance, the loss of RPE ability 
to regenerate and heal after wounding is a characteristic symptom of the disease [46].  There is 
therefore a pressing need for wound healing and cell migration models for cell regenerative 
studies, to allow for a better understanding and uncover unknown mechanisms underlying 
degeneration. 
There are various in vitro cell migration assays for wound healing and regenerative studies [72, 
73]. The most commonly used is the traditional mechanical, scratching, assay where usually a 
fine pipette tip is used to scratch (wound) the cell layer before allowing the cells to migrate and 
recover [74, 75]. Scratching however does not produce a highly repeatable wound; a 
disadvantage that can be overcome by stamping. Stamping is another mechanical wounding 
assay where a physical stamp of defined geometry is used to create the wound [76]. Stamping, 
as well as scratching, can however disrupt the ECM layer as well as form debris that might 
affect the migration process.  
Fencing, also known as gap closure assays, can be used to produce cell free regions where cell 
migration can be monitored after removing a solid [77], liquid [78] or gel barrier [79]. Cells 
grow around the physical barrier and then start migrating once it is removed. However, the lack 
of signalling from wounded cells as well as the absence of ECM proteins in the cell free regions 
does not really reflect what happens in vivo.  Other wounding techniques include chemical [80] 
and optical methods [81, 82]. Recently, microfluidic channels have also been used for 
migration assays by using chemicals to produce a wound in a cell monolayer or through 
defining migration paths for the cells [78]. Zhang et al. combined microfluidics with a physical 




mesenchymal stem cells towards tumor cells [83]. However, most of the above methods require 
extensive manipulation of the cell layer during both wounding as well as repair processes. 
Moreover, problems of quantification and reproducibility occur due to the difficulty of 
controlling the wounded areas. 
Studies combining electrical wounding with impedance spectroscopy overcome this problem; 
as electrical wounding can produce well-defined repeatable wounds, while impedance sensing 
provides a quantitative, high throughput, real-time measurement of the healing process. 
Electric Cell-substarte Impedance Sensing (ECIS) is an impedance-based platform where cells 
are directly cultured on ECIS microelectrodes and the changes in impedance measurements are 
recorded in real-time. Because biological cells act as insulators, attachment of cells on top of 
ECIS arrays is accompanied by an increase in impedance. ECIS measurements are therefore a 
reflection of changes in cell behaviour or morphology (See Section 2.7.1). 
In ECIS wounding assays, an elevated current pulse (0.1 mA- 3 mA) is used to wound the 
confluent cell monolayer through severe irreversible electroporation. The system then switches 
back to its normal operation where a small (1 μA) non-invasive current is used and the 
impedance is monitored while cells migrate to repopulate the electrodes [84]. The wound 
healing/migration rate represents the time taken by the cells to repopulate the electrode and is 
calculated according to Equation (3.1) described in Chapter 3.  Figure 2.2 shows the basic 






Figure 2.2: ECIS wound healing assay. (a) A schematic diagram showing the basic principle behind ECIS 
impedance measurements. Impedance (represented by the blue graph) increases when cells (blue) attach and 
spread onto the electrode (gold), reaching a plateau when a confluent layer is formed. (b) A schematic diagram 
describing the change in impedance measurements with ECIS electrical wounding. When a wounding pulse (red 
arrows) is applied to the confluent cell layer, the impedance drops to that of the cell-free level. With cell recovery, 
the impedance increases to reach a plateau when healing is achieved after a healing time (t).   
  
The huge potential of ECIS electrical wounding assays in cell migration studies is undeniable. 
However, an efficient migration assay depends to a great extent on the wounding parameters 
used. A major drawback of ECIS electrical wounding is that arriving at such parameters is 
normally achieved through trial and error experiments, during which electrode damage or 
incomplete cell death and detachment might occur. 
The ECIS platform has introduced another technique for cell migration studies known as the 
electric fence. This method is in essence similar to gap closure assays. Instead of using physical 
barriers to create a cell-free region, high electric pulses are applied before cell inoculation to 
prevent cell growth over the electrodes while cells spread and form a confluent layer in the rest 
of the culture well. This produces a clean electrode on which the cells can migrate and 
repopulate once the "electric fence" is switched off (Figure 2.3). Although the electric fence 
method has the advantage over electrical wounding of not requiring trial and error experiments, 
one can argue that cell migration assays based on electric fencing, like with any gap closure 





Figure 2.3: ECIS electric fence. A schematic diagram showing the principle underlying electric fencing. 
Elevated current pulses (red arrows) are applied to the electrodes before cell seeding. Cells (blue) grow around 
the electrode (gold) but not on top of it, creating an area empty of cells in the culture well (light blue rectangle). 
When the fence is off, the cells start to spread onto the electrode. The graph represents the changes in the 
impedance measurements accompanying the fencing process. t represents the time taken for cells to migrate after 
switching off the fence until a confluent cell layer is formed, reflected by the steady  plateau formation. 
 
Initially, ECIS cell migration studies used direct current (DC) wounding pulses [85, 86]. 
However, using a DC signal for wounding was a challenging, uncontrollable process as 
reported by Giaever and Keese [84]. These limitations were behind the present use of 
alternating current (AC) in ECIS electrical wounding. Keese et al. were the first to use AC 
pulses to perform wound healing assays on BS-C-1 (African green monkey kidney cells), NRK 
(normal rat kidney cells) and MDCK (Madin–Darby canine kidney cells) [84]. Ever since this 
study, ECIS has been intensively used to study wound repair as well as to investigate the effects 
of various factors on the healing process. The effects of various cytokines, kinases, adhesion 
proteins and signalling pathways on cell migration [87-93] and wound healing in the eye [94, 
95], the airway epithelium [96-100], chronic wounds [101, 102], and cancer metastasis [103-
112] have all been investigated. Moreover, there have been studies on the effect of negative 
pressure [113], radiation therapy [114] and specific medicines on migration and angiogenesis 




In the current study, the need for a physiologically relevant in vitro model of RPE layer repair 
that can be investigated quantitatively and reproducibly has been addressed through developing 
a tissue-on-a-chip approach. After establishing the hiPSC-RPE model on ECIS microelectrode 
arrays, an electrical wound healing assay was used to mimic RPE cell damage in both control 
and diseased hiPSC-RPE cell lines to study differences in cell migration abilities and repair. 
2.3.  Quantitative stem cell research 
 
The need for a non-invasive, quantitative technique that can monitor the differentiation process, 
growth kinetics and quality of stem cells is essential for determining the validity of stem cell-
based disease models.  Whether the stem cells under investigation are embryonic (ESCs) or 
induced-pluripotent stem cells (iPSCs),  with multi- or tissue specific- potency (progenitor 
cells)   [117], quality control measures are required to define suitability for disease modelling 
[118, 119]. Biochemical assays including reverse transcription polymerase chain reaction (RT-
PCR), western blotting and immunofluorescence assays, are usually used to make sure that the 
required differentiation path is reached [10, 11]. However, these assays are labour intensive, 
time consuming, end-point invasive procedures that destroy the cells under investigation. Due 
to its non-invasive, real-time, quantitative, automated nature, impedance sensing is 
increasingly used in the validation and characterization of stem cell-based models [14, 15]. 
Cho and Thielecke [120] were the first to use impedance spectroscopy to study and characterize 
growth of human mesenchymal stem cells (hMSCs). Following this study, impedance 
spectroscopy has been used to explore different aspects of stem cell research with many studies 
focusing on the kinetics of stem cell differentiation. Differentiation of stem cells is associated 
with a change in cell morphology, proliferation capacity and dielectric properties [121]. 
Impedance spectroscopy can detect these changes, defining distinctive impedance profiles for 




measurements with the differentiation of human mesenchymal stem cells (hMSCs) towards 
osteoblasts [11], using a planar 1mm diameter platinum electrode-based chip. This rise in 
resistance was accompanied by a change in morphology from fibroblastic-like to a cuboidal 
morphology. Commercial platforms have also been used to monitor adipogenic vs. osteogenic 
differentiation. Angstmann et al. [122] used the two commercial systems ECIS and 
xCELLigence to examine differences in early phases of MSCs differentiation towards 
adipocytes and osteoblasts, while Kramer et al. have used xCELLigence to study adipogenesis 
of the preadipocytes 3T3-L1 cells [123]. In agreement with the previous studies, there was a 
drop in the measurements with adipogenesis while differentiation towards osteoblasts showed 
an increase in the measured values.  
There are several factors that lead to the changes in impedance measurements during stem cell 
differentiation, including cell size and morphology changes. Differentiation towards certain 
cell types is associated with a decrease in size. In this case, a decrease in the measured 
impedance is expected simply because more gaps are expected to occur between adjacent cells 
where the current can pass through. However, in the case of osteogenic differentiation there is 
a significant increase in impedance associated with a decrease in cell size [11]. This can be 
attributed to mineralization and to the tight cell-cell junctions, forming a barrier that impedes 
the applied current [122, 124].  
Another factor affecting impedance measurements during stem cell differentiation is cell-
substrate adhesion. Changes in cell adhesion mechanisms and the amounts of secreted ECM 
proteins have been shown to affect cell morphology and function, which could in turn affect 
the differentiation process [125, 126]. Maercker et al. [127] have developed live cell chips to 
monitor cell adhesion as a marker of MSC differentiation. Cells were grown on electrode arrays 
for impedance measurements that reflected changes in cell adhesion. After stem cell 




was achieved, biochemical assays showed that the adhesion proteins had increased and 
translocated within the cells. 
Cell-adhesion, cell-cell tight junctions as well as the integrity of cell plasma membranes can 
all be non-invasively assessed through further analysis and modelling of impedance data. 
Impedance modelling can therefore be used to provide further differentiation markers without 
the need for any biochemical assays. Bagnaninchi and Drummond [124] have used ECIS 
modelling to distinguish between osteogenic and adipogenic differentiation of adult stem cells 
(ADSCs). They reported an increase in the impedance measurements with the osteo-induced 
ADSCs that was also accompanied by an increase in tightness of the cell-cell junctions as 
indicated by the ECIS built-in model. On the other hand, the adipo-induced cells showed a drop 
in the impedance measurements and looseness in cell-cell junctions. A variation in dielectric 
properties between the two differentiation paths was also monitored as indicated by the higher 
cell membrane capacitance measured for the adipo-induced cells. Changes in dielectric 
properties accompanying stem cell differentiation towards adipocytes was also reported by Lee 
et al. [15]. They reported that a change in the average dielectric constant of adipocytes occurred 
during the differentiation process, which was related to lipid vacuoles accumulation. 
It is worth noticing that impedance sensing is not entirely well-suited to monitor the 
differentiation process of all stem cell types. The use of impedance sensing to monitor neuronal 
and human embryonic stem cells differentiation has proven to be challenging. Neurons do not 
reach confluence when forming neuronal networks [128] and there will always be parts of the 
network not sensed by the electrodes. hESCs are known to grow in flat colonies [129], making 
the measurement impossible if the cells are away from the electrodes. In these cases, it is 
recommended to use interdigitated electrodes [10, 130] due to their ability to cover a wider 





In the current study, the maturation of the HepaRG cell line and the establishment of a co-
culture has been confirmed using impedance measurements before any hepatotoxicity assays 
were conducted. In the proposed AMD model, ECIS has been used to distinguish between the 
differentiation and maturation kinetics of the case and control hiPSC-RPE cell lines.  
2.4. Therapeutic approaches 
 
In this work, the proposed disease models-on-a-chip has been used to investigate therapeutic 
approaches to stimulate cell recovery. This section describes the two approaches used; namely 
drug stimulation and electrical stimulation. 
2.4.1. Drug stimulation 
 
Oxidative stress occurs due to the imbalance between reactive oxygen species (ROS) 
production and antioxidant defences, causing damage to a wide range of molecular species 
such as lipids, proteins and nucleic acids [131]. Oxidative stress has been implicated in 
different diseases including chronic wounds, neurodegenerative diseases, diabetes and cancer 
[131, 132]. Oxidative damage has also been linked to hepatotoxicity and liver failure caused 
by acetaminophen as well as other cholestatic drugs [133]. 
The retina is particularly susceptible to oxidative stress because of its high consumption of 
oxygen and its exposure to visible light [134]. Moreover, the amount of antioxidants present in 
the retina was found to degrade with age giving rise to high concentrations of ROS [135]. 
Hence, the role of oxidative stress in age-related retinal diseases like AMD [136, 137].   
Antioxidants have attracted a wide interest recently, with many studies focusing on their 
protective and therapeutic potentials of ROS-dependent diseases. N-acetylcysteine (NAC), an 
ROS scavenger and the precursor of the detoxifying enzyme glutathione (GSH), has been 




approved by the Food and Drug Administration (FDA) for treatment of acetaminophen 
overdose. The use of NAC is not limited to the treatment of paracetamol toxicity though. In a 
study on citreoviridin cytotoxicity, Liu et al. [138] have indicated that citreoviridin-induced 
cell death was ROS-dependent and that pre-treating hepatocytes (HepG2) with NAC, reversed 
citreoviridin toxic effects. In a different study, NAC was shown to have an anti-inflammatory 
effect preventing apoptosis and completely abolishing acute fulminant liver failure (FLF) in 
mice [139]. 
 NAC has also shown a promising effect on treating retinal diseases as it minimized the 
oxidative stress associated with diabetic retinopathy and AMD [140]. The novel thiol 
antioxidant, N-acetylcysteine amide (NACA), has been reported to be more effective than its 
parent compound, NAC. This was attributed to the increased ability of NACA to permeate cell 
membranes and the blood brain barrier due to its neutral carboxyl group. In vitro and in vivo 
experiments on rodents and human cells suggested that NACA may be a novel treatment for 
AMD and other retinal diseases [136]. 
In the current study, NAC has been used in an attempt to stimulate cell recovery after 
paracetamol-induced injuries in HepaRGs. The effect of oxidative stress on hiPSC-RPE 
migration followed by NAC treatment has also been explored. 
2.4.2. Electrical Stimulation 
2.4.2.1.  Endogeneous Electric Fields 
 
The existence of endogenous direct current electric fields (DC EF) within biological tissues 
has been known for more than two centuries [141]. In the late 1700s, Galvani's experiments on 
frog preparations provided proof for the existence of what he termed animal electricity, and is 
now referred to as bioelectricity [142-144]. In 1794, Galvani also demonstrated the existence 




other leg to contract upon touching [142-144]. Based on this pioneering work, Matteucci 
measured injury potentials at the cut end of nerves and muscles using a galvanometer in 1831 
[142]. Twelve years later, Emil Du-Bois Reymond, the founder of modern electrophysiology, 
was able to measure a current of 1A flowing out of a cut in his own finger, another evidence 
for the existence of injury potentials [145].  
DC electric fields exist within tissues due to spatial variations in the functioning of ion pumps, 
or leaks across individual cells or layers of cells, such as an ion-transporting epithelium. The 
resulting ionic gradients drive extracellular ionic current flow, establishing the voltage 
gradients [141, 146]. How the cells sense these gradients and how they respond to the 
corresponding electric fields is a complicated, not fully understood process. The immediate 
target of electric fields is likely to be the plasma membrane [145, 147, 148]. The EF has been 
proposed to redistribute integrins, charged lipid and protein molecules within the plasma 
membrane or modify the membrane potential at the ends of the cell facing the poles of the 
electric field [145]. It is suggested that electric fields also cause a redistribution of receptors 
and activate polarized signaling pathways specially of PI3K (Phosphoinositide 3-kinase), 
which was found to have a critical role in mediating EF-directed cell migration [149-151]. Ca2+ 
is known to regulate processes such as signal transduction, cytoskeletal reorganization, cell 
orientation, migration, cell differentiation and proliferation [148]. A significant increase in 
Ca2+ concentration in the presence of an externally applied EF has been reported suggesting a 
role for Ca2+ in EF-induced cellular responses [145, 152].  
2.4.2.2. Mimicking Bioelectricity: Set ups and techniques  
 
Vibrating probes and glass microelectrodes have been used to measure and confirm the 
presence of endogenous EFs in vitro [141, 145, 147]. In vivo, microneedle arrays have been 




electric potential at skin surface with no direct skin contact have been reported using the Bio-
Electric Imager [154].  
Electrotaxis chambers, also known as galvanotaxis chambers, are in vitro systems that apply 
external EFs and investigate their effects on various cellular processes [145]. The name refers 
to the electrotaxis phenomenon where an electric field is used to direct cell migration. In this 
set up (Figure 2.4), cells are usually cultured inside a petri-dish and glass coverslips are used 
to form a lid creating a thin chamber (~ 400 m deep) of well-defined geometry. This allows 
for an accurate calculation of the imposed EFs, while the small volume allows for fast heat 
dissipation keeping Joule heating inside the chamber at a minimum [155]. EF application is 
performed using a DC power supply and agar salt-bridges in order to connect the metal 
electrodes to the culture medium while keeping any harmful electrode products away from the 
cells [145, 155].  
 
 
Figure 2.4: Electrotaxis chamber. A schematic diagram showing the general set up of an electrotaxis 
(galvanotaxis) chamber. The set up consists of a DC power supply, 2 metal electrodes, 2 beakers filled with a 
conductive salt solution, 2 agar salt bridges and a petri-dish where the cells are cultured.  The agar bridges are 
used to connect the EF to the cell culture while keeping the cells away from any possible harmful electrode 





 Recently, microfluidic channels have replaced petri-dishes of the traditional galvanotaxis 
chambers [95, 152, 156-161]. Moreover, complex microfluidic networks with interconnecting 
segments have been used to create multiple electric field strengths while providing a uniform 
flow field on the same chip [162]. In this work, a commercial microfluidic channel has been 
used to investigate the effects of an externally applied DC EF on RPE migration. Ag/AgCl has 
been used as the electrode material while agar bridges connected the EF to the cell culture 
inside the microchannel.  
2.4.2.3. EF physiological role  
 
Bioelectricity plays a major role in various cellular processes from cell cycle, cell division, 
differentiation, cell proliferation and migration to the establishment of left-right body 
asymmetry in fetal development [141, 145, 147, 148]. Endogenous EFs therefore affect 
multiple cell behaviours including embryonic development [163], wound healing [147, 164], 
nerve sprouting [165, 166], spinal-cord repair [167, 168], as well as cancer cell migration in 
metastasis [169-172].  
i. EFs and Wound Healing 
 
An injury potential is a DC voltage gradient that is induced within the extracellular and 
intracellular spaces by current flowing into and around an injury [145]. In epithelia, a 
transepithelial potential (TEP) occurs due to the directional transportation of ions causing a 
difference in net charge between the apical and basal epithelial sides. This is also coupled with 
the high resistance established by the sealing action of cell-cell tight junctions. As shown in 
Figure 2.5, in wounded epithelia, the potential drops at the wound site while remaining the 
same at distant areas. Potential gradients drive the electric current flow towards the wound 




wound EF [147]. Injury potential gradients are normally in the order of tens of millivolts. EFs 
varying from 42 mV/mm in cornea wounds to 140 mV/mm at skin wounds in humans have 
been reported [141, 145, 147, 148]. It is worth mentioning that the measured injury potentials 
were found to vary both spatially and temporally [147]. The current flowing out of a wound 
varies spatially, having the strongest magnitude at the wound edge. The magnitude of the 
electric current changes with time as well. Currents at skin and cornea wounds were found to 
gradually increase during the first 1-2 hours after wounding and persist during the healing 
process before decreasing again when healing is achieved [173-175].  
Injury EFs act as a directional cue directing cells to migrate into the wound during the healing 
process, thus playing a major role in wound repair [5, 145, 147]. Song et al. have demonstrated 
the importance of endogenous EFs in healing. Through inhibiting the transportation of ions 
using ouabain, benzamil and furosemid, a significant decrease in TEP, and in turn the induced 
wound EF, was monitored. This led to a delay in wound healing in a dose dependent manner 





Figure 2.5: Transepithelial and injury potentials. (a) A schematic diagram showing the presence of a 
transepithelial potential between the apical and basal layers of an epidermal epithelium. (b) A cross section of the 
basolateral cuboidal  layer showing the directional transportation of Na+ and K+ ions, causing a difference in net 
charge and coupled with the sealing action of cell-cell junctions to maintain TEP. (c) In injured epithelia, a low 
resistance path is created allowing Na+ ions to flow outside of the wound, short-circuiting the TEP and generating 
an injury current. The TEP is not affected away from the wound however, and therefore an EF is established 
directing cell migration into the wounded area.  Figure modified from [177]. 
 
EFs are suggested to play an overriding guidance role in directing cell migration in epithelial 
wound healing. Zhao et al. [173] have investigated the effect of applied EFs on wound healing 
in the presence of other co-existing chemical cues. It was found that EFs of physiological 
strengths were able to direct cell migration overriding other cues. According to the polarity of 
the applied EF, wound healing was either enhanced or impaired if applied in the opposite 
direction to that of the healing vector. EFs as low as 25 mV/mm with reverse polarity caused 
the wound to open up as cells migrated directionally away from the wound under the influence 




Cell division, nerve sprouting and endothelial migration are all important elements in wound 
healing. Electric fields have been shown to control and direct these behaviours. Song et al. 
[178] have used drugs to manipulate ion transport affecting endogenous wound EFs. They 
demonstrated that an increase in these EFs caused an increase in cell division in wounded 
corneal epithelium by almost 40% with more nerves sprouting towards the wound. On the other 
hand, reducing the endogenous EFs decreased the rate of cell division as well as the directional 
nerve sprouting towards the wound edge [178].   
Immune cell migration is a fundamental process in wound healing that could be compromised 
in chronic wounds. The effect of applied EFs on immune cell migration has been investigated 
by Li et al. In one of their studies on lymphocytes [179], they used microfluidic devices with 
integrated on-chip electrodes to demonstrate the cathodal migration of human blood T-cells 
when activated by antibodies. In another study, they showed the consistent electrotactic 
cathodal T-cell migration even in complex co-existing electrical and chemical guiding cues 
[180]. Electrotaxis can therefore be used as a guiding tool to direct migration of immune cells 
and assist in the wound healing process. 
Impaired re-epithelialization due to defective cell migration into the wound is a characteristic 
symptom of chronic wounds associated with diabetic and pressure ulcers, as well as 
degenerative diseases [181]. The application of electrical signals to promote cell migration in 
such cases could form a new therapeutic platform. The role of EFs in retinal injury and retinal 
degeneration has been the subject of many studies. Migration of human and immortalized 
retinal pigment epithelium cell lines has been thoroughly investigated by various groups. 
Gamboa et al. have studied the effect of different field strengths (50-600 mV/mm) on the 
migration of wounded RPE cell layers as well as single cells [182]. In their studies, RPE cells 




anode. While the same RPE reorientation behaviour was noticed by other groups, the direction 
of the reported RPE migration varied. For instance, Sulik et al. [183] and Han et al. [184] 
reported the cathodal migration of human RPE. Different cell types exhibit varying migration 
capabilities and the different electrotactic response between different cell lines and even 
between cells originating from the same tissue has been reported. Cells derived from the same 
tissue have been found to migrate in opposite direction or even fail to migrate directionally at 
all [185, 186]. These opposite responses indicate that the effects of EFs on cells are cell-type 
and species specific, and therefore cell electrotactic response needs to be established 
experimentally on an individual basis. 
ii. EFs and Stem cell research 
 
Stem cells have a great potential in the treatment of several degenerative diseases [187]. 
However, directing and homing of transplanted stem cells towards the targeted organ is key to 
a successful therapy [161]. Using externally applied EFs to guide the migration of stem cells 
could be a solution to such a problem; especially after the reports on successful trials in 
directing stem cell migration [161].  
Due to their huge promise in neuroregenerative studies and the repair of the central nervous 
system, a lot of research has been dedicated towards guiding the migration of neural stem and 
progenitor cells [188, 189]. Neural stem cells (NSCs) as well as neural progenitor cells (NPCs) 
have both been shown to possess a galvanotactic behaviour in the presence of a DC EF [146].  
Feng et al. [190] have shown that even a small DC EF as low as 16 mV/mm induced a 
significant directional migration of human NSCs towards the cathode. They also demonstrated 
that this electrotactic response was time and voltage dependent, and that reversing the polarity 




cathodal migration of NPCs in externally applied DC EFs [188, 191]. The electrotactic 
behaviour of other stem cell types has also been reported [161].  
2.4.2.4. Electrical stimulation therapeutic potential 
 
Electrical stimulation has shown promising results in in vivo treatment of various diseases 
including cancer [192-195], chronic wounds [196] and spinal cord injuries [167, 168, 197].  
In 2002, electrical stimulation was approved in the United States, for the treatment of chronic 
wounds and ulcers that do not respond to standard wound healing strategies [196]. Direct 
currents [198-200], high- or low-voltage pulsed currents [201], alternative currents [202], and 
low-intensity currents (less than 1mA) [196], have all been used in the treatment of diabetic, 
pressure and other chronic ulcers [203]. Reversal of polarity of the applied current has also 
been studied [198, 201]. Varying successes have been reported and more trials are still needed 
to arrive at accepted protocols for applying electrical stimulation for wound healing. 
In this work, preliminary results show that electrical stimulation can direct the migration of 
RPE cells as well as control their alignment. The potential of using electrical stimulation to 
enhance cell recovery in AMD is discussed. 
II. Impedance Spectroscopy of Adherent cells 
2.5. Dielectric properties of biological tissues 
 
The dielectric properties of cells and biological tissues are mainly attributed to interfacial 
polarization [204, 205]. This form of polarization, often referred to as the Maxwell-Wagner 
effect, occurs due to the accumulation of charges between interfaces with different dielectric 
properties as shown in Figure 2.6 [206, 207]. Cell membranes play a major role in interfacial 




cytoplasm and the external medium [204, 207]. 
 
Figure 2.6: Maxwell Wagner effect. (a) A model of a cell (light blue) immersed in an electrolyte (pink). Charges 
in the conductive cytoplasm are separated from those in the extracellular medium (electrolyte) by the non-
conducting membrane. (b) Applying an external electric field (red plates) causes the re-distribution of charges and 
results in dipole formation (dotted circles). Figure modified from [207]. 
 
Cell models are used to analyze the cellular dielectric properties of cells in suspension. These 
models consider cells as spherical and ellipsoidal shells represented by analytical equations 
that relate the electric parameters of the cell components to the dielectric spectrum [204, 208, 
209]. However, due to the complex cellular structures, numerical simulation techniques, such 
as Finite Difference Modelling (FDM) and Finite Element Analysis (FEA), are required to 
better characterize cell-cell tight junctions and other complex structures [210-212]. 
The dielectric properties of cells and biological tissues are frequency dependent. The 
conductivity of cellular structures increases with frequency leading to less charge 
accumulation. This change in cellular permittivity and conductivity takes place through a 
serious of steps known as frequency dispersions [206, 207, 213]. Three main dispersion regions 
were described by Schwan in 1957: the -, - and -dispersions [205]. At low frequencies 
(centred at about 100 Hz), the α-dispersion region occurs due to ionic diffusion and is normally 




kHz-10 MHz) takes place due to the change in interfacial polarization of the cellular plasma 
membranes. The γ-dispersion, first described by Foster and Schwan in 1989 [214], is centred 
at 10 GHz and depends on the aqueous content of the biological species and the presence of 
small molecules. An additional sub-dispersion δ, lying between the  and  regions, was first 
described by Pethig in 1984 and is attributed to the dipolar moments of large molecules such 
as proteins [215]. Impedance spectroscopy of biological tissues is usually confined to the α and 
 regions. The different dispersion regions are illustrated in Figure 2.7.  
2.6. Electrical Impedance Spectroscopy  
2.6.1. Theory 
 
Electrical Impedance Spectroscopy (EIS) is an electrochemical technique originally used for 
corrosion studies and coating evaluations, however, it has been recently widely used in 
biotechnology, cell culture monitoring and disease modelling [56, 216]. Impedance 
spectroscopy is based on applying an AC excitation signal and measuring the complex 
impedance, Z, of a system [217]. The measurements are scanned through a range of frequencies 
to define the impedance spectrum, hence the term spectroscopy [218]. The excitation current 
or voltage signal is normally very small allowing for a non-invasive measurement, which is the 






Figure 2.7: Dispersion regions. The change in cellular permittivity with frequency through different regions 
known as the α-, β-, δ- and γ- dispersions. Figure modified from [206]  
 
The measured complex impedance represents the ratio between voltage and current according 






𝐼𝑜 sin(𝜔𝑡 − 𝜙)
   (Ω)                                          (2.1) 
Where; V(t) is the voltage as a function of time, I(t) is the current as a function of time,  is the 
angular frequency (=2f) and  is the phase shift between the voltage and the current [218]. 
The voltage and current are only in phase if the system is purely resistive.  However, for cellular 
assays this is usually not the case as the cell capacitive properties will cause a phase shift 
between the applied voltage and measured current. Since cellular dielectric properties are 
frequency dependent, a spectrum of impedances measured at different frequencies would 
provide more information on cell properties than single frequency measurements [218].  
There are various ways of plotting the complex impedance Z, the simplest of which is shown 




of the impedance vector indicates the magnitude |Z| and the angle between the vector and the 
x-axis is the phase shift .  
 
Figure 2.8: Complex impedance plot. A plot defining the complex impedance by its magnitude ǀZǀ (red vector) 
and the phase shift  (angle between the x-axis and the impedance vector). Z’ represents the real part of the 
impedance (resistance) while Z’’ represents the imaginary part (capacitance). Figure modified from [218]. 
 
Nyquist plots are also a very common representation of the complex impedance [218, 222-
224]. In Nyquist representations, the impedance real component is plotted on the x-axis against 
the imaginary component on the y-axis. However, the measurement frequencies cannot be 
extracted from such plots, a drawback that is overcome by Bode plots. In Bode plots, the 
impedance magnitude or its phase is plotted on the y-axis against frequency on the x-axis in 
logarithmic scale [218, 222, 223]. For more detail on Nyquist and Bode plots of simple RC 
circuits, see Appendix C [218, 224]. For further analysis, equivalent circuits and data fitting 
are used to model the impedance allowing for a deeper insight into different cellular properties 





2.6.1.1. Impedance elements and Equivalent circuits 
 
When a metal is in contact with an electrolyte, a potential arises due to the unequal distribution 
of charges at the electrode-electrolyte interface. A double layer of charges is formed at the 
interface with one layer at the electrode surface and the other layer, with opposite polarity, just 
inside the electrolyte. This double layer behaves as a capacitor and is known as the double-
layer capacitance (Cdl) as suggested by Helmholtz [225]. The Helmholtz planes at the 
electrode-electrolyte interface are shown in Figure 2.9. In situations where an electrochemical 
reaction takes place, some charges will leak through the double layer into the electrolyte. The 
transfer of these charges experiences a charge transfer resistance Rct representing the speed of 
the charge transfer reaction. An ionic diffusion process also takes place where ions diffuse from 
the bulk of the electrolyte to the interface and a diffusion impedance, known as the Warburg 
impedance, Zw , arises. For infinite diffusion, the Warburg impedance appears on a Nyquist 
plot as a diagonal line with a slope of 45o. However, when the diffusion is limited, the finite Zw 
appears as a semi-circle at very low frequencies [218, 225]. 
Cdl often shows a non-ideal behaviour which may occur due to various reasons including 
surface roughness, slow adsorption reactions or non-uniform current distribution [225]. This 
non-ideal capacitor is normally referred to as a constant phase element (CPE) and its impedance 
can be expressed as: 
  𝑍𝐶𝑃𝐸 = 1 ((𝑗𝜔)
𝑛⁄ 𝐶)                                                                (2.2)  
Where; ZCPE is the impedance of the constant phase element, j
2 = -1,  is the angular frequency 
and n is a constant that defines the behaviour of the CPE. When n=1, a purely capacitive 
behaviour is observed. With decreasing n-values, resistive behaviours start to appear with a 





Figure 2.9: Electrode/electrolyte interface. A schematic diagram showing the ionic charge distribution and 
diffusion at an electrode/electrolyte interface. A double layer capacitor is formed between the inner Helmholtz 
layer (IHP) at the electrode site and the outer Helmholtz layer (OHP) inside the electrolyte. Ionic diffusion and 
charge transfer occur from the bulk electrolyte to the electrode and vice-versa. The figure is modified from [221]. 
 
The simplest equivalent circuit used to model the impedance of the electrode-electrolyte 
interface was developed by Randles in 1947 [227] and is shown in Figure 2.10. The main 
components of this circuit are the double layer capacitance Cdl and the charge transfer resistance 
Rct connected in parallel. At low frequencies where the effect of diffusion is more pronounced, 
the Warburg impedance Zw is introduced in series to Rct. Moreover, the solution resistance Rs 
is connected in series to this parallel circuit and dominates the overall impedance at very high 
frequencies. Rs  can be determined on the Nyquist plot at the intercept of the semicircle on the 
ZRe-axis [218, 224]. Rs depends on the solution resistivity as well as the area of the solution 









Where, Rs is the solution resistance,  is the resistivity of the solution in a chamber with area A 
and length l [228]. 
 
Figure 2.10: Randles equivalent circuit. (a) Randles model of the electrode-electrolyte interfacial impedance. 
The double layer capacitance (Cdl) is connected in parallel with the faradaic process elements (charge transfer 
resistance (Rct)  and the Warburg impedance (Zw)). The solution resistance Rs is connected in series with the parallel 
circuit. (b) Nyquist plot of Randles circuit. The 45o line represents Zw. Figure modified from [218, 225]. 
 
In this work, the small amplitude of the AC current (1A) and the range of frequencies used 
for impedance spectroscopy (4 kHz- 64 kHz), should prevent redox reactions from taking place. 
The effects of charge transfer and diffusion can therefore be neglected and the interfacial 
impedance can then be simplified to Cdl (or the non-ideal CPE) in series with Rs.  When 
biological cells are immobilized on top of the electrodes, they impede the current flow due to 
their previously mentioned insulating properties. In such cases, the cell impedance (Zcell), is 






Figure 2.11: Simplified equivalent circuit for cell-based impedance spectroscopy. (a) Simplified Randles 
circuit neglecting the effect of charge transfer and ionic diffusion. The circuit is simplified into the solution 
resistance (Rs) connected in series with the double layer capacitance (Cdl). (b) The effect of immobilizing 
biological cells on top of the metal electrode. An impedance due to the cultured cells (Zcell) appears and is 
connected to the previous circuit in series. 
 
2.7. Impedance-based cellular assays 
 
Giaever and Keese [229] were the first to employ impedance spectroscopy for cellular studies. 
Their system was commercialized in 1991 under the name Electric Cell-substrate Impedance 
Sensing (ECIS), which is described in more detail in the next section. Their initial design was 
different than the current commercial electrode arrays though. In their first experiments, 
mammalian fibroblasts were cultured onto four small working microelectrodes (3x 10-4 cm2) 
and one large counter electrode (2 cm2). The electrodes were fabricated by evaporating gold 
onto a petri-dish while using red wax for insulation. A single frequency of 4 kHz was used and 
a lock-in amplifier was used for the impedance measurements. Using their system, they were 
able to monitor cell attachment and spreading. Further fluctuations in the impedance 
measurements attributed to cell micromotion were also monitored. 
After this pioneering work, impedance spectroscopy has been extensively used for various 
biological assays including cell proliferation [12, 230-232], cytotoxiciy [66, 69, 233, 234], 
wound healing [84, 93, 235], cell signalling [236, 237], cell invasion [238] and blood-brain 




several electrodes/well, either individually or collectively addressed. Radial electrode 
arrangements, widely used for impedance tomography, have been adopted for some impedance 
sensing studies. In a study by Rahman et al., 8 gold working electrodes arranged in a radial 
pattern were used to study the anchorage-dependent cell behaviour of ovarian cancer cells 
(Ovca429) [230] as well as the electrical properties of Human Vein Endothelial cells 
(HUVECs) [240]. In 2008, Wang et al. [241] developed an on-chip migration assay, combining 
self-assembled monolayers (SAMs) with cellular impedance sensing. SAMs inhibited cell 
attachment and were therefore used to create an area devoid of cells, representing a wound in 
the cell layer. After the desorption of SAMS from the electrodes by applying an electrical DC 
signal, cells were able to migrate with the circular arrangement of the electrodes producing a 
spatial average measurement of cell migration. 
After their introduction for cell-based impedance studies in 1997 by Ehret et al., interdigitated 
electrodes were adopted for various cellular assays [242]. The relatively large area covered by 
the interdigitated electrodes means that the collective behaviour of a large number of cells is 
recorded as opposed to that of a few cells in the case of smaller sensing electrodes. For that 
reason, interdigitated electrodes are usually used for cytotoxicity assays and studies where the 
behaviour of a cell population is under investigation. 
Recently, contactless measurement has been used for cellular impedance studies [243, 244]. In 
such set ups, the electrodes are covered with a passivating material and are therefore not in 
direct contact with the cells or the culture medium, resulting in the disappearance of the 
reactions at the electrode-electrolyte interface. However, in order to capacitively couple 
through the passivation, high frequencies have to be used and any interesting effects occurring 




2.7.1. Electric Cell-Substrate Impedance Sensing 
 
Electric Cell-substrate Impedance Sensing (ECIS) is a real-time, label-free monitoring 
technology pioneered by Giaever and Keese [13, 229] in which a small non-invasive AC 
current (1 A) is applied through gold microelectrodes. ECIS uses a two-electrode set-up onto 
which adherent cells are directly grown on top of the planar microelectrodes. A 1V AC signal 
is applied through a 1M resistor and the changes in the time-course complex impedance 
associated with cellular events are monitored through in-phase and out-of-phase measurements 
using a lock-in-amplifier [13]. The measured in-phase and out-of-phase current is converted to 
the real (Z’(f))  and imaginary (Z’’(f)) parts of the complex impedance representing the resistive 
and capacitive components respectively. The basic ECIS set up is shown in Figure 2.12. 
 In order for the measured impedance to be dominated by that of the working (sensing) 
electrode, the impedance of the working electrode has to be much higher than that of the 
counter electrode and the solution resistance [247]. In order for the working electrode to have 
a higher impedance than the counter electrode, the area of the working electrode (typically 0.05 
mm² in standard ECIS arrays) is made significantly smaller than that of the counter electrode 
(18 mm2). The impedance contribution of the large counter electrode to the total impedance in 
that case is below one percent and can therefore be neglected [239]. The difference between 
working and counter electrode sizes as well as the close proximity between adherent cells and 





Figure 2.12: ECIS basics. A schematic diagram showing ECIS basic set up. ECIS mainly consists of a small 
(working) and a large (counter) electrode, an AC source and a lock-in amplifier. 1V AC signal is applied between 
the working and counter electrodes before the impedance is measured using a lock-in amplifier. The complex 
impedance Z(f) is analyzed into its two components: Z’(f) (real part, i.e. resistance) and Z’’(f) (imaginary part, i.e. 
capacitance). The current pathways can be analyzed to reveal data on cell-cell junctions (Rb), cell-substrate 
adhesion (α) and cell membrane capacitance (Cm) using the ECIS built-in model. 
 
When cells are cultured on top of the microelectrodes, they alter the current pathways due to 
the insulating properties of the cell plasma membranes. The measured impedance increases 
with cell growth until it reaches a plateau as the cells form a confluent monolayer on top of the 
electrodes. At low frequencies, the current is forced to flow under and in-between neighbouring 
cells and the measured impedance in this case is directly related to the properties of cell-
substrate adhesion and cell-cell tight junctions. Only at high frequencies, the current can 
capacitively couple through the plasma membrane and the impedance can give an insight into 
the integrity and the dielectric properties of the cell membrane [12, 248].  
ECIS has found many applications from cell attachment and spreading [12, 232], signal 




recently regenerative medicine [124]. ECIS migration assays also allow the combination of 
electrical wounding and impedance spectroscopy to quantitatively and reproducibly measure 
cell migration rates and changes in cell morphology accompanying wound healing [84]. ECIS 
has also found a niche application in blood-brain barrier permeability studies [239], where the 
ECIS model has provided real-time quantitative monitoring of the establishment or loss of cell-
cell tight junctions. It has to be noted that ECIS method of quantifying tight junctions is 
fundamentally different than the transepithelial electrical resistance (TER) measurement 
techniques. In these types of measurements, cells are usually cultured on permeable membranes 
between two chambers filled with the conductive medium. Electrodes are immersed in the two 
chambers and the measured impedance can then be used to assess cell-cell junctions and 
permeability. This set up is commonly known as the Ussing chamber [250-252]. ECIS however 
uses a built-in model to evaluate the resistance arising due to cell-cell tight junctions. The basics 
underlying this model are described in the next section. 
2.7.1.1. ECIS Model 
 
A major advantage of the ECIS platform over other commercial system is its built-in 
mathematical model that is able to deconvolve the impedance into its biologically relevant 
components. The impedance is scanned through various frequencies to recognize the different 
current pathways and translate it into data on cell-cell junctions (Rb), cell-electrode adhesion 
() as well as the cell membrane capacitance (Cm) [13]. At low frequencies (< 10 kHz), the 
current flows underneath and in-between the cells and therefore the measured impedance is an 
indication of how tight the cell-cell junctions are and how well-adhered the cells are to the 
electrodes. At high frequencies (> 40 kHz), the current can capacitively couple through the 
cells revealing data on the intracellular properties and the integrity of the cell plasma membrane 




solution resistance in series with the impedance at the electrode-electrolyte interface (Ze). For 
a cell-covered electrode, an impedance Zcell is added in series to the previous cell-free 
equivalent circuit (Figure 2.13). Resistive contributions due to the membrane ion channels and 
ion leakage are usually neglected and are not taken into consideration in this model. It has to 
be mentioned that in order for ECIS model to be valid, the cell layer under investigation has to 
be confluent.  
In order to arrive at a function describing the total impedance of the system, Giaever and Keese 
assumed cells as circular disks with radius rc, hovering above the electrodes at a distance h in 
a medium with resistivity ρ [13]. The specific impedance (the impedance for a unit area) for 
the cell-free electrode was defined as Ze(f), representing the impedance at the electrode-
electrolyte interface. The specific impedance for the cell was defined as Zm(f) and is mainly the 




                                                               (2.4) 
where, Ccl is the capacitance of the apical and the basal cell membrane capacitances, and            
Cm = 2Ccl  (F/ cm
2). In all their calculations, Cm was set as 1 F/ cm
2. 
It was assumed that the current flew radially in the space between the electrode and the 
hovering cells, and that the current density under the cells did not change in the z-direction. 
The electrode potential was defined as Ve while the electrolyte above the cell monolayer was 




Figure 2.13: ECIS model. (a) A cell-free electrode with current flowing freely through the electrolyte (right). 
The equivalent circuit of a cell-free electrode is represented by the impedance at the electrode/electrolyte interface 
in series with the solution resistance (left). (b) Cells covering the electrode will impede current flow. Current can 
either pass in between (red arrows) or under the cells (green arrows). At high frequencies, current can capacitively 
couple through the cells (purple arrows). Current pathways are analyzed to deconvolve the impedance into the 
model parameters (Rb, α, Cm) (right). The equivalent circuit of a cell-covered electrode introduces an impedance 
Zcell  connected  in series with the cell-free circuit (left). 
 
By analyzing the different current pathways, Giaever and Keese derived four differential 
equations in order to arrive at a transfer function (Equation (2.5)) that described the overall 
impedance of the system [12, 253]. The derivation of this function is described in more detail 



























+ 𝑅𝑠             (2.5) 
Where, I0 and I1 are modified Bessel functions of the first kind of the order zero and one. Ze is 









) with h representing 
the cell-electrode distance while  is the solution resistivity. 
Once the total impedance has been determined, it can then be deconvolved into three 
biologically relevant parameters (Rb,  and Cm). The parameter Rb (.cm2) is a measure of the 
resistance against current flow in the intercellular clefts and is thus a reflection of the tightness 
of cell-cell junctions. The parameter α is a measure of the impedance to current flow in the 
subcellular clefts which represents the level of cell-substrate adhesion.  According to Equation 
(2.6),  depends on the cell radius rc, the cell-electrode distance h and the electrolyte resistivity 




                                                                    (2.6) 
The cell membrane capacitance parameter Cm depends on the plasma membrane properties and 
morphology and can be determined from the membrane impedance Zm.  In practice, the 
parameters are retrieved through fitting the measured, experimental, impedance to the model 
transfer function using non-linear regression as described by Wegener et al [255].  
It is worth mentioning that determining a frequency range of high sensitivity is key to accurate 
ECIS data interpretation. Figure 2.14 shows a typical impedance spectrum for the impedance 
magnitude |Z| of a cell-free and a cell-covered electrode as a function of frequency. At low 





Figure 2.14: Impedance Spectrum. Graph showing the difference in impedance spectrum between a cell-free 
and a cell-covered electrode. As cells attach to the electrode, impedance increases in a characteristic way within 
a certain frequency range. This will be the range of frequency providing the highest measurement sensitivity.  
 
capacitance as indicated by a linear decrease with increasing frequencies. At high frequencies 
(> 105 Hz), the impedance of the cell-free electrode approaches the value of the electrolyte 
resistance. A cell layer covering the electrode surface increases the electrode impedance in a 
characteristic way within a certain frequency range. Monitoring cellular behaviours should 
therefore be performed within this range of frequencies. Usually, 4 kHz is the frequency of 
choice for cell morphology, adhesion and tight junction studies, whereas 40 kHz is used for 
studying cell coverage and the membrane dielectric properties [12]. Recording ECIS 
measurements at a frequency of 4 kHz has been reported to accurately reflect changes in cell 
motility and morphology with high sensitivity. Even slight alterations in cell-cell junctions and 
cell-substrate adhesion have been detected at this frequency [248, 256]. At higher monitoring 
frequencies, intercellular and subcellular resistive components do not contribute to ECIS 




however, capacitive contributions arising from the cell membranes are detected with high 
sensitivity as a big fraction of the current can couple through the membranes. Cell membrane 
capacitances of the cell layer add to the electrode capacitance in a reciprocal manner following 
Kirchhoff’s laws, decreasing the electrode capacitance values with cell coverage [12, 253]. 
 The sensitivity of a monitoring frequency can also be extracted from normalized presentations 
where the ratio of Z, R or C of a cell-covered electrode to that of a cell-free electrode               
(Zcell-covered / Zcell-free, Rcell-covered / Rcell-free, Ccell-covered / Ccell-free ), is plotted as a function of 
frequency. From these plots, the frequency range exhibiting a high sensitivity is normally the 
one providing a maximum normalized value [253].  
2.7.2. Other commercial systems 
 
Following the pioneering work of Giaever and Keese and the commercialization of ECIS, other 
commercial systems for impedance-based cellular assays have been developed.  The 
xCelligence system (previously known as Real-Time Cell Electronic Sensing, RT-CES) by 
Roche Applied Science [257] has found many applications including cell adhesion and 
spreading [258], cell invasion [259], blood-brain barrier function [260], cytotoxicity [59], 
cardiology [261], cell signalling [262] and co-culture studies [263]. In this system, cells are 
cultured on top of gold interdigitated electrodes usually at the bottom of a 96-well plate and 
the cell behaviour is reflected by a cell index (CI). This index represents the relative change in 
impedance between the cell-free and cell-covered electrodes averaged over three measurement 
frequencies of 10, 25, and 50 kHz [264]. However, the CI has been reported to not always 
accurately reflect cell behaviour specially in cell toxicity assays where a decrease in CI was 
not always associated with cell death [265]. 
More specialized systems were also developed. The CellKey system by Molecular Devices 




plates to measure changes in impedance. It mainly monitors cellular changes stimulated by 
ligand-receptor interaction, making it a good platform for drug screening assays [266, 267].  
A slightly different device for cell-based assays is the Bionas Discovery. Besides impedance 
measurements, it uses sensors for acidity and oxygen concentration providing information on 
the metabolic activity, allowing for a more comprehensive insight into cellular properties and 
mechanisms [268, 269]. The impedance is however measured at a fixed frequency of 10 kHz.  
2.8. Microelectrode Arrays: Design and Fabrication  
 
In this work, different sized, individually addressed microelectrode arrays have been designed 
and fabricated for ECIS measurements. This section introduces some design considerations 
and the basic microfabrication techniques. 
2.8.1. Design Considerations 
 
Microelectrode arrays (MEA) are formed in essence from a conducting layer (usually metal) 
placed between two insulating layers, namely the substrate and the passivation layer. Small 
openings are then made in the passivation layer, exposing the metal in specific areas to define 
the measuring microelectrodes that will be in contact with the biological cells [221].The design, 
number, size and arrangement of these microelectrodes all depend on the application they are 
used for [270, 271].  
Depending on the properties of the cells under investigation, an appropriate microelectrode size 
could be determined. For single cell studies for instance, the size of the sensing microelectrode 
should be in the range of 10-30 µm, the average size of a cell [221]. However, for studies where 
the collective behaviour of a cell population is of interest, larger electrodes can be used. In 
impedance-based assays, the microelectrode size directly affects the sensitivity of the 




the working electrode should dominate the overall impedance. Therefore, the impedance of the 
counter electrode has to be significantly smaller which is usually achieved by making its area 
much larger than that of the working electrode. A larger surface area can also be obtained 
through roughening of the counter electrode surface. Moreover, since the impedance of the 
electrode is connected in series with the solution resistance, decreasing the size of the working 
electrode, i.e. increasing its impedance, will allow the electrode resistance to dominate the 
solution resistance [13, 272]. Giaever and Keese have reported that decreasing the electrode 
area, increased the sensitivity of ECIS measurements [13, 248]. However, decreasing the 
electrode size will increase the interfacial double layer capacitance [228], therefore introducing 
some limitations on how small the microelectrodes can be made. In a study by Abdur Rahman 
et al., a 50 m electrode diameter was set as a lower limit for microelectrode size, below which 
high interfacial capacitance and non-uniform current distribution occurred [273].  
The sensitivity of the impedance measurements has been shown to decrease due to the 
capacitance introduced by the passivated electrode interconnections [274]. As the capacitance 
is inversely proportional to the thickness of the insulating layer, increasing the thickness of the 
passivation will reduce the capacitive coupling between the electrode interconnections and the 
solution. This parasitic passivation impedance can also be minimized by decreasing the 
electrode lead trace area. Price et al. observed that the passivated lead trace area to passivation 
coating thickness ratio has a critical value of 5.5, under which the impedance contribution of 
the coating is minimized. ECIS standard 8W1E (8 Wells, 1 Electrode/well) arrays have a 
passivated area of approximately 14 mm2 with coating thickness of 2 m. The passivation area 
to passivation thickness ratio is therefore much higher (~ 700) than the critical ratio defined by 
Price et al. This means that for ECIS arrays a coating capacitive component has to be 




The electrical performance of microelectrodes is obviously a primary criterion to be considered 
when designing a MEA chip. Other than the electrode impedance, the electric field distribution, 
the current density and the parasitic capacitance, issues like noise and electromagnetic 
interference should also be taken into account [221, 270]. Breckenridge et al. concluded that a 
minimum distance of 100 µm centre-centre distance should be left between any two electrodes 
to reduce interference and signal attenuation [275]. The distance between the electrodes should 
not be too large though if cell-cell communications studies are of interest. Depending on the 
specific design of the microelectrodes, other factors might have to be considered. For instance, 
when designing interdigitated microelectrodes, the number, width, height and spacing between 
the interdigitated fingers have been found to affect the sensitivity and signal to noise ratio of 
the measurements and therefore have to be optimized [271, 272, 276, 277]. Other 
considerations like power consumption/dissipation, heat dissipation, type of connections and 
circuitry used also have a huge effect on the proper functioning of the chip. 
Microelectrode arrays can either be individually addressed or considered as an integrated array 
depending on how the microelectrodes are connected. Although integrated arrays offer an 
average response for a cell population which is useful for certain cellular assays, cytotoxicity 
assays for instance, individually addressable MEAs offer advantages such as high spatial 
resolution as well as the possibility of sensing from multiple sites. They therefore have a great 
potential in neural networks and cell signalling studies [221]. How the electrodes will be 
addressed should be considered before designing the MEA system.  
In the current study, 6 and 16 microelectrodes/well are designed to allow for a high spatial 
resolution, monitoring a wider area of the culture well. Being individually-addressed allow for 




A miniaturization of the microelectrode size down to 20 m is attempted to allow for single 
cell studies. 
2.8.2. MEA Materials 
 
As described in the previous section, microelectrode arrays basically constitute of three layers: 
the substrate, the conducting layer and the insulating passivation layer. Choosing the right 
material for each of these layers is essential to obtain the required electrode performance and 
sensitivity [221, 270, 271, 278].  
Choosing an appropriate substrate material is the first step in the fabrication of microelectrode 
arrays. Typical substrates include silicon [274, 279, 280], glass [230, 240, 241, 273, 281-288] 
as well as polymers [289-291]. Silicon has always been the substrate of choice for the 
fabrication of semiconductors. Despite it not being transparent and having the disadvantage of 
introducing a parasitic capacitance when coated with silicon oxide, it is still used for MEA 
fabrication for biological applications as it allows for the integration of the measurement 
electronics [221]. 
Glass is increasingly used as a MEA substrate for cellular assays, due to its transparency, 
biocompatibility, high insulation and temperature resistance. Polymers are also transparent, 
highly biocompatible, and generally cheaper than glass, which makes polymer substrates a 
perfect candidate for disposable electrodes [221].  
There are lots of properties that need to be considered before deciding on a suitable electrode 
material. Durability, biocompatibility, low impedance and of course low cost and availability 
are all desirable characteristics of the microelectrode material of choice [221, 270, 271, 292-




Despite their relatively high cost, gold (Au) [230, 240, 273, 276, 281, 285, 289, 295-302] and 
platinum (Pt) [286, 287, 303-306] remain the most commonly used electrode materials ever 
since the introduction of MEAs in the 1970s [307].  Their inertness, low resistivity and ease of 
fabrication have made them great candidates for different applications [292].  Moreover, the 
interfacial impedance of gold or platinum can be reduced by increasing the surface roughness, 
hence increasing the surface area. Platinum black has been used for plating gold and platinum 
microelectrodes resulting in a lower impedance [221, 270, 308]. However, this technique was 
shown to be unstable as the platinum black layer does not have a high durability [221]. After 
the introduction of a method for sputtering titanium nitride (TiN) on platinum [309], TiN has 
been used for gold and platinum plating providing a lower impedance than that of the naked 
electrode [310-312].  
Electrode materials other than gold and platinum are also being used. First introduced as an 
electrode material by Gross et al [288, 313], indium-tin-oxide is increasingly used for the 
fabrication of MEAs due to its transparency, corrosion resistance and high biocompatibility. 
Other possible electrode materials include: glassy carbon [314], graphene [315], titanium 
[280], palladium [279], rhodium [316] and iridium [317]. 
The top layer of the microelectrode structure is the passivation layer. Generally, the main factor 
that should be considered when choosing the passivating material is the dielectric constant 
affecting the electrode capacitance. The dielectric strength is also a very important factor as 
exceeding it causes the insulation between the traces and the solution to break down. Another 
thing to consider is the thickness of the passivation layer, the thinner the insulation the lower 
its breakdown voltage [308]. Moreover, a thicker passivation layer will have a lower coating 




The most commonly used passivation layers include silicon nitride [301], silicon dioxide [241], 
as well as polymer compounds including polyimide [287, 306] and photoresist [240, 273, 285, 
286, 288]. Silicon nitride (Si3N4) is characterized by its high impermeability to ions and is a 
good choice for uniform insulative coating on a surface. Although silicon dioxide (SiO2) has 
good insulating properties, it is not completely impermeable to ions and some ions might be 
able to pass through it to the electrode layer. Polymers are also used for passivation as they 
exhibit high biocompatibility and good dielectric features. However, a thick layer is normally 
required to obtain good insulation [221]. In this study, 1m of Parylene-C has been used for 
passivation with either platinum or gold as the electrode material on a glass substrate. 
2.8.3. Microelectrode Fabrication  
2.8.3.1. Photolithography 
Photolithography is the most commonly used process for the fabrication of MEAs [318]. 
Advances in photolithographic techniques have made it possible to fabricate miniaturized 
micro- and nano- electrodes as well as multilayered structures [319, 320]. The basic steps of 
the photolithographic process are shown in Figure 2.15. The first step is to grow an insulating 
layer (for silicon substrates) on top of the substrate usually by oxidation. An adhesion layer is 
then deposited by evaporation or sputtering on top of the substrate in order to increase adhesion 
between the substrate and the electrode materials. Typical adhesion materials include titanium 
(Ti), chromium (Cr) and tantalum (Ta) [270]. After depositing the metal layer, a layer of 
positive or negative photoresist is added before being patterned by exposing it to UV light 
through a photomask. This process makes the photoresist either more (in case of positive 
photoresist) or less (in case of negative photoresist) soluble to a developing solution. After 
developing the photoresist, the metal is then etched using wet or dry etching. In wet etching, 
chemical solutions are used to remove the unprotected material while dry etching uses a 




ion etching.  The photoresist is then stripped off to reveal the required final pattern. After 
removal of the photoresist, an insulating layer is deposited onto the wafer and the same 
patterning steps are followed to open up selected areas in the passivation to define the 
measuring electrodes [318, 320].  
An alternative to the etching process is the lift-off method. In this process, a photoresist 
sacrificial layer is directly deposited on the substrate and patterned, yielding a negative pattern, 
before the metal layer is deposited on top. After developing, the photoresist together with the 
metal on top of it is removed, leaving only the metal layer that is directly adhered to the 
substrate. The main disadvantage of this process is that after removal of the photoresist layer, 
the metal on the side walls of the photoresist pattern could continue to adhere to the substrate. 
In the current study, only etching processes were used for microelectrode fabrication [321]. 
2.8.3.2. Screen-Printing 
 
Screen-printing is a simpler, cheaper process than photolithography. In this technique, the 
desired electrodes are defined by printing a thixotropic fluid (a special ink with a time-
dependent shear thinning property) through a high precision mesh screen or stencil with the 
required electrode patterns using a squeegee [322].  Ink materials include carbon nanotubes, 
platinum, silver, organo-gold, dielectrics, gold, carbon, and graphite [270]. The resolution of 
this technique is however limited and complicated designs are usually hard to print. 
Nonetheless, screen-printing is increasingly being used to fabricate disposable microelectrode 
arrays and has been reported as a microfabrication technique for electrochemical [323, 324] 






Figure 2.15: Photolithography. A schematic diagram showing the basic steps of the photolithographic etching 
process. 
 
2.8.3.3. Laser Ablation  
 
Laser ablation is another alternative platform for microelectrode fabrication, micromachining 
and the production of microelectronic devices.  A laser beam is used to directly pattern the 
electrode material through irradiation, allowing rapid prototyping and low-cost manufacture of 
complex chips and devices. Special mask projection methods can also be used to produce more 
complex designs [327].  
Rizvi et al. have used an excimer laser to fabricate microelectrodes for dielectrophoresis studies 
using laser ablation techniques [328]. In another study, they built a multi-level device by 
ablation of electrode patterns and layered insulators. Using a chrome-on-quartz mask, they 




also been combined with other techniques in order to achieve better fabrication capabilities. 
For example, Cugnet et al. [330] reported the fabrication of a microelectrode array based on 
femtosecond laser ablation and screen- printing processes. In a different study, Lee et al. have 
used an inkjet-based ultrashort pulsed laser patterning on a polymer substrate. They were able 
to achieve damage-free laser ablation through the optimization of the laser processing 
parameters including the input energy, scanning speed, and number of scans [331].  
2.8.4. Surface Modifications 
 
After the fabrication of the required MEA, usually a few surface modifications are done to 
guide and immobilize the cultured cells/tissues onto the electrodes or to improve the electrical 
performance of the chip [221, 294]. As mentioned previously in Section 2.8.2., coating the 
electrode with materials like platinum black or TiN can be used to increase the surface area 
and lower the electrode impedance [270, 308, 309].  Increasing the surface roughness and 
coating with specific proteins allow for an improved cell attachment to the electrode surface 
[221]. The hydrophilicity of the electrode surface is also an important element that needs 
consideration. As cells do not adhere to a hydrophobic surface, modifications that will increase 
the surface hydrophilicity are required if the MEAs are to be in direct contact with the 
biological cells [318]. In the current study, oxygen plasma has been used to make the surface 
of the MEA chip hydrophilic. All chips have been incubated with culture medium at least 2 
hours prior to cell seeding, therefore coating the chip surface with serum proteins.  
2.9. Summary 
 
This chapter has described recent advances in disease modelling including the use of stem cells 
and employing impedance measurements for a real-time, non-invasive quantification of 




related macular degeneration have been briefly described, and the therapeutic potential of 
antioxidants and electrical stimulation has been presented. The theory behind electrical 
impedance spectroscopy and the ECIS platform used in the current study has also been 
explained. Finally, microelectrode design considerations and fabrication methods have been 
discussed. 
In this work, two stem cell-based disease models-on-a-chip are proposed for ALF and AMD. 
Hepatotoxicity assays are conducted to model ALF, while electrical wounding is used to mimic 
RPE loss in AMD before exploring two therapeutic approaches. The next chapter introduces 










3.1. HepaRG-based ECIS model for hepatotoxicity studies 
3.1.1.  HepaRG cell culture on ECIS microelectrodes  
 
HepaRG cells (HRG116, BioPredic international, Rennes, France) were grown following the 
supplier’s protocols and using specialized media obtained from Biopredic Int. Each medium 
was made up using William's E Medium with GlutaMAX™ (Sigma), as the basal medium; 
with appropriate additives (ADD). Briefly, HepaRG cells were seeded (day 0) at 2.5x105  
cells/cm2, initially in Thaw, Seed and General Purpose HepaRG medium (GPS; ADD670) on 
ECIS microelectrode arrays (Applied Biophysics, USA), and the medium was changed daily. 
On day 3, the medium was changed to metabolic maintenance medium (MMM; ADD620) and 
HepaRGs were cultured, with the medium changed every other day, until they terminally 
differentiated into a co-culture of hepatocytes (the main functional cells of the liver) and 
cholangiocytes (the epithelial cells of the bile duct). On day 8, cells were washed twice with 
Hank’s balanced salt solution (HBSS; Sigma-Aldrich) before adding Rifampicin (Sigma) in 
serum-free hepatocyte induction medium (HIM; ADD650) with a ratio of 1:1000 (Rifampicin: 
HIM). The liver enzyme-inducer, Rifampicin, was used to upregulate the detox CYP450 
enzymes, specially CYP3A4, that are involved in drug metabolism and might be inhibited due 
to the presence of Dimethyl sulfoxide (DMSO) in the culture medium. 
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On day 9, HepaRGs were subjected to the different drugs and test compounds with different 
concentrations. Impedance was then monitored with measurements taken at 160s intervals over 
a 62.5 Hz to 64 kHz frequency (f) range, for up to 96 hours post-induction. The ECIS-Zθ built-
in model was used to translate impedance measurements into quantitative data on cell-cell 
junctions (Rb), cell-electrode adhesion () as well as the cell membrane capacitance (Cm).  
3.1.2. Hepatotoxins 
 
All hepatotoxins and compounds were added to the HepaRG cultures on day 9 after an 
induction phase as previously described. The model hepatotoxin paracetamol (APAP; A7085, 
Sigma-Aldrich) was added to the culture medium, MMM, with concentrations of 5mM, 10mM 
and 20mM using DMSO-vehicle as controls (< 0.1% DMSO final concentration in all 
experiments).  The effect on impedance measurements and modelling parameters was then 
observed. To test the effects of antioxidants on APAP-induced toxicity in HepaRGs, N-acetyl-
L-cysteine (NAC; Sigma-Aldrich) was used. After 24h of incubation with APAP, medium was 
aspirated and 400 l of MMM containing 10mM NAC was added to the HepaRG culture. Cells 
were incubated with NAC for 24h before the medium was aspirated again. 
 Phorbol-12-myristate-13-acetate (PMA; P8139, Sigma-Aldrich) is known to disrupt the 
integrity of hepatocellular TJs. Effects of various concentrations (50, 100, 200 ng/ml) of PMA 
on Rb (TJ barrier resistance) were tested using impedance monitoring for 24 hours on HepaRG 
cells.   
Parallel biochemical, Presto-blue and ATP-depletion, endpoint cell viability assays were also 
conducted for APAP and PMA. Moreover, the disrupting effect of APAP on HepaRG tight 
junctions was confirmed using fluorescence immunostaining of tight junction proteins, as well 
as transmission electron microscopy (TEM) imaging. All HepaRG biochemical assays and 
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staining were performed by the HepLab group, University of Edinburgh. A brief description of 
the methods used in such assays is provided in Appendix E. 
 The effect of other hepatotoxins on HepaRGs was also investigated. Amiodarone (Sigma) was 
added to the HepaRG culture medium with concentrations of 25, 50, 75 and 100 µM, while 
Cyclosporine-A (CsA; Sigma) was added using 10, 20, 30 and 40 µM concentrations. To test 
the effect of NAPQI (N-acetyl-p-benzoquinone imine; Sigma) on HepaRG tight junctions, 125, 
250 and 500 µM concentrations were added to different wells before monitoring real-time 
effect of the compound on impedance measurements.  Table 3.1 summarizes the different 
compounds used for the HepaRG-based assays and their corresponding concentrations. 
Test compound/ drug Concentrations 
Paracetamol (APAP) 5 mM, 10 mM, 20 mM 
Phorbol-ester (PMA) 50 ng/ml, 100 ng/ml, 200 ng/ml 
Amiodarone  25 μM, 50 μM, 75 μM, 100 μM 
Cyclosporine-A (CsA) 10 μM, 20 μM, 30 μM, 40 μM 
NAPQI 125 μM, 250 μM, 500 μM 
NAC  10 mM 
Table 3.1: Hepatotoxins and their corresponding doses. 
 
3.1.3. ECIS arrays 
 
Three different ECIS arrays were used for the HepaRG-based assays. All arrays were incubated 
with GPS medium for 2 hours before seeding with HepaRG. ECIS 8W10E+ arrays were mainly 
used for the APAP and PMA hepatotoxicity assays. This array has 8 wells, each having two 
sets of 20 circular 250 μm diameter measuring gold electrodes located on interdigitated fingers 
to provide measurements of cells upon a total of 40 electrodes. Each well has a substrate area 
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of 0.8 cm2 and a maximum volume of 600 μL. Due to their interdigitated design, these arrays 
provide an average for the cell population response, making them a good candidate for toxicity 
studies. 
Another array employing interdigitated fingers is the ECIS 96W20idf (96 wells, 20 
interdigitated fingers/well). This array has 96 wells and therefore is ideal for high throughput 
screening. 96W20idf arrays were used to conduct amiodarone, cyclosporine-A, paracetamol 
and phorbol-ester hepatotoxicity assays in parallel. Each well has a substrate area of 0.32 cm2. 
The electrodes have a 20 interdigitated finger configuration with a total electrode area of 3.92 
mm2. 
The third array used in this study is the ECIS 8W1DD (8 wells, 1 electrode/well, different 
diameters). This array is nearly identical to the ECIS 8W1E (described in Section 3.2.1) 
standard array with each well having a substrate area of 0.8 cm2 and one working electrode. 
The working electrodes come in four different diameters (25, 50, 100, 250 μm) with two wells 
of each size. The small sized electrodes were used in an attempt to differentiate between 
hepatocyte and cholangiocyte responses in a sub-population study. Figure 3.1 shows the 
different ECIS arrays used in the HepaRG-based studies. 
3.1.4. Impedance data analysis 
 
Impedance data were analyzed using Matlab. Generally, normalized data has been adopted to 
provide a more accurate way of comparing impedances of different culture wells. Data were 
normalized through dividing the impedance (or its corresponding modelling parameters) by its 
value at the challenge starting point (t=0). Moreover, non-normalized data has also been 
provided to show the true impedance values. 
 




Figure 3.1: ECIS microelectrode arrays. (a) 8W10E+  (b) 8W1DD  (c) 96W20idf [332]  
 
3.2. Electrically-induced Injuries 
3.2.1.  Keratinocytes ECIS wound healing assays 
 
Adult Human Epidermal Keratinocytes (HEKa, Invitrogen) were cultured with a density of 
2500 cells/cm2 in Epilife medium. ECIS 8W1E (8 Wells, 1 Electrode/well) arrays were used 
for the electrical wounding assays. These arrays have 8 wells with one 250 μm diameter sensing 
gold electrode/well. Each well has a 0.8 cm2 surface area.  Microelectrodes are fabricated on a 
transparent Lexan polycarbonate substrate onto which 50 nm thick gold electrodes are 
sputtered and passivated with 2 µm polymer resin. Sensing electrodes have a typical area of 
0.05 mm2 while the counter electrode has an area of 18 mm2. Arrays were incubated with the 
culture medium for 2 hours in a humidified incubator with 5% CO2, 37
oC, prior to cell seeding. 
Trial and error experiments were initially conducted to optimize the wounding parameters. 
After three independent experiments, it was decided on using a current of 3 mA at 40 kHz for 
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30s to achieve controlled wounding of keratinocytes. A formula defining wound severity was 
proposed in Equation (5.1) in Section 5.1, depending on the wounding pulse amplitude, 
frequency and duration. 
3.2.1.1. HEKa staining 
 
After wounding, the culture medium was removed from all wells and the cells were washed 
with phosphate buffered saline (PBS). 100 l of Acridine Orange/ Ethidium Bromide (AO/EB) 
vital staining solution was added at room temperature for 10 minutes before being removed 
and washed with PBS. The cells were then fixed in 10% formaline and ECIS culture wells were 
carefully removed from the substrate. One drop of DAPI (4′,6-diamidino-2-phenylindole) was 
added onto each electrode for nuclei DNA staining and a cover slip was put onto the electrodes 
before checking under a fluorescence microscope. 
3.2.2. Age-related macular degeneration model-on-a-chip 
3.2.2.1. hiPSC-RPE culture on ECIS microelectrode arrays 
 
 hiPSC-RPE cell lines were generated from a patient with LORMD and a healthy sibling as 
described in Appendix E and perfomed in Chandran’s Lab. by Shyamanga Borooah. Case and 
control hiPSC-RPE were then cultured on ECIS Medusa arrays (Applied Biophysics, NY, 
USA) incorporating a 2-electrode set up: working and counter electrodes. Each array has 8 
wells of 0.8 cm2 surface area with two 250 μm diameter gold working microelectrodes per well.  
The electrodes have the same areas previously described for 8W1E arrays (0.05 mm2 for the 
sensing electrode and an area of 18 mm2 for the counter electrode). The spacing between the 
electrodes on a Medusa array is 4.83 mm. The two working electrodes are addressed 
individually and measurements from one working electrode are recorded at a time. The Medusa 
array is useful for duplicating readings in the same well or to wound/electroporate one electrode 
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while leaving the other as a control within the same well. When connected to the array holder 
only the upper four wells are measured. To use the other four wells, the array is turned around 
and the contact pads at the other end are connected. Figure 3.2 shows a typical Medusa array. 
The ECIS electrode array was placed in an array holder inside a humidified incubator at 37°C 
and 5% CO2. All wells were incubated for 2 hours with the culture medium before seeding at 
confluency (100,000 cells/ cm2). Cells were initially cultured with retinal differentiation 
medium with 10% fetal calf serum (90% RDM, 10% FCS). On day 2 of culture, the media was 
changed to RDM with 2% serum and on day 6, RDM with no serum was used until the end of 
the experiment. Media was changed 3 times per week. Cells were cultured for 25 days to 
achieve RPE maturation before starting the wound healing assay.  
 
Figure 3.2: ECIS Medusa array. A picture of an ECIS Medusa array. Each well has two 250 μm diameter 
working electrodes. Only four wells can be connected at a time [332]. 
 
3.2.2.2. hiPSC-RPE ECIS wound healing assay 
 
An elevated current pulse (3 mA, 40 kHz, 30 seconds), optimized by trial-and-error 
experiments, was used to wound the confluent cell monolayer. Trial and error experiments 
were minimized by using the formulas (5.2- 5.4) to derive theoretical wounding parameters 
that generated the same current density used for wounding keratinocytes. The wounding pulse 
was mirrored by a drop in impedance to that of the cell free electrode. The system then switched 
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back to its normal operation to monitor cell repair.  The same wounding parameters were used 
with all cell lines.  
Trypan blue was used to confirm cell death. 15 minutes after wounding, the medium was 
aspirated and 200 μl of diluted trypan blue was added to the well under investigation. After 15 
minutes, trypan blue was removed and the wounded cells were optically observed. Only dead 
cells were stained blue as their plasma membranes were terminally compromised. 
3.2.2.3. Quantitative data analysis  
i. Average cell migration 
 
The migration rate of the case and control cell lines after electrical wounding was determined 
according to Equation (3.1):  
𝑚 = 𝑟 𝑡      (𝜇𝑚 ℎ)⁄⁄                                                     (3.1)  
Where; m is the migration rate, r is the electrode’s radius (125 µm) and t is the time in hours 
required for the impedance to reach its value prior to wounding. 
ii. Impedance based adhesion assay 
 
Cells were seeded with a high density (typically 100,000 cells/cm2) and the changes in their 
impedances were monitored for 1-2 days. The time it takes the cells to attach to the electrode 
surface and start spreading till they form a confluent layer is an indicator of the cell adhesion 
properties [12, 96]. Impedance measurements during the attachment phase were fitted with a 
straight line and the slope of the case and control curves were determined accordingly. 
Biochemical adhesion assays were also performed to confirm the obtained results. These were 
performed by Shyamanga Borooah and described in Appendix E. 
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iii. Cell-substrate adhesion parameter 
 
The built-in ECIS model analyzes current pathways, arriving at a transfer function (Equation 
(2.5)) that defines the measured impedance. Experimental data can then be fitted to the model 
transfer function and the model parameters (Rb, α, Cm) can be extracted [255].  A schematic 
diagram of the ECIS model showing the different current pathways in between, under and 
through the cells is shown in Figure 2.13. 
ECIS model was used to determine the cell-adhesion parameter (α).  α depends on the cell 
radius (r), the medium resistivity (ρ) and the cell-substrate distance (h) according to  Equation 
(2.6). ECIS model was used to investigate the differences in cell-substrate adhesion between 
the cell lines under investigation, and the corresponding effects on their migration rates. 
iv. Healing Kinetics 
 
ECIS data was exported to Matlab for further analysis. To better understand the healing 
kinetics, the healing impedance graphs were fitted to a sigmoid curve (also referred to as a 
sigmoidal dose-response) in which the hill slope and inflection points were calculated using 
Equation (3.2), therefore providing additional data on the differences between case and control 
migration. Please note that this sigmoidal equation has also been used to investigate the kinetics 
underlying APAP hepatotoxicity for the HepaRG-based model. 
 
𝑦 = 𝑎 +
𝑏 − 𝑎
1 + 10(𝑐−𝑥)𝑑
                                                        (3.2) 
Where; a is the y value at the sigmoid bottom plateau, b is the y value at the sigmoid top plateau, 
c is the inflection point, which is the x value when the response is half way between a and b, 
and d is the hill slope (slope factor or hill coefficient) which describes the steepness of the 
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curve. If it is positive, the curve increases as x increases. If it is negative, the curve decreases 
as x increases. The hill slope has no units. 
v. Moving Variance  
 
Matlab was used to analyze the increase in monitored impedance fluctuations accompanying 
cell transition using the moving variance method. First the signal was normalized and 
detrended using the Matlab ‘detrend’ function. Removing a trend that could have occurred due 
to a systematic increase or decrease in the data, reduces the overall variation and helps focus 
the analysis on the fluctuations under investigation. A sliding window was then used, within 
which the variance was calculated, to determine the amplitude of the impedance fluctuations. 
The variance was calculated over a total of 512 points (22.75h) within a 150 point window 
using a 1 point sliding step, and was plotted against time.    
3.2.2.4. Immortalized-RPE wounding 
 
Telomerase- immortalized retinal pigment epithelium (hTERT-RPE1) (ATCC CRL-4000TM) 
were cultured in ATCC-formulated DMEM:F12 with 10% fetal bovine serum (FBS) and 0.01 
mg/ml hygromycin B. Cells were seeded with a density of 40,000 cells/cm2  and cultured for 
two days before starting the migration assay. Culturing medium was changed 3 times per week.  
Two ECIS modes were used for hTERT-RPE1 migration studies: electrical wounding and 
electric fence. 8W1E was used for wounding while medusa arrays, with 2 sensing electrodes, 
were used for electric fencing. All arrays were incubated with complete culture medium for 2 
hours before cell seeding with a density of 40,000 cells/ cm2. A current of 1 mA at 40 kHz was 
applied for 30s to achieve complete cell death monitored by the drop in impedance to that of 
the cell-free electrode, and complete cell detachment. 
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For the electric fence technique, the fence was turned on instantly after adding the cell 
suspension. The fence excitation was applied to one of the two electrodes in the Medusa array 
well while the other electrode was left as a control. The ECIS default fence parameters were 
used (1 mA, 40 kHz, 3 pulses, pulse on for 1000 ms, pulse off for 10msec, 1 cycle, capacitance 
target: 4nF). The migration rate was calculated according to Equation (3.1) for both wounding 
and fencing.  
Wounding on different-sized electrodes was also investigated using an ECIS 8W1DD array. 
The formulas (5.2-5.4) were again used to derive theoretical wounding parameters that 
generated the same current density generated with previous wounding studies. 
3.2.2.5. Effect of antioxidants on RPE migration 
 
To test the effect of the antioxidant N-acetyl-L-cysteine (NAC) on wound healing and 
migration of the hiPSC-derived RPE cells, 10 mM NAC was added to the culture medium 
either for 2h or 24h before electrical wounding. The effect of NAC on the impedance 
measurements was then monitored for 24h.  
Furthermore, 100 M hydrogen peroxide (H2O2) prepared in retinal differentiation medium 
with no antioxidants (RDM – Antioxidants) was added to some wells with and without the 
presence of NAC to investigate the effect of oxidative stress and antioxidants on RPE 
migration. 
3.2.3. Electrically-induced Liver injuries 
 
Human hepatocellular carcinoma HepG2/C3A cells were obtained from the American Type 
Culture Collection CRL-10741, USA and cultured in Minimum Essential Medium Eagle 
(MEME Sigma). Cells were cultured on ECIS 8W1E arrays with a density of 11,000 cells/cm2. 
Trial and error experiments, based on the previously derived formulas, were used to define a 
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suitable wounding threshold. Parameters of 3 mA, 40 kHz, 20s were used to achieve complete 
cell death. 
3.3. ECIS Impedance measurements 
 
All impedance measurements in this work were conducted using the commercial Electric Cell-
Substrate Impedance Sensing instrument (ECIS ZӨ, Applied Biophysics). Multiple frequency 
impedance measurements (f = 62.5, 125, 250, 500, 1000, 2000, 4000, 8000, 16000, 32000 and 
64000 Hz) were recorded every 160 seconds. The measured complex impedance had a resistive 
and capacitive component which was determined through in-phase and out-of-phase 
measurements using a lock-in amplifier. The sensitivity of a monitoring frequency recorded in 
the impedance, resistance or capacitance measurements can be easily extracted from 
normalized presentations by plotting the ratio of the respective quantity for a cell-covered 
electrode to a cell-free electrode as a function of frequency (Zcell-covered / Zcell-free,                          
Rcell-covered / Rcell-free, Ccell-covered / Ccell-free ). The frequency range of choice should be the one that 
shows a maximum normalized value. According to Figure 3.3, a frequency close to 4 kHz 
provided the highest sensitivity in recording resistance measurements, while a high frequency 
greater than 40 kHz would be appropriate to monitor capacitance measurements. In this work, 
resistance data is presented at 4 kHz to reflect the establishment of cell-cell junctions and the 
capacitance at 64 kHz, which translates linearly to cell coverage.  




Figure 3.3: Choosing a sensitive frequency range. (a) The ratio between the cell-covered to cell-free resistances. 
The frequency at which the resistance ratio is maximized is expected to provide the highest sensitivity. (b) The 
ratio between the cell-covered to cell-free capacitances. The frequency where the capacitance is at its lowest is 
the most sensitive. 
 
3.4. Statistical Analysis  
 
All data are represented as mean  standard error. Matlab was used to perform one-way Anova 
and Tukey-Kramer multicomparison tests to determine whether the groups under investigation 
were significantly different from each other. Probability levels of P<0.05 and P<0.01 were used 
to determine data significance.  
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3.5. High-density, individually-addressed microelectrodes for 
ECIS measurements 
3.5.1. Biocompatibility studies 
 
20mm x 20mm chips were cut from 3 inch diameter, 0.5 mm thick glass wafers (Borofloat33, 
Plan Optik). The chips were cleaned by immersing in piranha solution (3:1, H2SO4:H2O2) for 
10 minutes before being rinsed with de-ionized (DI) water and then dried using a nitrogen gun. 
The chips were then coated with the passivation materials under investigation: 1 m of 
Parylene C (deposited using a SCS Labcoter machine), 800 nm of plasma enhanced chemical 
vapour deposited (PECVD) silicon nitride or 800 nm of PECVD silicon dioxide. The coated 
slides were placed inside 35mm plastic petri dishes (Fisher) before cell seeding. As a control, 
cells were cultured directly in a 35 mm petri-dish. All petri-dishes were incubated for 5 days 
before comparing the biocompatibility of the different materials. 
To test biocompatibility of adhesives that could be used to fix the culture chamber onto the 
glass chips, a commercial adhesive (Dymax, 1161-M) was compared against 
polydimethylsiloxane (PDMS). The commercial adhesive was applied and cured according to 
the manufacturer's protocol. PDMS was prepared with a ratio of 10:1 between the Sylgard 184 
silicone elastomer and its curing agent. The prepared PDMS was degassed in a vacuum 
chamber for 20-30 minutes to get rid of any bubbles present in the mixture. After applying 
PDMS to the edges of the culture chamber and fixing it on top of the glass chip, the chip was 
placed on a hot plate at 100 oC for 20 minutes until the PDMS was cured. 
Human fibroblasts (NIH 3T3) were used for the biocompatibility studies. They were cultured 
in Dulbecco's Modified Eagle Medium (DMEM + 10% serum + 1% penicillin streptomycin) 
at 3000 cells/ cm2 inside the chambers being studied. The culture chambers fixed with PDMS 
and the commercial adhesive were incubated at 37 °C, 5% CO2 for 5 days.  
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3.5.2. Hydrophilicity measurements 
 
An FTA 32 goniometer (First Ten Angstroms) was used to determine the hydrophilicity of the 
Parylene C coated chips. A drop of de-ionized water was placed on the chip surface using a 
pipette tip and the contact angle was measured. The chip was treated with oxygen plasma and 
the contact angle was re-measured to test the treatment effect on improving the chip 
hydrophilicity. 
3.5.3. Microfabrication of MEA chip 
 
3 inch diameter, 0.5 mm thick glass wafers (Borofloat33, Plan Optik) were used to fabricate 
the MEA chips. After wafer cleaning with Piranha solution (H2SO4 : H2O2, 3:1) followed by 
DI water rinse and drying, 100nm platinum was deposited on top of a 10nm titanium adhesion 
layer by electron-beam evaporation (Helios Series cluster tool, Advanced Neotech Systems 
Inc. (ANS)). The wafer was then spin coated with SPR350 positive photoresist (SVG Track 
System) and a mask was used to expose the metal (Karl Suss MA8 Contact Aligner). After 
developing the photoresist (SVG Track System), the metal was etched by ion etching using 
argon plasma (JLS RIE 80). The photoresist was O2-plasma stripped by placing in a barrel 
asher for 75 mins, followed by acetone and isopropyl alcohol (IPA) rinse. The wafer was then 
coated with a 1000 nm insulating layer of Parylene-C (SCS Labcoter). The same steps from 
photoresist spin coating and UV exposure, to photoresist developing were followed. Parylene 
was then etched using O2 plasma (JLS RIE 80) and the resist was stripped as previously 
described. The wafer was then diced into four 30mm × 30mm chips. The detailed run sheet of 
the fabrication process is shown in Appendix F. The fabricated chips had 16 square 
measurement microelectrodes with varying sizes of 20, 50, 100 and 200 m (See Figure 5.12). 
A 2 cm diameter culture chamber was then fixed onto the fabricated chips using PDMS.  
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A printed circuit board (PCB) which allows electrical connection with the ECIS MEA was 
fabricated in-house according to a previous design [333]. The PCB was made out of four layers 
of 1.6 mm FR-4 glass textolite (Figure 3.4). Layer four is designed to support the glass chip 
that is placed inside the opening of layer 3. Layer 4 was also used as a back plate for nylon 
screws. Layer two was used to create an enough space between the chip and the top layer, 
where all the electrical connections are made, to allow for the use of spring probes. The four 
layers of the PCB were screwed together using M3 nylon screws and nuts. The spring probes 
were then connected to ECIS holder arrays using IDC ribbon cables.  
 
Figure 3.4: PCB for MEA-ECIS connection. (a) A picture of the PCB assembly holding a MEA chip with a 
culture chamber on top. (b) An exploded view of (a) showing the different layers of the PCB. 
 
3.6. Electrical Stimulation 
3.6.1. Initial experiments  
 
A commercial microfluidic channel (Ibidi -slide I0.1 luer) was used for the initial electrical 
stimulation experiments. The microfluidic channel was 50 mm long, 5 mm wide and 200 m 
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high with two 60 l medium reservoirs where the salt bridges were inserted. 3mm diameter 
tygon tubes were filled with 2% agar and were used for the application of electric fields without 
having the Ag/AgCl electrodes in direct contact with the cell culture. The electrical stimulation 
set up is shown in Chapter 6, Figure 6.4.  The agar salt bridges were prepared by mixing 1g of 
agar in 50ml of phosphate buffered saline (PBS (2x)). The mixture was then placed on a hot 
plate and stirred until the powder completely dissolved. The tubes were filled with the mixture 
using a 1 ml glass pipette. The tubes were left over night for the agar/PBS gel to solidify. 
Freshly prepared agar tubes were used for every experiment. 
An electrophoresis power supply (EPS 600) was used to supply a DC voltage. Two 0.5 mm 
diameter Ag/AgCl electrodes were connected to the power supply and immersed in 50ml glass 
beakers filled with PBS. For each of the agar bridges, one end was immersed in one of the 
beakers of PBS, while the other end was inserted in one of the microchannel reservoirs.  
A handheld voltmeter (Precision Gold) was used to measure the potential difference before and 
after the salt bridges. The electric field (EF) applied to the channel was calculated by dividing 
the potential difference at the two ends of the channel by the channel's length. Simulations of 
the electric potential inside the microchannel were performed using COMSOL Multiphysics.  
To ensure the presence of an EF inside the channel, 5 m diameter, negatively charged, 
polystyrene beads (Sigma Aldrich) suspended in PBS were added to the channel and a DC 
voltage ranging from 10-30V was applied. The polarity was also reversed midway through the 
experiment to check the effect on the particles movement.  
For the cell-based experiments, various EF strengths (50-300 mV/mm) were applied. An EF of 
300 mV/mm was observed to have the largest effect on cell migration and alignment and was 
therefore used for all electrotaxis experiments. 
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hTERT-RPE1 cells were seeded into the channel with a low density (1500 cells/channel) and 
incubated for 4 hours before the application of a DC EF. Because the experiment was 
performed in an incubator with no CO2 supply, 100mM of HEPES buffer (Sigma Aldrich) was 
added to the culture medium. The experiments were performed at 37 oC and time lapse videos 
were recorded using digital inline holographic microscopy. 
The manual tracking plugin in ImageJ was used together with the ImageJ chemotaxis tool to 
manually track cells and define their motion paths under the effect of 0 and 300 mV/mm EFs. 
The change in cell alignment was defined by measuring the orientation angle, between the 
cell long axis and the horizontal axis (0o), before and after EF application. 
3.6.2. Impedance-based electrical stimulation  
 
For impedance-based electrical stimulation, an initial trial was conducted using the previous 
set up but with an ECIS flow array (1F8x1E) instead of the ibidi microchannel. The array had 
eight 250 μm diameter electrodes inside a flow channel of 50 mm length, 5 mm width and with 
a total channel volume of 90 μL. ECIS measurements were paused for half an hour intervals 
during which an external EF was applied to the array.  
3.6.3. Radial electrical stimulation 
 
A design for radial impedance-based electrical stimulation is proposed in this work. Inventor 
Autodesk has been used to design the microelectrode array, the electrical stimulation inserts, 
and the ECIS microscope stage, while COMSOL Multiphysics has been used for EF 
simulations. The chip has six 500 m diameter circular microelectrodes, where one central 
electrode is surrounded by five outer electrodes. The average spacing between the inner and 
outer electrodes is 6mm. 1 mm wide metal tracks connect the sensing electrodes to the contact 
pads having the same dimensions of those on ECIS arrays (2.38 mm x 4.44 mm with a pitch of 
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3.175 mm centre to centre). Spacing between all tracks is 1mm.  In order to have a radial EF 
that can direct cell migration towards a central wound in the cell layer, an insert was designed 
to place six 3 mm O.D. tubes in a circular arrangement, 1 cm apart from an inner 0.38 mm I.D. 
(Zeus) agar tube that is vertically aligned with the inner wounding electrode. A 107x160 mm 
holder, inspired from the design of the ECIS microscope stage, is designed to connect the chip 
contact pads to the ECIS pin connector. The chip holder also has a 40x50 window to allow for 
optical observations. All inserts, culture chamber and chip holder were 3D printed in-house at 
the mechanical workshop. The culture chamber has 4 x 19 mm groves that allow the insert to 
be placed at a distance 1mm above the substrate, forming a roof over the electrodes. The 
chamber also has three 3mm diameter, 2mm long feet to allow later alignment of the chamber 
and inserts with the electrodes.  
Disposable MEAs are suggested for the radial electrical stimulation experiments. Rectangular 
polystyrene substrates (5x9 cm) were laser cut from a T-75 tissue flask. 100 nm gold, with a 
3nm chromium adhesion layer, was sputtered through a mask leaving only the required pattern 
on the substrate. A second mask will be used for passivation through which 1 μm of Parylene-
C is deposited to define the electrode openings. Three holes, that fit the chamber’s feet, can 
then be drilled in the substrate surface allowing the alignment of the chamber and the inserts 
with the electrodes. 
3.7. Summary 
 
This chapter described the materials, methods and cell culturing protocols used in this work. 
The microelectrode designs and fabrication processes used were also demonstrated. More 






Drug-induced injuries: Acute liver 
failure disease model-on-a-chip 
 
 
This chapter introduces a HepaRG-based ECIS model for drug-induced acute liver failure. The 
establishment and characterization of the model, which integrates impedance sensing with the 
progenitor HepaRG cell line, is described. The kinetics of hepatotoxicity induced by several 
drugs and test compounds are then investigated using bioimpedance measurements and 
modelling. Finally, the potential of using impedance sensing to monitor differences between 
sub-populations of the hepatic co-culture is discussed. 
4.1. HepaRG-based ECIS model for hepatotoxicity studies: Model 
overview 
 
In this work, a robust platform for assessing drug hepatotoxicity has been developed for in vitro 
toxicity studies. A human liver model combining the highly-differentiated human hepatic cell 
line HepaRG with ECIS technology has been established. This liver-on-a-chip model allows 
for real-time, non-destructive, label-free monitoring and computational modelling of toxicity 
assessments. The model has been used to assess liver injury induced by the following drugs: 
paracetamol (APAP), amiodarone and Cyclosporine-A (CsA). 
The same protocol was followed for all hepatotoxicity assays. Figure 4.1 shows the protocol 
and technical workflow of these impedance-based assays. HepaRGs were seeded at confluency 




 co-culture. After the cell differentiation and maturation stage was complete, the impedance 
measurements reached a steady state plateau. The toxicity assays were then conducted on day 
8 of culture starting with an induction phase as explained in more detail in Section 4.3. 
Quantitative, real-time impedance measurements reflected changes in cell behaviour and 
morphology in response to well-known model hepatotoxins.  Impedance data were then further 
analyzed and modelled, deconvolving the impedance Z into its biologically-relevant 
parameters: 
 Tight junctions , barrier resistance parameter (Rb)  
 Cell-substrate adhesion parameter ()  
 Cell-membrane capacitance (Cm) 
As previously explained in Chapter 2 (Section 2.7.1.1), the range of frequencies at which the 
measurements are highly sensitive to cellular change, can be extracted from the impedance 
spectrum. The sensitivity of a chosen frequency can be determined by plotting the ratio of the 
impedance, resistance or capacitance for a cell-covered electrode to a cell-free electrode as a 
function of frequency. According to Figure 3.3 in Chapter 3, a frequency close to 4 kHz 
provided the highest sensitivity in recording resistance measurements, while a high frequency 
greater than 40 kHz would be appropriate to monitor capacitive measurements. In the current 
study, a frequency of 4 kHz was chosen to monitor changes in resistance while a frequency of 
64 kHz was used for capacitance measurements.   
4.2. Establishment and characterization of the HepaRG-model on 
ECIS microelectrodes 
 
To directly establish the HepaRG-based human liver model on ECIS microelectrode arrays, 
cells were seeded at high density (250,000 cells/cm2) on ECIS 8W10E+ (8 wells, 10 




observed changes in impedance were caused by cell differentiation and associated changes in 
cell morphology, and not by an increase in cell density. Impedance was recorded every 160s to 
monitor the kinetics of cell differentiation in real-time over 8 days of culture during which cells 
self-organized into a characteristic hepatocyte:cholongiocyte co-culture (Figure 4.2). 
 
Figure 4.1: Technical workflow for the human HepaRG-based Liver-on-a-chip approach. (a) Protocol 
timeline: The blue panel shows the experiment protocol while the graph illustrates the change in impedance 
measurements. HepaRG cells were seeded on day 0 at high density on ECIS microelectrode arrays. The 
impedance, Z, is recorded in real-time throughout cell differentiation (8 days). HepaRG cells self-organize into a 
terminally-differentiated hepatocyte:cholangiocyte co-culture; mirrored by an increase in impedance indicative of 
tissue barrier formation. On day 8, toxicity assays were conducted starting with a 24h induction phase followed 
by a 24h drug response phase at which the effect of the test compound under investigation was recorded at multiple 
frequencies. Ultimately, impedance of cells exposed to high toxic level reach the value of the cell-free electrode, 
demonstrating complete cell death and detachment from the microelectrodes. (b) Technical Workflow: A 
workflow showing the different steps of the hepatotoxicity impedance-based assay. After recording the impedance 
measurements, data were further analyzed using the built-in ECIS model. The impedance was then deconvolved 
into its biologically-relevant cell electrical parameters: Rb (cell-cell junctions), α (cell-electrode adhesion) and Cm 
(cell membrane capacitance).  
 
Figure 4.3(a) shows the protocol timeline of the characterization and establishment phase of 
the HepaRG-based ECIS model. Cells were cultured in general purpose seeding medium (GPS) 
for the first two days before switching to metabolic maintenance medium (MMM) on day 3. 
The culturing medium was then changed every other day until the cells were terminally-
differentiated. Figure 4.3(b) depicts the mean resistance (n=21) at 4 kHz (R4kHz) throughout the 




electrodes/well provided an average for the co-culture response. Media changes were 
characterized by a peak in resistance associated with cell response to environmental change 
(temperature, nutrients, pH). The impedance measured independently across the wells 
demonstrated the robustness and reproducibility of the HepaRG human liver model on the ECIS 
chip. For all subsequent studies, real-time impedance was monitored prior to toxicity tests, as 
a calibration step to evaluate the quality of HepaRG-based model established onto the ECIS 
microelectrodes. Prior to the hepatotoxin challenge, all human liver models were evaluated 
against these criteria, decreasing considerably the potential for false toxicity reading due to 
poor establishment of the model.  
 
Figure 4.2: HepaRG on ECIS microelectrodes. A phase-contrast image of day 8 HepaRG co-culture on a 100 
µm diameter ECIS microelectrode (illustrated by the dotted circle); partitioned into in vivo-like hepatic cords and 
cholangiocyte-like cells.   
 
To further characterize the hepatocyte:cholangiocyte co-culture, the ECIS built-in model was 
used for an in-depth analysis. It is worth noting that the model is valid only when the cells 
completely cover the electrodes. Therefore, following completion of the cell attachment phase 
(12h), the cell-cell junction barrier resistance (Rb), cell-substrate adhesion () and the cell 
membrane capacitance (Cm) were all measured throughout the establishment of the HepaRG-




through establishment of cell-cell junctions reaching a maximum value of 3.43 ± 0.30 Ω.cm2. 
Cell-adhesion () was found to increase sharply during the first 25h then more gradually before 
finally reaching a steady-state plateau at 6.30 ± 0.37 Ω0.5cm  on day 6. First,  translated as 
further cell spreading onto the microelectrodes after the initial attachment phase, whereas the 
steady increase in -associated cell-adhesion after the drop is likely associated with 
establishment of the co-culture. Cell membrane capacitance (Cm), averaged over the two cell 
populations, was observed to increase in about 25h and to remain at a constant plateau value of 
1μF/cm2 thereafter. The Cm, Rb, and  parameters characterized the establishment and 
behaviour of HepaRG co-culture for all experiments.  
In parallel, staining and biochemical assays were used to characterize morphology and 
phenotype of HepaRG cell cultures (on day 8) as a baseline assessment of functional 
competence as a drug-testing model. Figure 4.3(d) shows fluorescent staining panel of nuclear 
(DAPI; blue), actin filaments F-actin (phalloidin; red) and the drug metabolic enzyme CYP3A4 
(green). Figure (4.3(d)) shows that HepaRGs maintained high CYP3A4 activity (green); with 
punctate F-actin ‘bands’ surrounding bile canaliculae which is representative of structural 
hepatic polarity. Real-time PCR demonstrated strong CYP1A2, CYP2E1 and CYP3A4 
(metabolic/detox enzymes belonging to the cytochrome P450 family) mRNA gene expression 
compared with a representative hepatic cell line (HepG2/C3A) as shown in Figure 4.3(e). Thus, 
the HepaRG cells were shown to maintain intact phenotype and metabolic competence for 







Figure 4.3: Establishment and characterization of human hepatic HepaRG-based model on impedance 
sensing arrays. (a) Protocol timeline: The blue panel shows the protocol followed for the establishment of the 
HepaRG-based model on ECIS arrays.  (b) Resistance measurements: The resistance at 4 kHz (R4kHz) increased 
steadily until reaching a plateau on day 6, reflecting the completion of the differentiation phase and epithelial 
polarization. (c) ECIS model parameters: Graphs show the changes in the barrier function (Rb), cell-substrate 
adhesion () and cell membrane capacitance (Cm) with the establishment of HepaRG cell-cell tight junctions, and 
cell-electrode adhesion. (d)Immunostaining: Immunofluorescent staining of HepaRG cells on day 8 showed a 
highly differentiated phenotype: Extensive hepatic CYP3A4 activity (green); punctate staining of F-actin bands 
indicative of bile-canaliculae structures [red; phalloidin-staining]; with vivo-like hepatic cords and cholangiocyte-
like cells. (e) RT-PCR: Metabolic competence for APAP metabolism was shown by high expression of CYP2E1, 






Figure 4.4 shows the corresponding capacitance measurements at 64 kHz during the HepaRG 
differentiation phase. The capacitive part of the impedance is a reflection of the electrode cell-
coverage. As the HepaRGs were cultured at confluency, thus already covering the electrodes 
at the beginning of the experiment, the measured capacitance showed a relatively small change 
with the establishment of the HepaRG-based model. Hence resistance has been selected to 
monitor HepaRG differentiation kinetics. 
 
 
Figure 4.4: Normalized capacitance as a function of time during HepaRG differentiation. The imaginary part 
of the impedance (capacitance) mirrors cell-electrode coverage. Because HepaRGs were cultured at confluency, 
the capacitance measurements at 64 kHz showed almost no change and therefore it could not be used to monitor 
HepaRG differentiation. 
 
4.3. Hepatotoxicity impedance-based assays 
4.3.1. Paracetamol (Acetaminophen) 
 
Acetaminophen (APAP) hepatotoxicity remains the leading cause of acute liver failure. Despite 




functional liver architecture, temporal and quantitative effects of direct APAP toxicity on 
adhesion structures have not been previously explored and mechanistic insight into APAP-
induced TJ disruption in hepatocytes is lacking. Thus, the HepaRG-based ECIS platform was 
used to investigate dose-dependent effects of APAP on cell-cell TJs, cell-substrate adhesion 
and the integrity of the cell membrane.  
Following the establishment of HepaRG co-culture for 8 days, a 24h CYP3A4-induction with 
Rifampicin was conducted. CYP3A4, a member of the CYP450 family, metabolizes 
acetaminophen to the reactive metabolite, NAPQI (N-Acetyl-p-benzoquinone imine). Since 
CYP450 detox enzymes can be inhibited by solvents such as DMSO, a possible constituent of 
proprietary culture medium, induction with the liver enzyme-inducer Rifampicin was used. It 
is worth mentioning that Rifampicin induction had no effect on the cells as reflected by the 
resistance measurement and its deconvolved modelling parameters as shown in Figure 4.5. 
The HepaRG culture was then subjected to a dose-response challenge with the hepatotoxin 
acetaminophen (0-20 mM). Quantitative impedance measurements were taken every 160s over 
24h in an effort to detect earlier, key biological events (cell behavior parameters: Rb, α, Cm) in 
response to APAP. Following paracetamol addition, a time- and dose-dependent decrease of 
impedance was observed at all frequencies indicating a global decline in cellular health. 
Figure 4.6 (b) shows the corresponding decrease in normalized R4kHz with the measurements 
dropping to almost that of the cell-free electrode, at the highest dose (20 mM). The 
corresponding non-normalized data with the no-cell (medium only) control are shown in Figure 
4.7. Normalized data was a more accurate way to compare the amount of decrease 
accompanying APAP introduction to the different culture wells. Data was normalized by 
dividing the measured impedance (or the deconvolved parameter) by the value at the challenge 





Figure 4.5: Effect of Rifampicin on HepaRGs.All the toxicity assays were preceded by a 24h induction phase 
of rifampicin. Rifampicin showed no effect on HepaRGs as monitored by ECIS. (a) Effect of Rifampicin on 
resistance: inducing the cells did not have any effect on cell behaviour or their morphology as reflected by 
resistance measurements. (b) Induction did not cause any disruption to the cell-cell tight junctions, cell-substrate 
adhesion or cell membrane integrity as illustrated by the modelled Rb,  and Cm values. 
To investigate further the mechanisms of paracetamol toxicity on HepaRGs, the APAP-induced 
effect on Rb, , as well as Cm was investigated. It was clear that Rb values decreased in a dose-
dependent manner (Figure 4.6 (c)). Similarly, Figure 4.6 (d) demonstrates dose-dependent 






Figure 4.6: Real-time normalized impedance monitoring of HepaRG-based liver-on-chip device following 
24h APAP challenge. (a) Protocol timeline: Following 24h Rifampicin induction in confluent HepaRG cells on 
day 8, cells were treated on day 9 for 24h with APAP (0mM, untreated control; 5mM; 10mM; and 20mM); (b) 
Post-challenge resistance kinetics: APAP caused a dose-dependent decline in normalized resistance at 4kHz (c) 
Cell-cell tight junctions: APAP disrupted TJs in a dose- and time-dependent manner; (d) Cell-substrate adhesion 
disruption suggesting cell detachment from the electrode surface (e) Decrease in Cm values reflecting how cell 
membrane integrity was compromised at high APAP doses (10-20 mM). 
 
Although no significant differences between APAP doses were evident before 15h,  could 
clearly quantify and discriminate between APAP-induced effects on cell adhesion in real-time 
(15-24h) as opposed to standard 24h end point hepatotoxicity assays. In contrast to Rb and , 




Cell membrane integrity was compromised only at high paracetamol doses (10 mM, 20 mM), 
with no effect detected at low doses.  
 
 
Figure 4.7: Non-normalized APAP dose response. (a) The 24h effect of APAP on the true, non-normalized 
resistance in real-time showing dose- and time- dependent decrease in measured values. The effect of APAP on 
tight junctions, cell-substrate adhesion and cell membrane capacitance is illustrated in (b), (c) and (d) respectively.  
 
 
At higher doses, a drop in Cm after 8 hours could be associated with sudden rupture of the cell 
plasma membrane, with total cell death quantified at 20h for 10 mM and 15h for 20 mM APAP. 
The measured resistance as well as the model parameters at 6, 12 and 24h are presented in 




APAP Challenge Control 6 hrs 12 hrs 24 hrs 
Resistance (Ω)     
5 mM 1680.90 ± 126.82 1603.0 ± 73.6 1346.1 ± 34.3* 930.92 ± 95.27** 
10 mM 1508.30 ± 74.02  1418.50 ± 49.13 1042.2 ± 36.6** 585.45 ± 72.24** 
20 mM 1513.8 ± 101.3  1191.20 ± 52.68** 706.7 ± 60.1** 421.6 ± 20.4** 
Rb (Ω.cm2)     
5 mM 3.585 ± 0.36 3.53 ± 0.25 2.6 ± 0.1** 1.13 ± 0.32** 
10 mM 3.25 ± 0.33 2.37 ± 0.28** 1.15 ± 0.26** 0.185 ± 0.080** 
20 mM 3.45 ± 0.23 1.78 ± 0.30** 0.20 ± 0.09** 0** 
α (Ω0.5cm)     
5 mM 6.4 ± 0.2 6.30 ± 0.16 5.880 ± 0.087 2.97 ± 0.29** 
10 mM 6.32 ± 0.24 6.75 ± 0.30 5.84 ± 0.08 2.67 ± 0.67** 
20 mM 6.27 ± 0.69 5.93 ± 0.10 4.69 ± 0.37 1.49 ± 0.75** 
Cm (µF/cm2)     
5 mM 1.01 ± 0.01 1.060 ± 0.007 1.060 ± 0.016 1.040 ± 0.017 
10 mM 1.03 ± 0.04 1.080 ± 0.049 0.9 ± 0.1 0** 
20 mM 1.10 ± 0.07 1.06 ± 0.14 0.36 ± 0.22* 0** 
 
Table 4.1: Non-normalized APAP dose response. The effect of APAP on the non-normalized resistance, Rb, α 
and Cm at different time points of the toxicity assay. From the table, it is clear that the earliest and most significant 
effect of APAP is on the cell-cell tight junctions even at the low dose of 5mM. * P<0.05; ** P<0.01 (significantly 
different from control). The greyed areas indicate time points at which the model could be invalid due to cell 
detachment resulting in a non-confluent cell layer. 
 
The resistance bar graphs show a time dependent APAP dose response. For the highest dose 
(20mM), the decline is significant even after only 6 hours of the challenge. After 12 hours, the 
decrease in resistance is significant for the other doses and at the end of the 24h assay, the 
resistances reach their minimum values close to that of the cell free electrode for the high doses. 
As mentioned before, the main effect of APAP was on the cell-cell junctions. At 6h, a 
significant decrease in Rb is measured for the high doses (10-20 mM, more significant for 
20mM). At 12h, the decrease in Rb is significant even for the 5mM dose while the cell-cell 
junctions are almost demolished for the 20mM. The effect of APAP on cell-substrate adhesion 
does not occur as early as that on cell-cell junctions. No significant decrease in adhesion is 
monitored at 6h or 12h. At 24h, however, all doses show a significant decrease in cell-substrate 
adhesion. The effect of APAP on the integrity of the cell membrane is only monitored for the 
high doses. It is more pronounced at 24h where Cm reaches zero as the membrane integrity is 





Figure 4.8: Non-normalized APAP dose response bar graphs. The effect of APAP on the non-normalized 
resistance (a), Rb (b),  (c) and Cm (d) is shown at different time points (6h, 12h and 24h) of the toxicity assay.   * 
P<0.05, ** P<0.01 (significantly different from control). 
 
To summarize, the most prominent effects at all tested APAP doses were on cell barrier 
resistance. ECIS measurements showed an earlier effect and disruption to Rb, even at a low 
‘non-toxic’ dose of 5 mM. After 10h, parameters of cell adhesion () and cell membrane 




cells are irreversibly compromised. Since the sensitivity of ECIS measurements to changes in 
cell-cell junctions and adhesion is more pronounced at low frequencies, resistances at 4 kHz 
were used to monitor the effect of APAP on HepaRG morphology. The effect of APAP on 
capacitance measurements at 64 kHz is also shown in Figure 4.9. This translates into electrode 
cell-coverage and cell attachment/detachment. 
In order to gain more insight into the kinetics of APAP toxicity, a sigmoid curve was fitted to 
the R4kHz measurements (Figure 4.10 (a)). A significant difference (P<0.01) between the 
sigmoidal slope of the 5mM and those of the 10mM and 20mM APAP concentrations was 
observed. This difference in slopes was related to the dose-dependent decline of the 
measurements (Figure 4.10 (b)). Moreover, the APAP dose response occurred in a time-
dependent manner, with the decrease in resistance measurements passing through two phases: 
a short phase showing a relatively small decline in resistance following APAP addition, and a 
longer (main) phase showing a more pronounced APAP toxic effect.  A delay in the start of 
this main phase was noticed and was also significantly (P<0.01) dependent on the APAP 
concentration, varying from 1.0 ± 0.2h for the 20 mM dose and 5 ± 1h for 10 mM to  8.0 ± 1.5h 









Figure 4.9: APAP capacitance dose-response. (a) Normalized capacitance measurements showing earlier cell 






Figure 4.10: Sigmoidal fitting of the non-normalized APAP dose response. (a) Sigmoid curve fitted to non-
normalized resistance measurements following the addition of 5 mM, 10 mM and 20 mM APAP (b) Bar graph 
comparing the sigmoidal slopes of the different APAP doses. The higher doses (10 mM, 20 mM) of APAP showed 
a significantly higher sigmoidal slope, indicating a faster decline in the measured resistances.(c) Bar graph 
showing the delay in response for the three APAP concentrations. The APAP effect was accompanied by a delay 
in the main phase response that varied from around 1h for the 20mM and 5h for the 10mM to almost 8h for the 
5mM APAP doses. ** P<0.01. 
 
i. Biochemical hepatotoxicity assays and staining 
a. PrestoBlue and ATP-depletion 
 
To assess hepatotoxic response to APAP in HepaRG cells and for comparison with impedance 
measurements, dose-dependent hepatotoxicity was detected at 24 hours, by multiplexing ATP-
depletion endpoint assay with the PrestoBlue cell viability assay (Please note that all 
hepatotoxicity biochemical assays and staining were performed by the HepLab group at the 




Such assays estimate the functional or metabolic state of the cell, typically, mitochondrial 
reductive activity/ dysfunction as a correlate of oxidative stress in response to a hepatotoxin. 
Prestoblue and ATP values are expressed relative to the levels found in control cells, arbitrarily 
set at a value of 100%.  Interestingly, the effect of APAP on cell viability and ATP depletion 
was not as dramatic as monitored with impedance sensing. ATP content decreased to only 50% 
of control values at 20 mM APAP; with minimal change observed for 5-10 mM. Cell metabolic 
activity, as measured by Prestoblue (providing also a quantitative measure of viability and 
cytotoxicity), was more pronounced in sub-toxic (5 mM) and intermediate (10 mM) dose 
APAP, compared with ATP-depletion assay.  
Moreover, unlike quantitative real-time ECIS cytotoxicity monitoring, these biochemical tests 
can not simultaneously provide information on individual structural components, and lack the 
sensitivity and specificity required for time-resolved mechanistic studies. 
b. HepaRG Intercellular integrity following APAP toxicity 
 
To ascertain whether reduced Rb values were due to physical disruption of TJs, potentially 
leading to cell death, TEM (transmission electron microscopy) coupled with ZO-1 (Zona 
Occuldens, TJ- associated protein) immunofluorescent staining was performed after 24h of  
APAP exposure.   
Phase-contrast images showed the progressive loss of the characteristic hepatocyte (H)/ 
cholangiocyte (Ch) in vivo-like hepatic cord phenotype with increasing APAP concentrations 





Figure 4.11: Parallel biochemical hepatotoxicity assays following 24h APAP challenge. (a) Classic ATP-
depletion endpoint assays. (b) PrestoBlue live-cell viability. Prestoblue and ATP values are expressed relative to 
the levels found in control cells, arbitrarily set at a value of 100%. 
 
 
Figure 4.12: HepaRG phase contrast images following 24h APAP challenge. Characteristic hepatocyte (H) / 
cholangiocyte (Ch) in vivo-like hepatic cord phenotype in control cultures (a) is progressively lost with increasing 





Confocal microscopy demonstrated structural disruption of TJ, indicated by a reduced intensity 
of the green immunofluorescence staining of ZO-1 with increasing APAP dose (Figure 4.13). 
Down-regulation of ZO-1 proteins may result in decreased cell survival through disruption of 
TJ integrity and adhesion to extracellular matrix components in HepaRG cells. The ‘chicken 
wire’ network of delineated ZO-1, progressively decreased, as the hepatic cord phenotype was 
compromised. 
 
Figure 4.13: ZO-1 immunofluorescence staining of HepaRG following APAP treatment for 24h. Confocal 
microscopy demonstrated reduced intensity (green immunofluorescence staining) of the hepatic tight junction-
associated structural protein ZO-1, with increasing APAP. The ‘chicken wire’ network of delineated ZO-1, 
progressively decreased, as the hepatic cord phenotype was compromised. (a) Untreated control (0 mM), (b) 5mM, 




TEM imaging confirmed dose-dependent disruption of TJ-barrier function prior to cell death 
with 10mM, 20mM doses. Examination of TEM ultrastructure at 5mM APAP showed no 
evidence of TJ structures. However, an ‘electron-dense’ perimeter was observed around 
hepatocytes; perhaps indicative of subcellular redistribution of TJ proteins in response to 
cellular stress Figure 4.14 (b).  
 
 
Figure 4.14: TEM ultrastructural imaging of HepaRG following 24h APAP challenge. (a) Typical 
ultrastructure in untreated controls, showing numerous mitochondria (Mt) with tight junctions (arrows), which 
seal bile canalicular lumen (BC) formed between two adjacent hepatocytes. (b) At 5 mM APAP, although discrete 
TJ structures were not visible, an ‘electron-dense’ perimeter surrounded hepatocytes (red arrowheads), adjacent 
cholangiocytes (Ch). At 10mM (c) and 20 mM (d) APAP, TJs were not present, with cells commonly exhibiting 
necrotic (NH) or apoptotic (AP) appearance, with Type-I blebbing.  Altered mitochondria shape was evident, 






Figure 4.14(a) shows typical ultrastructure in untreated controls, showing numerous 
mitochondria (Mt) with tight junctions (red arrows), which seal bile canalicular lumen (BC) 
formed between two adjacent hepatocytes. Tight junctions were completely demolished for the 
higher 10 mM and 20 mM APAP doses (Figure 4.14(c) and (d) respectively). Many cells 
showed a necrotic (NH) or apoptotic (AP) appearance, with Type-I blebbing. Altered 
mitochondria shape was also evident, although retaining some dense mitochondrial granules 
(DMGs). 
4.3.2. Phorbol ester  
 
Phorbol ester activation of phosphokinase C (PKC) has been shown to disrupt TJ integrity and 
significantly reduce polarity in human hepatic HepG2 cells [35]. To validate Rb impedance 
measurements, and test whether APAP-induced disruption of TJs could implicate a PKC-
dependent signalling pathway, a dose-response with the PKC-activator, phorbol-12-myristate-
13-acetate (PMA) was performed using different concentrations of 50, 100 and 200 ng/ml  
(Figure 4.15). The only quantified effect of PMA was on Rb, decreasing by around 30% at all 
doses before increasing again towards their original values (Figure 4.15(c)). Figure 4.16 shows 
the corresponding non-normalized data of the 24h PMA test. Exact values for the non-
normalized resistance, Rb, α and Cm at 6h, 12h and 24h of the PMA challenge are provided in 
Table 4.2. A significant decrease (P<0.01) in the resistance measurements was recorded at 6h 
for the highest (200 ng/ml) dose. Interestingly, this was the first dose to increase and return 
back close to its original resistance values. At 12h, all doses showed a significant decrease in 
resistance (P<0.01). After this decline in resistance values, all doses showed an increase in the 
measurements. The decrease in resistance measurements was attributed to Rb disruption, since 







Figure 4.15: HepaRG tight junction disruption following PMA challenge (a) Normalized resistance initially 
decreased 20% followed by an increase back to pre-challenge resistance values; (b) Rb (cell-cell tight junctions): 
the only measured effect of the PKC-activator PMA was on Rb, which decreased by 30% at all doses tested, 





Figure 4.16: Non-normalized PMA dose response. (a) Non-normalized resistance initially showed a decrease 
following the introduction of phorbol-ester to the cell culture. This was followed by an increase back to the pre-
challenge original values; (b) The only significant effect of phorbol-ester was on Rb (cell-cell tight junctions), 
which like the resistance decreased at all doses tested returning close to original values; (c-d) No effects were 
detected on either α or Cm. 
 
PMA Challenge Control 6 hrs 12 hrs 24 hrs 
Resistance (Ω)     
50 ng/ml 8415.60 ± 137.35 7779.9 ± 143.9 6943.5 ± 116.6** 7447.1 ± 260.1* 
100 ng/ml 8339.2 ± 151.1 7582.4 ± 296.5 6846.20 ± 94.17** 7666.5 ± 218.5 
200 ng/ml 7546.90 ± 58.38 6803.7 ± 44.4** 6459.8 ± 146.2** 7509.1 ± 308.9 
Rb (Ω.cm2)     
50 ng/ml 2.970 ± 0.078 2.620 ± 0.089 2.09 ± 0.07** 2.43 ± 0.14* 
100 ng/ml 2.90 ± 0.07 2.52 ± 0.02* 2.010 ± 0.057** 2.55 ± 0.10* 
200 ng/ml 2.46 ± 0.03 2.010 ± 0.007** 1.770 ± 0.063** 2.49 ± 0.17 
α (Ω0.5cm)     
50 ng/ml 4.80 ± 0.02 4.840 ± 0.076 4.610 ± 0.052 4.50 ± 0.05 
100 ng/ml 4.93 ± 0.11 4.920 ± 0.075 4.660 ± 0.037 4.56 ± 0.18 
200 ng/ml 4.530 ± 0.046 4.790 ± 0.082 4.790 ± 0.073 4.63 ± 0.08 
Cm (µF/cm2)     
50 ng/ml 1.480 ± 0.017 1.560 ± 0.032 1.520 ± 0.013 1.52 ± 0.02 
100 ng/ml 1.470 ± 0.018 1.560 ± 0.006 1.510 ± 0.014 1.53 ± 0.02 
200 ng/ml 1.530 ± 0.024 1.59 ± 0.01 1.550  ± 0.035 1.60 ± 0.02 
Table 4.2: Non-normalized phorbol ester dose-response. The only significant effect of PMA was on cell-cell 
tight junctions (Rb ); whilst no significant decrease was measured for either the cell adhesion parameter or cell 
membrane capacitance.  * P<0.05; ** P<0.01: significantly different from control. The greyed areas indicate time 




For Rb measurements however, both the 100 and 200 ng/ml doses showed a significant decrease 
at 6h; and at 12h all doses expressed a significant decrease in Rb (P<0.01). At 24h, the values 
of Rb increased for all doses returning close to the original values in the case of the highest dose 
(200 ng/ml), whereas the other doses (50 ng/ml, 100 ng/ml) still showed a less significant 
decrease (P<0.05). Figure 4.17 shows bar graphs describing the effect of PMA at 6h, 12h and 
24h on HepaRGs.   
 
Figure 4.17: Non-normalized PMA dose response. Bar graphs showing the effect of PMA on the non-
normalized parameters (a) Resistance , (b) Rb  (c)  and (d) Cm at different time points (6, 12, 24h) of the toxicity 




Biochemical hepatotoxicity assays were also performed at the end of the PMA challenge (24h). 
PMA was found to cause moderate increases of both ATP-content ( Figure 4.18 (a)), and 
PrestoBlue live-cell viability (Figure 4.18 (b)). This might be due to hormetic effects (low dose 
stimulation) of the PKC activator, PMA. 
 
 
Figure 4.18: Parallel biochemical hepatotoxicity assays following 24h APAP challenge (a) Classic ATP-
depletion endpoint assays.(b) PrestoBlue live-cell viability Prestoblue and ATP values are expressed relative to 
the levels found in control cells, arbitrarily set at a value of 100%. 
4.3.3. NAPQI effects on TJs  
 
Excessive production of the metabolite NAPQI is the major cause behind APAP hepatotoxicity 
[25]. Direct effects of different concentrations of NAPQI on tight junctions were therefore 
tested using impedance sensing. At a high dose of NAPQI (500 μM), normalized resistance 
showed an approximate 50% decrease over 20 hours, indicating a decline in cellular health 
(Figure 4.19 (a)). An abrupt (0-2 hours) and sustained (0-20 hours) disruption of TJs occurred, 
with a 50% decrease in the impedance parameter (Rb) after 6 hours (Figure 4.19 (b)). α also 
declined by 20% after 20 hours for the highest dose (Figure 4.19(c)). Minimal effects recorded 
on both Rb and α (at 125 and 250 μM), may reflect detoxification of NAPQI by intrinsic stores 





Figure 4.19: Effect of NAPQI on tight junctions. (a) Effect of NAPQI on normalized resistance, cell-cell 
junctions (b), cell adhesion  (c) and cell-membrane integrity (d). 
 
4.3.4. Other hepatotoxins 
 
To demonstrate versatility of the HepaRG-based ECIS model, case studies demonstrating the 
potential utility of impedance biosensing were performed, incorporating impedance 
spectroscopic modelling in drug development. Different classes of drugs causing other types of 
liver injury, were tested on HepaRG cells. Specifically, dose-dependent real-time toxicity 




i. Amiodarone  
 
Following the same protocol used for APAP toxicity assay, amiodarone was added to the 
HepaRG culture medium with different concentrations (25, 50, 75 and 100 µM ) and a 24h 
dose-response assay was conducted. amiodarone was found to affect the time course impedance 
in the highest dose of toxin tested (100 µM). Figure 4.20 (a) depicts the drop of 4 kHz resistance 
associated with the addition of 100 µM of toxin. Consequently a corresponding drop in Rb, α 
and Cm was observed at this concentration. 
Significant effects of the lowest dose of amiodarone was found in the barrier function Rb after 
10h of exposure; whereas both the cell adhesion parameter and the cell membrane integrity 
were unaffected.  
ii. Cyclosporine-A 
 
Cholestatic drugs, which induce leaky TJs, can generate toxic mechanisms (similar to APAP) 
in HepaRG cells, including ROS-mediated disruption of TJs. The immunosuppressive agent 
cyclosporine-A (CsA) is known to cause cholestasis [34]. CsA was added to HepaRG on Day 
9 of culture with 10, 20, 30 and 40 µM concentrations and a 24h impedance-based toxicity 
assay was performed (Figure 4.21). A dose- dependent decrease in resistance was monitored 
after adding CsA. The main effect of CsA was on the cell-cell junctions. The decrease was dose 










Figure 4.20: Amiodarone challenge.  (a) Following amiodarone addition, a drop in resistance was observed in a 
dose dependent manner.  (b) Effect on cell-cell junctions (Rb): amiodarone affects Rb in a dose-dependent manner. 
(c) Effect on cell-electrode adhesion: α decreases at high doses of amiodarone (75μM, 100μM) suggesting that 
cells detach from the electrode’s surface depending on the dose used. (d) Effect on membrane integrity: the cell 












Figure 4.21: Cyclosporine-A challenge (a) A slight decrease in resistance was monitored after adding CsA which 
occurred in a dose dependent manner. (b) Effect on cell-cell junctions (Rb): the main effect of CsA was on the 
cell-cell junctions. (c) Effect on cell-electrode adhesion (d) Effect on membrane integrity 
 
4.4. Monitoring sub-populations 
 
As previously described in Section 4.2, HepaRG cells terminally differentiate into a 
hepatocyte:cholangiocyte co-culture on top of the ECIS 250 µm microelectrodes. In order to 
monitor responses from each sub-population separately, smaller sized electrodes (25, 50, 100 
µm) were used. Clear differences in the measured impedances between the two populations at 
high frequency were monitored. The sub-populations were optically identified based on their 




Figure 4.22: HepaRG sub-population ECIS monitoring. (a) Hepatocytes covering a 50 µm diameter 
microelectrode (b) Hepatocytes covering a 100 µm diameter microelectrode (c) Resistance at 64 kHz on 100 µm 
diameter electrodes, sampling hepatocytes in one well (blue) and Cholangiocytes in another well (red). 
Measurements from a 50 µM electrode sampling hepatocytes is also shown in green. 
 
It was noticed that small electrodes sampling hepatocytes displayed 24h cycles of large peaks 
in impedance measurements (Figure 4.22). However, microelectrodes sampling only 
cholangiocytes did not show these peaks. Interestingly, the 24h cycles observed for hepatocytes 
disappeared when cultured with reduced serum (2% FBS). This ruled out environmental or 
equipment factors as the possible reason behind the observed cycles. An explanation for such 
measurements is that the small electrodes might be picking up a hepatocyte circadian rhythm 
behaviour. Larger electrodes (250 µm diameter) average the measurements of a larger group of 




Biochemical assays will be needed to confirm if what is measured for hepatocytes is indeed 
due to a circadian rhythm. 
4.5. Summary 
 
This chapter described the first disease model-on-a-chip presented in this thesis. The ALF 
model employs a liver biochip approach integrating the hepatic progenitor cell line, HepaRG, 
with the impedance sensing platform, ECIS. After the establishment and characterization of the 
HepaRG-based ALF model, impedance spectroscopy was used to investigate the effect of the 
model hepatotoxins; paracetamol, amiodarone and Cyclosporine-A on the hepatic co-culture. 
Dose- and time- dependent responses to the tested drugs were observed. Moreover, impedance 
analysis and modelling showed how cell-cell tight junctions and cell-adhesion are 
compromised due to drug-induced toxic effects; revealing an unknown mechanism of 
paracetamol hepatotoxicity. The obtained results were confirmed using biochemical assays, 
immunofluorescence staining of tight junctional ZO-1 proteins as well as ultrastructural TEM 
imaging.  
Smaller electrodes sampling a sub-population of the HepaRG co-culture showed differences in 
the measured impedance. While the impedance measurements of the hepatocytes sub-
population displayed 24h cycles of large peaks, electrodes sampling only cholangiocytes did 
not share this phenomenon. Starvation of hepatocytes by reducing serum concentration seemed 
to demolish this response, suggesting that these 24h cycles might represent a circadian rhythm. 
More assays will be needed however to confirm that. 
The ALF model-on-a-chip allowed for a non-invasive, quantitative assessment of the effect of 
hepatotoxins on tight junctions and tissue structure, providing an invaluable tool for pre-clinical 
drug studies and revealing previously unknown mechanisms underlying paracetamol toxicity; 






Electrically-induced Injuries:          
An in vitro model-on-a-chip for      
age-related macular degeneration 
 
In the previous chapter, the potential of impedance sensing in studying drug-induced injuries 
has been established. Impedance sensing can also be used to study electrically-induced injuries. 
These types of assays are usually referred to as electrical wound healing assays as they focus 
on studying cell migration during healing processes and regeneration. In this study, 
keratinocytes were initially used as a model for electrically-induced injuries to better 
understand ECIS wounding mode and the quantitative monitoring of cell regeneration and 
migration. ECIS electrical wounding assays were then used to model degeneration of retinal 
pigment epithelium associated with age-related macular degeneration (AMD). Moreover, in a 
preliminary study, electrical wounding was used to investigate the migration abilities of 
hepatocytes in order to gain more insight into the regenerative abilities of liver cells. 
Finally, high density microelectrode arrays with high spatial resolution and different-sized, 
individually-addressed square microelectrodes were designed and fabricated in-house before 





5.1. Optimization of ECIS wounding parameters 
 
Wound healing is a naturally occurring response to tissue injury. Following an injury, cellular 
events take place to reconstitute and restore the tensile strength of injured skin. The ability of 
keratinocytes to renew and regenerate is well known, making this cell type a suitable candidate 
for cell migration studies. An adult human epidermal keratinocytes (HEKa) cell line was used 
for the initial electrical wounding experiments to establish an in-depth understanding of ECIS 
wound healing assays and optimize the wounding parameters. 
ECIS 8W1E (8 wells, 1 electrode/well) arrays were used for the wounding experiments where 
each of the culture wells was seeded with 2500 cells/cm2. The wounding process started after 
the establishment of a confluent cell layer, 4-7 days after seeding. In order to determine the 
wounding threshold, a trial and error experiment was conducted using previously established 
wounding parameters as an initial guide [84]. Table 5.1 shows the different wounding 
parameters used together with their effect on ECIS measurements and wound healing. 
Impedance data was modelled using the ECIS built-in model and the effect of wounding on the 
tight junctions, cell-substrate adhesion as well as the cell membrane capacitance was also 
investigated. It was noticed that current amplitudes < 3 mA did not cause complete cell death, 
reflected by the very fast cell recovery (~1-2h). Electroporation was suggested to occur under 
these conditions. Applying a wounding pulse for a long time led to no recovery after wounding, 
possibly due to thermal effects causing damage to the cells around the wound edges, therefore 
affecting their functionality and hindering the migration process. Moreover, low frequencies 
(<10 kHz) were shown to cause electrode damage if applied for a long time. After 3 independent 
experiments, it was concluded that wounding pulses of 3 mA at 40 kHz for 30s were suitable 





From Table 5.1, a formula predicting the severity of the wound for specific wounding 
parameters was developed as follows:  
                    
𝑊𝑜𝑢𝑛𝑑 𝑆𝑒𝑣𝑒𝑟𝑖𝑡𝑦 =  
𝐴𝑝𝑝𝑙𝑖𝑒𝑑 𝐶𝑢𝑟𝑟𝑒𝑛𝑡 (𝑚𝐴) ∗ 𝑃𝑢𝑙𝑠𝑒 𝑑𝑢𝑟𝑎𝑡𝑖𝑜𝑛 (𝑠)
𝐹𝑟𝑒𝑞𝑢𝑒𝑛𝑐𝑦 (𝑘𝐻𝑧)
            (5.1) 
For each cell type, a threshold using the above formula can be determined, below which 
electroporation is most probable to take place and above which no wound healing is expected. 
It has to be noted that trial and error experiments still have to be performed first in order to 
determine such a threshold for a specific cell line. Moreover, slight differences in healing times 
might occur even when using the same wounding threshold.  
Figures 5.1 (a) and (b) show the resistance and capacitance measurements accompanying 
keratinocytes wound healing. It is worth noting that while the resistance measurements will 
decrease with cell death, as more current will be able to flow freely through the culture well, 
the capacitance measurements will on the other hand increase. This is because the capacitance 
arising due to the cell dielectric properties contributes to the total impedance in a reciprocal 
manner according to Kirchoff’s law, i.e. the capacitance measurements will decrease with cell 
attachment and increase with cell detachment and/or death. Although the HEKa impedance 
measurements after wounding dropped close to the level of the cell-free electrode (~2000 Ω), 
the cells did not completely detach from the electrodes. This behaviour has been reported for 
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Table 5.1: Trial and error wounding parameters. After HEKa reached confluency, different wounding 
parameters were applied to each of the culture wells. The healing process was monitored through ECIS impedance 






In these cases, it is suggested that cells from the wound edges migrate underneath the dead cell 
layer to close the wound. Furthermore, the possibility of wounding the cell layer using a train 
of short pulses using the electric fence set up was explored. Fencing was applied for 20 minutes, 
lysing the cells on top of the electrode. Impedance measurements dropped close to that of a 
cell-free electrode followed by a 16h recovery. However, the cells still did not detach from the 
electrodes. In order to confirm cell death, viability staining was performed using Ethidium 
Bromide (AO/EB). Dead cells on top of the microelectrodes stained red while the healthy cells 
in the rest of the wells were stained green. DAPI was also used for nuclei staining.  
 
Figure 5.1: Keratinocytes ECIS wounding assay. (a) Resistance measurements during wound healing after 
wounding using different wounding parameters. (b) Capacitance measurements during HEKa healing after 
wounding the cells using different wounding parameters. (c) Confluent HEKa on ECIS microelectrodes before 
wounding. (d) HEKa after wounding with a pulse of 3 mA, 40 kHz for 60s. (e) AO/EB staining showing living 






5.2. hiPSCs-based ECIS model of macular degeneration 
5.2.1. Establishment and Characterization of the AMD model-on-a-chip 
 
The dysfunction of retinal pigment epithelial (RPE) cells, RPE degeneration and the decline in 
their wound healing abilities are the main implications in age-related macular degeneration 
(AMD). In this work, ECIS electrical wounding assays have been used to mimic the loss of 
RPE in AMD. Induced pluripotent cells were successfully derived from a patient with late-
onset retinal macular degeneration (LORMD) and one unaffected sibling according to a 
previously published protocol [334, 335] and as briefly explained in Appendix E. In each case, 
the cells were differentiated towards RPE cells before being plated on ECIS microelectrode 
arrays (Figure 5.2 (a)). Final RPE maturation was completed on the microelectrode arrays using 
a stepped 25-day protocol that progressively moved towards a serum-free medium (Figure 5.2 
(b)).  The hiPSC-RPE control and case cell lines were plated at confluency onto ECIS Medusa 
arrays with a density of 100,000 cells/cm2 on day 0. Retinal differentiation medium (RDM) 
was used as the culturing medium with the concentration of fetal bovine serum being changed 
from 10% initially, to 2% for days 2-5, and then to 0% from day 6 onwards. The medium was 
changed every other day until the maturation of RPE was achieved. 
Real-time quantitative monitoring of the spectroscopic complex impedance, with a resistive 
and capacitive component, was performed throughout the RPE maturation phase by acquiring 
multi-frequency data points at a 160s interval. Generally, the method of Wegener et al. [12], in 
which the resistance is measured at medium frequencies while the capacitance measurements 
are recorded at high frequencies, was followed. The resistance in that case mainly reflects the 
establishment of cell-cell junctions and cell-substrate adhesion, while the capacitance 




Figure 3.3 in Chapter 3, the monitoring frequencies chosen for resistance and capacitance 
measurements, providing highly sensitive measurements, were 4 kHz and 64 kHz respectively. 
The 25-day time-course maturation process was found to be highly robust and reproducible for 
both case (N= 9) and control wells (N= 11) thus offering a criterion by which to reject faulty 
in vitro models. The changes in the resistance measured at 4 kHz that characterized RPE 
maturation and were associated with initial cell spreading, morphological changes and barrier 
formation are shown in Figure 5.2 (c). First a steep increase in resistance that peaked at 15 kΩ 
was observed on day 2 of culture and this was followed by a slow decrease over 5.5 days to a 
plateau with an average value of 8.5 kΩ. The formation of the confluent cell layer and the 
hiPSC-RPE differentiation stages were also observed under a microscope. It was noticed that 
the drop in ECIS measurements following the peak in resistance was mirrored by a change in 
cell morphology from fibroblastic-like cells towards polygonal cobble-stone mature epithelial 
cells. After RPE maturation, an automated electrical wound healing assay was performed and 
subsequent cell migration associated with healing phase was monitored. Before conducting the 
electrical wounding assay, the establishment and maturation of the RPE layer on top of the 
microelectrodes was confirmed using biochemical assays. Immunostaining showing the 
expression of the transmembrane RPE specific protein Bestrophin(red), Ezrin(green) and 
DAPI(blue) illustrated markers of mature RPE (Figure 5.2 (d)) , while  RT-PCR revealed that 
both case and control hiPSC-RPE lines expressed global epithelial and RPE specific markers, 
including the phagocytosis marker MERTK, the basal marker BEST1, the apical membrane 
associated marker Ezrin, the pigmentation marker PEDF(pigment epithelium derived factor), 






5.2.2. Electrical wound healing assays of the hiPSC-RPE layer 
 
As previously described, a mature RPE layer was established after 25 days of culture, which 
entirely covered the bottom of the culture well including the gold microelectrodes. An RPE 
injury (analogous to focal RPE loss observed in macular degeneration) was then created as a 
circular wound with an elevated electrical pulse in the microelectrode area. Then the wound 
healing process was monitored for both case and control cell lines with ECIS. 
Electrical pulse parameters have been optimized through trial and error experiments. A 3 mA 
current pulse at 40 kHz applied for 30 seconds was found to cause cell death while preserving 
the microelectrode integrity. Figure 5.3 shows the corresponding drop in R4kHz that followed the 
electrical wound. R4kHz reached a value of 2600Ω corresponding to a cell-free electrode. This 
indicated cell death. Light microscopy confirmed that some cells detached from the 
microelectrode while the few remaining were stained positively with trypan blue indicating 
irreversible electroporation and death.  
Wound healing was then monitored until the RPE layer fully recovered (5 days), and was 
characterized by two distinct phases (Figure 5.3 (a)).  First, the cells from the wound edges 
migrated underneath the layer of dead cells in a radial pattern to close the wound. They 
repopulated the microelectrode with a characteristic steep increase in resistance followed by a 
peak that indicated the end of cell migration. Then a maturation phase was observed where the 
resistance slowly decreased to a plateau in a similar way to that described for early RPE 
maturation. Light microscopy indicated that once cell migration was complete, elongated cells 





Figure 5.2: Development and characterization of the hiPSC-RPE model on ECIS microelectrodes. (a) 
Patient’s fibroblasts were expanded and reprogrammed to a pluripotent state before being differentiated to RPE. 
Cells were plated (day 0) on ECIS microarrays. Cells were then allowed to mature for an additional 3 weeks period 
according to the timeline protocol shown in (b). From day 1 the spectroscopic complex impedance was monitored 
in real-time throughout RPE maturation and is displayed in (c) as the resistance at 4kHz. It showed an increase 
with cell spreading and maturation followed by a decrease reflecting changes in cell morphology and size.  After 
25 days an automated electrical wound healing assay was performed and subsequent cell migration associated 
with healing phase was monitored. (d) Immunostaining showing the expression of the transmembrane RPE 
specific protein Bestrophin (red), Ezrin (green) and DAPI (blue) illustrated markers of mature RPE. (e) RT-PCR 




The mean and standard error of the migration rate for all case and control cell lines is shown in 
Figure 5.3 (d). It shows that wounding was a reproducible process, producing a defined and 
concise wound every time. When calculating the migration rate as the time to repopulate a 250 
µm electrode, it was found that the control cell line had a significantly (P< 0.01) higher 
migration rate (10.69 ± 0.21 µm/h) than the case cell line (8.60 ± 0.46 µm/h).  
The corresponding capacitance measurements at 64 kHz are shown in Figure 5.4. The 
capacitance increased with cell wounding, close to the value of the cell-free electrode, before 
decreasing again with the healing process to reach the pre-wounding values. The capacitance 
measurements of the control cell lines showed a faster decrease reaching a plateau before the 
case cell line. This was attributed to the control cell line having a higher migration rate than the 
case cell line. 
In order to gain more insight into the healing kinetics, R4kHz was fitted to a sigmoid during the 
migration phase as exemplified for one case and one control cell line in Figure 5.3 (c). No 
significant difference (P= 0.057) was found between the hill slope of the control (0.54 ± 0.07) 
and that of the case cell lines (0.41 ± 0.04) (Figure 5.3 (e)). However, there was a significant 
difference between the case and control at the sigmoid inflection point. Figure 5.3 (f) shows 
that the inflection point had a significantly (P= 0.0009) higher value for the case cell line (8.94 
± 0.29 h) than that of the control cell line (7.06 ± 0.27 h). These results suggest that the lower 
migration rate of the case cell line might be attributed to a delay in initiating migration. Once 
the cells rearranged themselves radially and started to move, they migrated with a speed similar 






Figure 5.3: hiPSC-derived RPE ECIS Wound Healing Assay. (a) Wounding hiPSC-RPE: The resistance 
kinetics for one case study after wounding and during healing were monitored. Trypan blue was used to stain dead 
cells that did not detach from the electrodes. (b) Control vs. Case migration: wounding was a reproducible process, 
producing a defined wound every time. The control cell line (N= 11) migrated faster than the case cell line (N= 9) 
to achieve wound healing. (c) Sigmoid fitting: the case and control healing curves were fitted to a sigmoid curve. 
The parameters of the fitting curve were further analyzed. (d) Migration rate bar graph: the control migration rate 
was 10.69 ± 0.21μm/h while that of the case cell line was 8.60 ± 0.46 μm/h. The two rates were significantly 
different (P= 0.0046). (e) Sigmoid hill slope bar graphs: the difference between the control and case hill slopes 
were not found significantly different. (f) Sigmoid inflection bar graphs: inflection points were found significantly 






Figure 5.4:  Capacitance measurements of hiPSC-RPE migration. The capacitance measurements of the 
control cell lines showed a faster decrease reaching a plateau before the case cell line. This was attributed to the 
control cell line having a higher migration rate than the case cell line. 
 
5.2.3. Observed similarities between healing and maturation processes 
 
During the wound healing process, a transitional stage was observed in which cells showed a 
change in morphology which was similar to the changes accompanying the early RPE 
maturation (Figure 5.5  (a)), although on a much shorter time scale. Cells around the wound 
edge went through a transition from cuboidal to elongated cells before returning to their original 
polygonal morphology after repopulating the electrodes (Figure 5.5 (b)). This was accompanied 
by a decrease in resistance when the epithelial stage was reached. Increased fluctuations were 
also observed for these transitional phases. A moving variance analysis of the ECIS 
measurements was applied after wounding following the work of Schneider et al. [336] (Figure 




phase) to a more quiescent state (low variance). No significant differences were found between 
the case and control cells with an average half-time transition of 11.5h. These data suggest that 
the ability of the case cells to return to the original RPE morphology after completing migration 
was not affected by the LORMD mutation. Cell morphology and impedance data strongly 
suggested that cells were able to close the wound through integrin-mediated “mesenchymal” 
migration [337]. 
5.2.4. Cell-substrate adhesion properties 
 
One of the advantages of the tissue-on-a-chip approach is the ability to exploit the quantitative 
impedance data collected throughout RPE maturation and wound healing.  
The first monitored difference between the control and case cell lines was at the ECIS 
attachment and spreading phase during the first 24 hours after culture. R4kHz measurements 
showed that the case cell line attached to the electrodes and spread to form a confluent layer 
more readily than the control cell line (Figure 5.6 (a)). The corresponding capacitance (C64kHz) 






Figure 5.5: Similarities between early RPE maturation and healing processes. (a) Differentiation and 
morphology changes: case and control cell lines changed their morphology from a fibroblastic-like to a cuboidal 
shape during the differentiation and maturation stage. This was accompanied by an increase in measurement 
fluctuations. (b) Wounding and morphology changes: unwounded cells changed morphology from cuboidal to 
elongated to migrate and repopulate the electrodes. The reverse process then occurred after closing the wound. (c) 
Moving Variance showed a clear transition phase associated with a transition from an elongated to a cuboidal 






As the case and control cell lines were seeded at confluency on the microelectrode arrays, the 
first 24h of measurements were considered to constitute an impedance-based adhesion assay 
revealing data on the cell-substrate adhesion. Generally in these types of assays, the 
microelectrodes are entirely covered with a tight layer of cells that upon attachment to the 
electrode surface causes a significant increase in the measured resistance. The difference in the 
measurements between different cell lines can therefore be attributed to cell attachment and 
adhesion to the substrate [12]. 
 
 
Figure 5.6: Case vs. Control Cell-Substrate Adhesion. (a) hiPSC-RPE ECIS adhesion assay: comparing the 
resistances of the case and control cell lines during the first 24 hours of culture, showed how the case cell line 
attached more quickly to the electrodes and were able to reach a plateau faster than the control cell line. (b) 
Attachment slope: the slopes of the attachment curves for both case and control cell lines were calculated through 
a linear fit. The slope was significantly higher for the case cell line (P<0.01) which was consistent with the case 
cells arriving at a plateau before the control cells. (c) Cell-substrate adhesion parameter (α): α was determined at 
t=160h (day 6) for both case and control cell lines.  α of the case cell line was significantly higher than that of the 
control cell line (P= 0.002), indicating that the case cell line obtained a higher cell-substrate adhesion. (d) Adhesion 





For further analysis, the slope of each of the attachment curves was fitted to a linear model and 
they were found to be significantly different (P<0.01) with a value of 5.45 ± 0.64 Ω/h for the 
control and 9.43 ± 0.76 Ω/h for the case cell line (Figure 5.6  (b)). After this attachment phase 
however, the case and control cell lines followed similar kinetics throughout the differentiation 
and maturation phases (Figure 5.8). 
To further investigate the potential role of cell adhesion, the ECIS model was used to determine 
the cell-substrate adhesion parameter (α) after 7 days of culture (t= 160h) (Figure 5.6 (c)). 
Again the case cell line showed significantly (P<0.01) higher adhesion (7.80 ± 0.28Ω0.5cm ) 
than the control cell line   (6.50 ± 0.15Ω0.5cm  ). 
 
Figure 5.7: Attachment and Spreading Capacitance. During the attachment phase, the capacitance of the case 









Figure 5.8: Differentiation and maturation kinetics. During the attachment phase (first 24h), the case cell line 
adhered to the microelectrodes faster than the control cell line expressing a higher resistance and reaching a plateau 
first. After this phase, both the case and control cell lines followed a similar trend during differentiation and 
maturation. 
 
These findings were confirmed by a biochemical adhesion assay (Figure 5.6 (d)) that showed 
a clear difference between the adhesion properties of the case and control cell lines. The case 
line showed a significantly higher adhesion to ECM proteins (including collagen IV and 
tenascin) than the control cell line. It is worth mentioning that for the case and control cell lines 
cultured on ECIS arrays, the microelectrodes were coated with a mixture of proteins present in 
serum prior to culture.  
Finally, to explore further the link between cell adhesion and cell migration, electrical 
wounding of an additional RPE cell line was conducted. The immortalized cell line hTERT-
RPE1 was chosen for this study as it is regularly used for in vitro RPE migration assays despite 




confluency, an ECIS wound healing assay was conducted and the healing rate and adhesion 
properties were compared to that of the hiPSC-RPE.  The wounding parameters for hTERT-
RPE1 were 3 mA, 40 kHz, 30s. In contrast to the hiPSC-RPE, the wounded cells completely 
detached leaving a clear electrode, which already suggested that the cells adhered less to the 
electrodes (Figure 5.9). Comparing the cell-substrate ECIS parameters of the different cell lines 
showed that hTERT-RPE1 were the least adherent to the electrode surface followed by the 
control hiPSC-RPE and then by the case cell line having the highest α. This was in turn reflected 
in the migration rates with the immortalized hTERT-RPE1 having the highest migration rate of 
14.79± 0.39 µm/h followed by the control cell line (10.69 ± 0.21 µm/h) and then by the case 
line (8.60 ± 0.46 µm/h) having the slowest migration rate of the three cell lines. These data 
strongly suggest that the difference observed in cell migration rate between the case and the 
control cell lines may be attributed to a difference in cell adhesion properties.  
ECIS electric fence was also used to determine hTERT-RPE1 migration rate (Figure 5.10). The 
electric fence was switched on before seeding ECIS arrays to prevent the cells from attaching 
to the electrode surface while they grew everywhere else in the culture well. When the fence 
was turned off, the cells started to migrate to cover the electrodes. The migration rate calculated 
using this method was found to be 12.43 ± 1.10 μm/h. The slower migration rate than the one 
calculated using the regular ECIS wound healing assay might be due to the absence of the 









Figure 5.9: Effect of cell-substrate adhesion on the migration of immortalized and hiPSC-derived RPE. (a) 
Wounding hTERT-RPE1: Graph showing changes in resistance measurements during hTERT-RPE1 attachment 
and wounding assays. Wounded cells completely detached from the electrode surface upon wounding leaving 
clear electrodes. Wound healing was achieved as cells migrated to repopulate the electrode. (b) Cell-substrate 
adhesion bar graph: hTERT-RPE1 had the lowest adhesion parameter (α), followed by the control cell line and 
the case line with the highest α. (c) Migration rate bar graphs: hTERT-RPE1 had the highest migration rate. It was 






Figure 5.10: hTERT-RPE1 Electric Fence. (a) RPE cells on an ECIS microelectrode with the electric fence on 
(cell-free electrode) and after turning off the fence (cell-covered electrode). (b) ECIS Impedance measurements 
for a control well (blue) and a well where the electric fence was applied (red).  
 
5.3. A preliminary study: Electrically-induced liver injuries 
 
In an initial study, ECIS wounding assays were conducted in order to determine the migration 
abilities of HepaRG cell line. Unfortunately, the hepatocyte:cholangiocyte co-culture was not 
able to migrate after electrical wounding, showing no signs of recovery. The hepatocyte cell 
line (C3A) was used in an attempt to study cell migration and regeneration after liver injury. 
Different wounding parameters were used in trial and error experiments.  It was noticed that 
the healing abilities of the C3A cells were limited to partial injuries. Small wounding thresholds 
(current amplitudes < 3 mA and short pulse durations ≤ 5s) caused a drop in impedance but not 
to that of the cell- free electrode indicating that complete cell death was not established. In 




which was reflected by the amount of decrease in the impedance measurements; the larger the 
drop in impedance, the longer it took the cells to recover (Figure 5.11). A wounding threshold 
of 3 mA, 20s, 40 kHz caused a drop in impedance to that of the cell-free electrode suggesting 
complete cell death. Recovery in this situation was a long process, and it took the cells almost 
4 days to repopulate the electrodes, with a very low migration rate of 1.3 ± 0.2 μm/h. The 
limited abilities of C3As in wound healing has recently been reported by Navarro [29], where 
C3A monocultures were observed not to heal after scratch wounding. 
 
Figure 5.11: Effect of wound severity on C3A wounding. The graph shows the increase in C3As healing time 
with increasing wound severity. Complete cell death was mirrored by a decrease in impedance to that of the cell-
free level. The impedance measurements after wounding illustrate the slow healing ability of this cell line. 
 
 
5.4. High density, different-sized square microelectrode arrays for 
ECIS measurements 
 
A microelectrode array with 16 different-sized square electrodes was designed and fabricated 




allows for monitoring a wider cell population, while having small electrodes would allow for 
single cell migration studies. The chip was used to investigate real time ECIS measurements 
and to perform electrical wound healing assays. 
The MEA design was adopted from a previous design [333]. The chip had 16 working platinum 
electrodes inside the culture well with 4 different sizes (20 m, 50 m, 100 m, 200 m) as 
shown in Figure 5.12. A PCB was designed to connect the microelectrodes to ECIS array 
holders using ribbon cables. Wells of 2 cm diameter, cut from 5 ml syringes were glued onto 
the chip to provide a reservoir for cell culture media. Biocompatibility studies were conducted 
in order to confirm the suitability of the materials used for passivating the chip as well as for 
attaching the culture well. 
 




5.4.1. Biocompatibility studies 
 
In order to decide on a material for the MEA passivation, the biocompatibility of different 
insulating materials was investigated. Glass cover slips were coated with silicon dioxide, silicon 
nitride and Parylene-C and their effect on the attachment and proliferation of fibroblasts (NIH-
3T3) was monitored and compared to a control group of cells cultured in a petri-dish. Cells 
cultured on Parylene-C showed very similar attachment and proliferation to that of the control. 
In the case of silicon dioxide on the other hand, cells did not proliferate at all even after 4 days 
of culture (Figure 5.13). It was therefore decided to use Parylene-C as an insulating material 
for the MEA chip. 
 
Figure 5.13: Biocompatibility of insulating materials. (a) Control group: fibroblasts cultured in a petri-dish. (b) 
Silicon nitride: cells showed less spreading than monitored in control. (c) Parylene-C: cell spreading and attahment 





In order to fix the culture chamber on top of the chip, a biocompatible commercial adhesive 
(Dymax) was used. However, cells cultured in the adhesive-fixed chamber were all dead after 
one day of culture. Signs of the adhesive leaking inside the chamber were also noticed (Figure 
5.14 (b)). PDMS is highly biocompatible and it has been widely used in biological applications. 
It was decided on using PDMS to fix the chamber onto the chip (Figure 5.14 (a)).  
 
 
Figure 5.14: Adhesive biocompatibility test.  (a) PDMS showed high biocompatibility. (b) Commercial 
adhesive leaked into the chamber causing cell death. 
 
5.4.2. MEA Surface Modifications 
 
Hydrophilicity is an important factor that is required in order for the cells to attach to a surface 
and proliferate. After coating the MEA chip with Parlyene-C, the surface hydrophilicity was 
measured. The contact angle of a drop of water on top of the chip was measured using a 
goniometer and was found to be 90o indicating that the surface was hydrophobic. Treatment 
with oxygen plasma has been reported to increase surface hydrophilicity [339]. The parlyene 
passivated chip was treated with oxygen plasma before re-measuring the contact angle. This 
time the surface was found to be highly hydrophilic with a contact angle much less than 10o 




Another factor that could improve cell attachment and proliferation on the chip is protein 
coating. The effect of ECM proteins on cell migration and proliferation has been widely studied 
[231]. Usually, laminin or fibronectin coating is used before cell seeding. In all of the studies 
presented in this thesis, the electrode arrays were coated with serum proteins by incubating the 
arrays with culture medium for 2 hours prior to cell culture. 
5.4.3. ECIS measurements  
 
After incubating the MEA with culture medium for 2 hours, hTERT-RPE1 were seeded with a 
density of 40,000 cells/cm2. The chip was then connected to ECIS using the fabricated PCB as 
shown in Figure 5.15. 
 
Figure 5.15: MEA –ECIS Interface 
Impedance measurements reflected cell growth and proliferation on the different sized 
microelectrodes with impedance values increasing with decreasing the electrode size (Figure 
5.16).  
Wounding experiments were performed using ECIS electrical wounding mode using the 




However, these wounding parameters were determined for 250 µm electrodes and different 
wounding parameters for smaller electrodes still needed to be determined. Due to the limited 
number of fabricated MEA chips, ECIS 8W1DD arrays with different sized electrodes were 
used for these trial and error experiments. The 8W1DD arrays have electrodes of 25, 50, 100 
and 250 µm diameter. The impedance measurements showed similar values to those recorded 
for the MEA chip as shown in Figure 5.17. 
                    
Figure 5.16: hTERT-RPE1 ECIS measurements of the square MEAs. The graphs show the impedance 
measurements recorded by ECIS for the different-sized square microelectrodes covered by a confluent layer 
of hTERT-RPE1. The measured impedances decreased with increasing the electrode size. 
 To arrive at wounding thresholds using a minimum number of trials, it was decided to define 
wounding parameters that will result in the same current density produced at the 250 µm 
electrodes with the previously determined wounding pulse. 
In ECIS wounding mode, an AC signal is applied through a 1 kΩ resistor connected in series 
to the oscillator. Since the impedance of the counter electrode can be neglected due to its much 




voltage and that measured at the working electrode could be extracted from the simplified ECIS 
circuit shown in Figure 5.18, according to Equation (5.2). 
 
Figure 5.17: 8W1DD impedance measurements. The graphs show how the impedance measurements of 
hTERT-RPE1 increase with decreasing electrode size. 
   
 
Figure 5.18: ECIS wounding circuit. A schematic diagram showing a simplified ECIS circuit for the wounding 








𝑉𝑒 = 𝑉𝑎𝑝𝑝𝑙𝑖𝑒𝑑 ∗  
𝑍𝑒
𝑍𝑒 +  1000
  (V)                                     (5.2) 
  
After calculating the voltage (Ve) at the 250 µm electrode for an applied wounding pulse of 1V, 
40 kHz, 30s, the current density at the electrode was calculated according to: 
𝐽𝑒 =
𝑉𝑒
𝑍𝑒 ∗ 𝑒𝑙𝑒𝑐𝑡𝑟𝑜𝑑𝑒 𝑎𝑟𝑒𝑎 
 (A m2⁄ )                                         (5.3 ) 
The amount of charge corresponding to the wounding current at the electrode (Ie) was 




  (C)                                                                     (5.4 ) 
Once the values of Ve, Je and Qe for the 250 μm electrodes were calculated, wounding 
parameters for the different sized electrodes were determined resulting in the same current 
density. The theoretically determined wounding parameters did not cause cell wounding in 
some cases and the actual applied signal had to be slightly higher. This could have resulted due 
to the simplicity of the model used to determine the wounding parameters. Factors like the 
solution resistance as well as the amount of ECM produced by the cells should be considered 
when determining the wounding parameters. Nonetheless, the parameters determined using the 
above equations provided very close values to the actual final parameters. This saved lots of 
trials as well as avoided any damage to the electrodes during the trial and error wounding 
experiments. Table 5.2 shows the different hTERT-RPE1 wounding parameters determined for 







Electrode Size Wounding Parameters 
250 µm               1 mA, 40 kHz, 30s                         
100 µm Calculated: 400 µA, 40 kHz, 5s  
Actual: 600 µA, 40 kHz, 5s 
50 µm Calculated: 100 µA, 40 kHz, 1.2s  
Actual: 600 µA, 40 kHz, 2s 
25 µm Calculated: 40 µA, 40 kHz, 300 ms  
Actual: 200 µA, 40 kHz, 1s 
                                                                                                                                                                                       
Table 5.2:  Wounding parameters for different electrode diameters. 
Based on the wounding parameters defined for the 8W1DD arrays, RPE cells cultured on the 
MEA chip were wounded. A defined wound was achieved for the 200 µm, 100 µm, 50 µm 
square electrodes but not for the 20 µm ones. Figure 5.19 (a) shows wounded RPE cells on top 
of a 50µm square electrode. The migration process was monitored through the impedance 
measurements and the migration rate was determined as 12.07 ± 0.1 μm/h (Figure 5.19 (b)). 
Note that the average migration distance (d) was calculated as:  
𝑑 =  
𝑋 + 𝑋√2
2
                                                                (5.5 ) 






Figure 5.19: Wounding on the MEA chip. (a) Wounding RPE on a 50μm square electrode. (b) Impedance 
measurements of three 200μm electrodes during ECIS wound healing assays.  Please note that the poor quality of 




In the current study, the need for a patient-specific, physiologically relevant in vitro model of 
wound healing and regeneration has been addressed through developing a tissue-on-a-chip 
approach.  Electrically-induced injuries were used to study cell loss and low cell migration 
abililties in degenerative diseases. . First, keratinocytes were employed as a model to further 
investigate ECIS electrical wounding mode and find a formula that could help arrive at a 
wounding threshold. ECIS wounding was then used to mimic RPE loss in age-related-macular 
degeneration. The hiPSC-RPE-based model was first established on ECIS microelectrodes 
before cell migration and regenerativeabilities of a control and case cell lines were compared. 




control cell line derived from a healthy sibling. ECIS modelling and biochemical assays showed 
that this is possibly related to the stronger cell-substrate adhesion expressed by the case cell 
line. Further experiments with an immortalized RPE cell line, confirmed the relationship 
between higher adhesion and low migration rates.   
In a preliminary study, cell migration assays were conducted on the HepaRG cell line to 
examine its migration ability. HepaRGs did not migrate at all indicating their very low 
regenerative abilities, which could be a reason behind why this cell line are recommended to 
be cultured at confluency. 
Finally, high density microelectrode arrays with high spatial resolution and different-sized, 
individually-addressed microelectrodes were designed and fabricated. ECIS RPE wound 
healing assays were performed on the different-sized square microelectrodes and a migration 


















Towards a new therapy:    
Stimulation of wound healing 
 
 
The tissue-on-a-chip disease models proposed in this work offer powerful, high throughput 
platforms for translational studies and the evaluation of potential therapies. This chapter 
provides an investigation of two therapeutic approaches where drug-stimulated and electrically-
stimulated wound healing are investigated. First, the effect of the antioxidant NAC on cell 
recovery in ALF and AMD is explored followed by evaluating the potential of electrical 
stimulation as a new therapy for AMD.  Finally, a design that integrates radial electrical 
stimulation with impedance sensing, allowing for the quantification of cellular behaviour 
within the EF is proposed. 
6.1. Drug-stimulated wound healing 
 
Since oxidative stress is associated with both age-related macular degeneration as well as 
paracetamol toxicity, the effect of the anti-oxidant N-acetyl-L-Cysteine (NAC) on HepaRG and 
RPE cell recovery was investigated.  
6.1.1. Antioxidants and HepaRG 
 
Following an APAP ECIS toxicity assay, 10mM NAC was added to HepaRGs for 24h and its 
effect on cell recovery was monitored (Figure 6.1). Following the dose-response decrease in 




NAC introduction. More experiments are needed however to make sure that this effect was 
indeed due to NAC and not just due to the addition of fresh medium. 
 
Figure 6.1: The effect of NAC on paracetamol toxicity. After the 24h induction and 24h APAP assay, 10 mM 
NAC caused a small increase in the measured resistance. However, this effect might be due to the addition of fresh 
medium pointing towards the need for more experiments. 
 
6.1.2. Antioxidants and RPE 
 
The effect of NAC on the migration of the case and control hiPSC-RPE cell lines was 
investigated. 10 mM NAC was added to the culture medium and cells were either incubated for 
2h or for 24h with NAC before wounding. NAC had no effect on the migration of the case cell 
line. However, a decrease in the control cell migration was observed after incubating the cells 
with NAC for 2h (Figure 6.2).  
To understand more the effect of oxidative stress on RPE migration, 100 µM hydrogen peroxide 
(H2O2) was introduced to the culture medium for 3 hours before conducting the wounding 
experiment. Before stressing the cells using H2O2, RDM was substituted by an antioxidant-free 




stress experiment. For some wells, 10 mM NAC was added for 2h before adding H2O2. For the 
rest of the wells, H2O2 was added directly to the medium without the addition of NAC first. 
Interestingly, the oxidative stress has caused a slight increase in the control cell line migration 
rate (Figure 6.3). Increase in migration rate with oxidative stress has been reported before [340]. 
NAC treatment before the addition of H2O2 caused the migration rate to decrease. For the case 
cell line, oxidative stress did not affect the migration rate while NAC treatment caused a slight 
increase in migration. This might be due to the fact that for the case cell line, the cells are 
already stressed due to AMD. More experiments with different NAC and H2O2 concentrations 
and varying incubation times are required before arriving at any conclusions. 
 
Figure 6.2: The effect of NAC on RPE migration. (a) NAC had no effect on the case migration rate. (b) 2h 




Figure 6.3: Oxidative stress and RPE migration. (a) No effect on case migration was monitored with oxidative 
stress. However, NAC treatment caused a slight increase in migration rates.  (b) An increase in the control 
migration rate was noticed with oxidative stress. This increase dropped with NAC treatment. 
 
6.2. Electrically-stimulated wound healing 
6.2.1. Linear Electrical stimulation 
 
The role of electrotaxis in directing cell migration has been widely investigated. In this work, 
preliminary studies were conducted to investigate the potential of electrical stimulation in 
enhancing RPE wound healing. The immortalized RPE (hTERT-RPE1) cell line was used for 
the initial electrical stimulation experiments. A microfluidic channel was used instead of the 
traditional electrotaxis chamber shown in Figure 6.4 (a). Cells were seeded on the commercial 
‘Ibidi’ microfluidic channels (Figure 6.4 (b)) and an external EF was applied between the ends 
of the channel 4 hours after seeding. A DC voltage was applied using an electrophoresis power 
supply and 2% agar salt bridges were used to connect the Ag/AgCl electrodes to the 
microfluidic channel. A handheld voltmeter was used to measure the potential difference before 





Figure 6.4: Electrical Stimulation set up. (a) Traditional electrotaxis chamber. (b) Microfluidic channel used 
for initial electrical stimulation experiments. (c) Experimental set up. 
 
To ensure the presence of an EF inside the channel with the external application of a DC 
potential, charged polystyrene beads were added to the culture medium. The negatively charged 
particles moved towards the cathodic end of the microfluidic channel even when the polarity 
was reversed. The potential inside the channel was simulated using COMSOL Multiphysics 
and is shown in Figure 6.5.  
 
Figure 6.5: COMSOL voltage simulation inside the microfluidic channel. Simulation showing the change in 
the DC potential inside the channel during the electrical stimulation experiments. The two white circles represent 




Electrical stimulation was performed inside an incubator (with no CO2 supply), at a controlled 
temperature of 37 °C. 100 mM HEPES buffer was added to the culture medium to compensate 
for the absence of the CO2 supply. Time-lapse microscopy of cell migration under the effect of 
50-300 mV/mm EFs was recorded using a digital inline holographic microscope. A 300 
mV/mm EF was applied for 5 hours and was found to direct cell migration in a direction roughly 
perpendicular to the EF, in comparison to the random migration monitored under no EF 
conditions. The hTERT-RPE1 cells also aligned their long axes with an orientation angle (Ɵ) 
of 155.90°  1.12° that was significantly different from the orientation angle under no EF 
conditions (P < 0.01). Cell elongation was also observed. Cell migration was tracked using the 
ImageJ manual tracking plugin. Figure 6.7 shows the direction of cell migration under no EF 
conditions against an applied EF of 300 mV/mm.  
6.2.2. Impedance monitoring of Electrically-stimulated healing 
 
Combining electrical stimulation and impedance sensing would allow for quantitative 
monitoring of electrically-stimulated healing in real time. In such a set up, the on-chip electrical 
wounding technique is used to create a defined injury before quantitatively monitoring the 
healing process under the effect of external electrical stimulation. As a first attempt to use 
impedance measurements to monitor cell migration under the effect of an external EF, ECIS 
flow arrays were used. The arrays have 8 working electrodes of 250 m diameter inside a 
microfluidic channel. The electrical stimulation set up was the same as for the initial 
electrotaxis experiments and is shown in Figure 6.8. In order to avoid interference between 
ECIS electrical signals and the external EF, the EF was applied for half an hour intervals during 








Figure 6.6: Effect of electrical stimulation on cell alignment. (a) Random cell alignment under no EF 
conditions. (b) Cell alignment in the presence of a 300 mV/mm. The orientation angle Ɵ is measured from the 0o 
horizontal axis in the direction of cell motion (c) Bar graphs showing the effect of an external EF on the alignment 
(orientation angle). The difference in the orientation angle was significantly different (P < 0.01) between no EF 






Figure 6.7: Tracking RPE cell migration.  (a) Random cell migration under no EF conditions. (b) An EF of 300 




Figure 6.8:  ECIS-based electrical stimulation set up.  (a) ECIS flow arrays. (b) Experiment set up. 
 
hTERT-RPE1 cells were cultured until confluency before wounding the cell layer using 
wounding parameters of 1mA, 40 kHz, 30s. When applying an external EF, the counter 
electrode was damaged as the gold layer lifted off.  The counter electrode (CE) on those arrays 
ran through the length of the channel, which according to the EF simulations (Figure 6.5) meant 




electrochemical corrosion. The design of the ECIS flow arrays was therefore unsuitable for the 
electrical stimulation set up presented in this study. It was decided that a new design is needed 
to allow for the use of ECIS and electrical stimulation. 
6.2.3. A proposed design for impedance-based radial electrical stimulation  
 
Electrical stimulation experiments are usually applied linearly in one direction to investigate 
the effect of EFs on cell migration and wound healing. A stimulating system where an external 
EF is applied radially, could speed up the wound healing process by directing the cells towards 
a wounded area, to close it from several directions in parallel. 
A design for a MEA chip that can monitor cell radial migration is proposed as part of an 
impedance-based electrically stimulating system. The MEA has five 500 m diameter 
surrounding a central 500 m electrode onto which an ECIS wounding pulse can be applied. A 
counter electrode shaped like a horse-shoe surrounds the 6 working electrodes (Figure 6.9).  
In order to have a radial EF that can direct cell migration towards the central wound, an insert 
with 6 outer holes, for holding the 2% agar bridges, is inserted inside the culture chamber, 
forming a roof 1 mm above the cell culture, reducing Joule heating and minimizing the medium 
evaporation. The stimulation insert also has a central opening that holds an agar tube above the 
central working electrode onto which an injury is electrically induced. The culture chamber 
also has three feet to allow for later alignment of the chamber and insert with the inner 
electrode.  The outer agar bridges all have the same polarity, opposite to that of the single inner 
agar bridge. The central tube is chosen to be smaller than the working electrode (500 m) in 
order to direct cell migration towards the centre of the wound. Figures 6.10 and 6.11 show the 
designs of the culture chamber and the insert respectively. Another design for an insert that 




                                         
     




Figure 6.10: Proposed design for the culture chamber. (a) Top view: The chamber has groves that allow for 
positioning the stimulation insert 1mm above the electrodes. (b) Bottom view: The chamber also has three feet 








Figure 6.11: Proposed design for the stimulation inserts. (a) The insert can hold 6 outer tubes surrounding a 
much smaller inner tube. The insert also has rectangular arms that fit into the groves of the culture chamber. (b) 
An insert design with three windows that allow for optical observations. 
 
The potential gradient resulting from such an arrangement is simulated using COMSOL 
Multiphysics and is shown in Figure 6.12. The insert is designed so that all of the electrodes 
remain at a constant potential in order to avoid corrosion of the gold layer and the electrode 
damage that was previously reported when using ECIS flow arrays. A chip holder that allows 
for optical observations and connects the MEA chip with ECIS is also designed as shown in 
Figure 6.13.  
Because the MEA surface conditions affect cell migration, disposable MEAs, fabricated by 
screen printing or laser ablation, are suggested for the electrical stimulation system. This will 
ensure the same surface conditions, not mediated by cell attachment proteins, for all 
experiments. A very simple technique for microelectrode fabrication has been investigated. 
Rectangular polystyrene substrates were laser cut from a T-75 tissue flask. The microelectrodes 
were prepared by sputtering gold through a mask, leaving only the required patterns on the 




for passivation and can be deposited using a second mask to define the electrode openings. To 
test the feasibility of the set up and the alignment of the various parts of the system, all inserts, 
culture chamber and chip holder has been 3D printed in-house. Figure 6.14 shows how the 
radial MEA can be connected to ECIS using the 3D-printed chip holder. 
 
Figure 6.12: COMSOL voltage simulation of the radial set up. The black circles show the location of the 








Figure 6.13: Proposed design for the radial MEA holder. The chip holder has a window that allows for optical 
observations. The chip also has a threaded hole that allows for connection with ECIS array holder. 
 
 
Figure 6.14: Radial MEA-ECIS interface. (a) A picture showing how the MEA holder connects a prototype 
chip to the ECIS holder array. (b) A picture showing the position of the 3D-printed insert with respect to the 




An initial experiment using polystyrene particles was performed in a petri-dish where five agar 
bridges were arranged radially, encircling an inner agar bridge with opposite polarity. Holes 
were drilled in the petri-dish cover to keep the agar bridges in place during the experiment. 
Initially, the negatively charged particles moved towards the positive inner tube as required. 
However, a few issues were monitored. First, to obtain an EF that caused the particles to move, 
high voltages (70-100 V) needed to be applied. This is due to the EF distribution, being 
dispersed into the whole area of the petri-dish instead of being confined to a small area, as in 
the case of a microfluidic channel or an electrotaxis chamber. Secondly, because of the thermal 
effects of applying such high voltages, the agar bridges melted during a period of 30 mins of 
EF application. Moreover, the medium evaporated fairly quickly, possibly due to heating 
effects. All these issues need to be addressed before applying radial electrical stimulation to 
cultured cells and are discussed in the next chapter. 
6.3. Summary 
 
This chapter examined the potential of two approaches as new therapies for stimulating cell 
recovery and healing in drug-induced acute liver failure and age-related macular degeneration.  
First, the therapeutic potential of the antioxidant NAC on paracetamol toxicity and on RPE 
healing capabilities was investigated. While 10 mM NAC caused a slight increase in impedance 
measurements following paracetamol addition, a similar increase was recorded when adding 
fresh culture medium. More experiments will therefore be needed to examine the effect of 
different NAC concentrations. For hiPSC-RPE cultures, NAC had no effect on the migration 
of the case cell line. However, a decrease in the control cell migration was found after 
incubating the cells with NAC for 2h. Oxidative stress induced with H2O2 had no effect on the 





The potential of using electrical stimulation to enhance RPE migration in degenerative diseases 
was then examined.  Externally applied EFs directed RPE cell migration perpendicular to the 
field. Furthermore, the cells were elongated and changed their alignment with the EF 
application.  
Impedance sensing could offer a real-time, quantitative method of monitoring electrically-
stimulated cell migration. In an unsuccessful trial, ECIS flow arrays were used with an 
externally applied EF to monitor the directed RPE migration. However, the design of the ECIS 
electrodes led to the damage of the chip when subjected to the DC EF.  
A design combining between impedance sensing and an electrically stimulating system is 
proposed. This system will apply an EF in a radial direction, aiming at stimulating cell 
migration and directing cells to close a wound from different directions at once, hence speeding 
up the healing process. 
The obtained results together with some limitations and considerations of the proposed disease 




Chapter 7                               
Discussion 
 
7.1. Stem cell-based disease models: insights into disease 
mechanisms 
7.1.1. Drug-induced liver failure: APAP disruption of tight junctions 
 
Tight Junction (TJ) barrier dysfunction and chemical disruption of adhesion sites are the main 
features in the pathogenesis of various diseases including hepatitis, inflammatory bowel 
disease and cancer [341].  Pro-apoptotic signals are also accompanied by diminished 
intercellular and cell-substrate interactions. Therefore, development of non-invasive 
technologies, which can assess tight junctions and tissue structure quantitatively, will provide 
an invaluable tool for pre-clinical drug discovery. In this work, a human HepaRG-based liver 
biochip, combining human HepaRG cells with impedance spectroscopy, is introduced as a new 
enabling tool for drug hepatotoxicity screening. Impedance measurements have been used to 
examine the effect of the model hepatotoxins: paracetamol (APAP), amiodarone and 
cyclosporine-A (CsA) on the hepatocyte:cholangiocyte co-culture. The measurements  showed 
a dose- and time-dependent decrease in response to the added drugs. Subsequent ECIS 
modelling of the total impedance signal has revealed previously unknown, temporal effects of 
APAP toxicity; specifically, the dose-dependent disruption of hepatic tight junctions and cell-
matrix adhesion, as reflected by the extracted barrier resistance Rb, and the adhesion parameter 





Follow-up studies provided a more mechanistic insight into APAP toxicity. Activation of the 
protein kinase C (PKC) signalling pathway has been shown to affect epithelial barriers [342]. 
A preliminary study using the HepaRG-based ECIS chip, has demonstrated that the (PKC) 
activator, phorbol ester (PMA) caused an induced-disruption of TJs similar to APAP. This 
suggests that APAP toxicity, likely via oxidative stress, may involve a PKC-dependent 
signalling pathway. 
TJ destabilization, evident even at sub-toxic APAP concentration (5 mM), was confirmed via 
down-regulation of the TJ-specific protein ZO-1 and through TEM ultrastructural imaging; 
which in turn, showed signs of cellular apoptosis and necrosis, at intermediate doses (10mM). 
Using confocal immunofluorescent staining, it was shown that APAP-induced diminution in 
expression of the TJ-associated protein ZO-1, indicative of injury to the epithelial tight junction 
complex, correlates with a fall in impedance measurements (at 24h).  
7.1.2. Age related macular degeneration: a role for cell-adhesion  
 
In this study, a tissue-on-a chip approach was developed to investigate RPE layer damage and 
repair, in order to mimic retinal macular degeneration. Differences in wound healing between 
case and control RPE cell lines, associated with an inherited macular degeneration were 
reproducibly and quantitatively identified. The obtained results demonstrated that the healing 
rate was reduced in the case cell line and that differences in healing resulted from a reduced 
migration rate in the case RPE line when compared to the control. 
Although the central role of cell adhesion in cell migration is established, the relation between 
migration rate and adhesion level is more subtle. Generally a cell line will have an optimum 
cell migration rate at intermediate levels of adhesion to allow both efficient cell-substrate 
attachment, and release [343]. In the present study, the lower migration rate of the case cell 





cell line. Moreover, the cells undergoing migration adopted a radial pattern of wound healing 
around the site of damage suggesting a single cell “mesenchymal” migration as opposed to 
collective “Amoeboid” migration [337]. “Mesenchymal” migration is integrin dependent and 
therefore directly linked to cell adhesion properties.  
Adhesion and migration parameters were measured separately and therefore represent 
independent, quantitative parameters that will help to achieve a better understanding of the 
complex relationship between adhesion and migration.  In the future, this could be used to 
identify potential therapeutic agents that promote cell migration and healing by modulating cell 
adhesion (lower or higher).   
The case cell line (late onset retinal macular degeneration) results from a mutation in the gene 
encoding the protein C1QTNF5 [49].  Previous studies have indicated that mutant C1QTNF5 
may affect cellular adhesion.  Studies performed by Shu et al.  [344] found that HEK-EBNA 
cells stably expressing C1QTNF5 had reduced adhesion to laminin coated plates when 
compared with cells transfected with wild type protein.  However, no differences were found 
when comparing fibronectin coated plates. These differences might have resulted from a 
number of causes including inherent adhesion differences in the cell lines [345]. ECIS Medusa 
microarrays in this study were coated only with FCS and not with laminin, which may result 
in a different cell-substrate adhesion profile.  Further studies will need to be performed using 
other substrates for comparison.  
There have been previous studies on the effect of different agents on the adhesion and migration 
of RPE [95, 347]. Chan et al. have investigated the role of antioxidants on RPE adhesion and 
migration using ECIS wound healing assays. They studied the inhibitory effect of (-)-
Epigallocatechin gallate (EGCG) [95], resveratrol [220] and lycopene [94] on platelet-derived 





reported that while all the three antioxidants have inhibited PDGF-BB induced RPE migration, 
only (-)-EGCG had an effect on adhesion to fibronectin. Reservatrol and lycopene inhibited 
migration signalling pathways with no effect on adhesion. In vivo, optical coherence 
tomography studies in AMD suggested that aberrant adhesion/migration of intraretinal RPE 
might underlie progression to more advanced disease [347].   
The role of oxidative stress in age-related macular degeneration has been implicated [134, 135, 
137]. However, the role of oxidative stress on RPE migration and adhesion is still not clear. 
Jiang and He [340], have reported that an increase in ROS production enhanced RPE migration 
under the influence of the oxidative stress agent, tertiary-butyl hydroperoxide (TBH), in small 
concentrations (up to 30 M/L). Higher concentrations of TBH on the other hand completely 
inhibited RPE migration. The focal adhesion kinase (FAK) and vinculin expression in RPE 
cells decreased and their distribution were changed after the treatment of higher concentrations 
of TBH. 
In another study [348], long term cultured RPE cells (> 5 weeks) were found to develop 
resistance to negative effects of oxidative stress. ARPE-19 cells cultured for 5 weeks were less 
sensitive to chronic oxidative stress induced by hydrogen peroxide than those cultured for 1 
week. Long-term cultured RPE cells are expected to secrete more ECM proteins and be more 
adhered to a substrate than more recently cultured cells. This again suggests a relation between 
cell adhesion and effect of oxidative stress. 
When hiPSC-derived RPE cells were subjected to a low concentration (10 M) of hydrogen 
peroxide (H2O2), it was noticed that RPE migration rate increased for the control but not the 
case cell line. The different effect of oxidative stress on both cell lines may be attributed to 





needed where the effect of higher H2O2 concentrations on control and case cell migration is 
investigated in more depth. 
7.2. Electric Cell-Substrate Impedance Sensing: Considerations 
and Limitations 
 
Due to its high sensitivity and non-invasive, quantitative nature, ECIS has emerged as a well-
established platform for cellular-based assays. Although the measurement itself is fairly simple, 
arriving at the right interpretation of the impedance measurements requires a thorough 
understanding of various factors. It also has to be noted that despite its great capabilities, ECIS 
has some limitations that need to be considered before designing an experiment.  
7.2.1. ECIS sensitivity 
 
Real-time impedance measurements are a reflection of cell growth and maturation, mirroring 
with high sensitivity the establishment of barrier functions as well as the formation of a 
confluent cell layer that is ready for manipulation. ECIS measurements are sensitive enough to 
record cell micromotion reflected by small fluctuations in the measurements, a property that 
was first reported by Giaever and Keese [13]. Micromotion has been linked to cell metabolism 
and is observed on ECIS circular electrodes for all cell lines. It can be quantified and used to 
detect small changes in cell behaviour [349].  
Increased fluctuations monitored by ECIS were also reported by Schneider et al. [336] and 
were attributed to the ruffling of cell membranes during EMT (epithelial-to-mesenchymal-
transition) process. The ECIS-based age macular degeneration model presented in Chapter 5, 
Section 5.2.3 of this thesis have shown similar fluctuations that were monitored during 





change in cell morphology from cuboidal to elongated shape suggesting an EMT/MET 
transition, was observed. 
The high sensitivity of ECIS comes with a downside though, with the impedance not always 
reflecting a change in cell physiology. Changes in environmental parameters (pH, temperature) 
will instantly affect the impedance measurements and therefore need to be considered when 
analyzing the data. A change in medium properties will affect cell behaviour, in response to 
nutrients for instance, which will be reflected in the measured impedances. In this work, 
changing the culture media caused a temporary increase in impedance measurements.  
7.2.2. ECIS and cell confluency 
 
Establishing a confluent cell layer on ECIS microelectrodes is essential for meaningful 
modelling [12, 13]. As the model is based on the analysis of current pathways in between the 
cell-cell junctions, through the cell-electrode gap as well as through the cell membrane, only a 
confluent cell layer will ensure the validity of the modelling parameters (Rb, , Cm). This 
requirement limits the use of the mathematical model. In toxicity assays for instance, the model 
is only valid during the early hours (< 15h) of the assay when most of the cells are still alive 
and attached to the electrodes.  It is worth mentioning that another model limitation was found 
when culturing the hiPSC-RPE cells for more than 25 days where poor fitting was observed. 
This might have been due to the secretion of a large amount of ECM proteins, adding an extra 
impedance that was not substituted for in ECIS mathematical model. 
Confluency is also a necessity for wound healing assays. A confluent cell layer has to be formed 
before applying a wounding pulse in order to define an accurate migration rate. It will also 






7.2.3. Measurement frequency 
 
ECIS measurements can either be made while scanning through multiple frequencies (MFT 
mode) or recorded at a specific single frequency (SFT mode). While MFT is required for ECIS 
modelling, SFT allows for a much higher temporal resolution [350]. However, it does not allow 
for deconvolution of the impedance into its biologically relevant parameters.  
In this study, the impedance was measured systematically at 11 frequencies. For the sake of 
clarity, the results were presented at two relatively low and high frequencies (4 kHz and 64 
kHz) that maintained sensitive meausrements. Because at low frequencies the current flowing 
between the ECIS microelectrodes can only pass in between or under the cells, low frequencies 
are normally used to study the tightness of cell-cell junctions as well as the cell-substrate 
adhesion. At high frequencies on the other hand, the current can capacitively couple through 
the cell membrane and the measurements are therefore a reflection of electrode cell coverage.  
Recording ECIS measurements at a frequency of 4 kHz has been reported to accurately reflect 
changes in cell motility and morphology with high sensitivity. Even slight alterations in cell-
cell junctions and cell-substrate adhesion have been detected at this frequency [248, 256]. The 
measurements at 4 kHz are a reflection of all alterations in sub- and intercellular spaces 
including tight junctions.  At higher monitoring frequencies, intercellular and subcellular 
resistive components do not contribute to ECIS measurements as much as they do at a lower 
frequency of 4 kHz. In the higher frequency range (typically ≥ 40 kHz), capacitive 
contributions arising from the cell membranes are detected with high sensitivity as a significant 
fraction of the current can couple through the membranes. Cell membrane capacitances add to 
the electrode capacitance in a reciprocal manner following Kirchhoff’s laws, resulting in 





capacitance above a certain threshold frequency depends linearly on the fraction of electrode 
covered with cells [12].  
Plots of the resistance and capacitance vs. frequency can be used to determine the appropriate 
range of frequencies for a certain study. In this work, the highest sensitivity, represented as the 
largest difference between cell covered electrodes and cell-free measurements, was observed 
at around 4 kHz for resistance and 64 kHz for capacitance. Hence, the choice of these two 
frequencies for data representation. 
Using the correct frequency is crucial for an efficient wounding assay. Electrical wounding is 
typically performed at high frequencies, as the current can penetrate the cell membrane leading 
to irreversible electroporation when applied for a time longer than a specific threshold [84]. 
However, it has to be noted that long application of a wounding pulse can cause cell death due 
to heating rather than membrane rupture. Cells may even stick to the electrodes hindering the 
migration of healthy cells from the wound edges. 
7.2.4. Choosing a suitable electrode array design 
 
Selecting a microelectrode array that is suitable for the application in hand is an element worth 
considering [350]. Arrays with one sensing electrode are usually used to study barrier function 
and cell migration. The fluctuations in impedance measurements obtained using this type of 
array will allow for monitoring micromotion, and make it an ideal candidate for wound healing 
studies. Based on that, 8W1E arrays and Medusa arrays having one or two sensing electrodes 
per well, were used for wound healing assays in the current studies. On the other hand, arrays 
with multiple electrodes per well or interdigitated electrodes average the impedance over a 
larger electrode area, including more cells in the measurements and resulting in reduced 
fluctuations due to micromotion. For the toxicity assays presented in this work, interdigitated 





 It is important to note that even for the ECIS 250 m diameter electrodes, impedance 
measurements are still averaged for cells on top of the sensing electrode, which does not allow 
for studies of single cells.  
Small electrodes for single cell studies have been widely employed for extracellular recordings 
and neural network studies. Decreasing the electrode size to a single cell resolution however, 
increases the electrode characteristic impedance and noise. Choosing an electrode size again 
depends on the application. While small electrodes in the range of 10-30 m might provide 
more insights on single cell electrical properties and morphology, other properties like barrier 
functions and cell-cell signalling cannot be studied. However, small electrodes could allow 
monitoring of unknown behaviours that might have been averaged out by the 250 m diameter 
electrodes.  When using ECIS 8W1DD arrays to monitor maturation of HepaRG, the smaller 
electrodes (25-50 m) were able to resolve peaks in the impedance measurements that followed 
a specific cycle and were not identified with the 250 m electrodes. It was suggested that these 
measurements were a reflection of a circadian rhythm, although a thorough investigation is 
needed before confirming that. Moreover, electrodes sampling only hepatocytes provided 
measurements that were significantly different than those of electrodes sampling 
cholangiocytes. This suggests that small electrodes, that can accommodate a sub-population of 
cells, will be ideal for co-culture studies. However, it is still difficult to get exactly one or two 
cells of the same sub-population on one electrode, and cell immobilization techniques might 
be required in these cases.  
ECIS modelling with small electrodes on the 8W1DD arrays, as well as on the MEA chip 
fabricated in- house, failed. This might have been due to the presence of only 1-2 cells on top 
of the sensing electrode, not allowing for a full analysis of the current pathways. Electrical 





was not controlled.  This could have been due to the miniaturized dimensions of the electrode, 
meaning that cells surrounding the electrode were also killed due to heating, leading to an 
uncontrolled wound.  
Another option when deciding on an array to use for impedance sensing is to use custom chips 
specifically designed for the study under investigation. While ECIS multi-electrode arrays have 
multiple electrodes covering a wide area of the culture well, these electrodes are not 
individually addressed and the final impedance measurements represent an average. Having 
electrodes that can be addressed individually allows for a more detailed study. In wound 
healing assays for example, having more than one electrode could reveal information on how 
cells distant from the wound react to an injury created on another electrode in the same well. 
In this work, microelectrode arrays with different-sized, individually-addressed square 
microelectrodes with high spatial resolution were fabricated and used for RPE ECIS wound 
healing assays. The different-sized electrodes (20 μm, 50 μm, 100 μm, 200 μm) were used to 
monitor RPE spreading and attachment before wounding assays were conducted. A migration 
rate comparable to that obtained with ECIS 250 μm circular electrodes was obtained. 
7.2.5. Defining wounding thresholds 
 
Defining the right wounding parameters is essential for an efficient wound healing assay. If the 
wounding pulse is too short, insufficient wounding or electroporation can occur, whereas if the 
wounding is too long or performed at a low frequency the electrode could be damaged [84]. 
However, determining a wounding threshold is not an easy task with many factors needing to 
be considered. Trial and error experiments are normally used to define wounding parameters 
for a specific cell type. Unfortunately, this method is time consuming and not cost efficient. 
Arriving at a formula that will relate wounding parameters together and can be used to 





on the wounding pulse amplitude, frequency and duration as proposed in Equation (5.1). In 
reality, it is not that simple however as a wounding threshold is also dependent on the cell 
electrical properties, cell-substrate adhesion, protein coatings present as well as on the 
conductivity of the culture medium, all of which are reflected by the impedance measurements. 
Therefore, the impedance of the cell layer to be wounded has to be taken into consideration.  
Trial and error experiments were initially performed in this work to define suitable parameters 
for the keratinocytes wounding model. To wound other cell lines however, theoretical 
wounding parameters, resulting in the same current density obtained with the previously 
determined threshold, were derived using Equations (5.2 - 5.4). The same process was used to 
define suitable wounding parameters for different sized electrodes. Although these 
theoretically-derived wounding parameters did not cause total cell death in some cases, they 
were very close to the value of the final wounding pulse. This method therefore dramatically 
minimized the process of defining the appropriate wounding threshold. 
As an alternative to the regular electrical wounding assay, an electric fence method can be used 
where elevated current pulses are applied onto the sensing electrodes preventing cells from 
attaching to the electrode. When the fence is lifted off, cells start to migrate inwards to populate 
the electrodes. An advantage of the electric fence technique is the absence of debris resulting 
from dead cells around the electrodes that might hinder cell migration. However, for a 
physiologically relevant wound healing study, a confluent cell layer has to be established and 
wounded before investigating the healing process.  Fencing on the other hand represents a very 
good tool to study the influence of different protein coatings on cell migration as the electrode 






7.3. Electrical stimulation: Effects on cell alignment and 
migration  
                                                                                                                                                         
The therapeutic potential of electrical stimulation has been pointed out in the treatment of 
various diseases including chronic wounds, cancer and spinal cord injuries with varying 
reported successes. The potential of using electrical stimulation for AMD treatment has been 
examined in this work. An externally applied EF (50-300mV/mm) caused RPE cells to migrate 
in a direction perpendicular to that of the EF. RPE directed migration due to an applied EF has 
been previously reported by various research groups, with different migrating directions being 
observed. Different cell types have been known to exhibit varying migration capabilities, with 
different electrotactic response between different cell lines and even between cells originating 
from the same tissue. Cells derived from the same tissue have been found to migrate in opposite 
directions or even fail to migrate directionally at all [185, 186]. The effect of electrical 
stimulation on cell migration is therefore cell-type specific and experiments will have to be 
conducted for each cell line on an individual basis.  
The applied EF has also caused the cells to realign their long axes almost perpendicular to the 
field. This behavior has been reported before by Gamboa et al. as well as other groups [182].  
As cell alignment is known to play a major role in tissue regeneration, applying an external 
electric field could be used as a therapeutic approach for degenerative diseases [351].  
In healthy retina, RPE loss is compensated for by an increase in RPE cell size and migration to 
close the wound. In the current study, it was observed that applying an external EF was 
accompanied by RPE cell elongation. The three changes in RPE behavior and physiology: 
alignment, elongation and directed cell migration, occurring due to the application of an 






In a clinical study by Karba et al [199], applying an EF radially, with a positive electrode placed 
on the wound surrounded by four negative electrodes, was reported to significantly enhance 
healing of pressure ulcers in patients with spinal cord injuries. On the other hand, applying the 
EF linearly with the electrodes placed at opposite sides across the wound caused minor 
improvements. In the current study, both case and control hiPSC-RPE cells were shown to 
migrate radially after wounding. These results inspired the design of a new stimulating system 
that is proposed in this work. This system will apply an EF in a radial direction, aiming at 
stimulating cell migration and directing cells to close a wound from different directions at once, 
hence speeding up the healing process. Moreover, electrical stimulation will be combined with 
impedance sensing to provide a method of quantifying the effects of the EF on the cultured 
cells in real-time. In a previous unsuccessful trial presented in this work, ECIS flow arrays 
were used in an attempt to monitor RPE migration directed by an external EF. However, due 
to the design of the ECIS electrodes, with the counter electrode having a different potential at 
its two ends, the chip was damaged when subjected to the DC EF due to electrochemical 
corrosion. This issue is addressed in the proposed system with all of the electrodes designed to 
remain at a constant potential in order to avoid lifting of the gold layer and electrode damage. 
However, preliminary experiment using charged polystyrene beads in a petri-dish has 
uncovered other issues underlying the radial stimulation set up. As the EF was dispersed in the 
petri-dish, very high potentials had to be applied to arrive at the required EF strength. Due to 
thermal effects accompanying these high voltages, the agar bridges melted during a period of 
20-30 minutes. Medium evaporation was also observed. 
The design proposed in this work already addresses the issue of medium evaporation, as the 
electrical stimulation insert is positioned 1mm above the substrate forming a roof and keeping 
Joule heating at a minimum. This means however that the second design of the insert with 





In order to obtain higher EF strengths while applying lower DC potentials, the distance between 
the inner agar bridge and the outer bridges could be made smaller. Agar bridges with higher 
conductivity could also be prepared, using for instance 10x PBS instead of the 2x PBS used in 
this study. More trials will be needed to arrive at an optimized design that can be used for radial 
electrical stimulation of cell cultures. 
7.4. Summary                                                                                                                          
 
This chapter discusses the results obtained in this work. Mechanisms underlying the modelled 
diseases were described; specifically the APAP-induced tight junction disruption as well as the 
role of cell adhesion in macular degeneration. Some considerations and limitations surrounding 
ECIS measurements and electrical wounding were also presented. Finally, the therapeutic 





Conclusions and Perspectives 
 
 
This chapter provides a summary of the work presented in this thesis with an outlook on areas 
for future developments, followed by some concluding remarks. 
8.1. Summary 
 
In this thesis, the need for a physiologically relevant in vitro disease model that can be 
investigated quantitatively and reproducibly has been addressed through developing a tissue-
on-a-chip approach. The disease models combining stem cell technology and electric cell-
substrate impedance sensing, provided a high-throughput platform that can investigate disease 
mechanisms in real-time. The first model-on-a-chip was developed for drug-induced acute liver 
failure studies. The progenitor cell line, HepaRG, was cultured on ECIS microelectrodes and 
allowed to terminally differentiate into a hepatocyte:cholangiocyte co-culture. Hepatotoxicity 
assays were then conducted using the model hepatotoxins: Paracetamol, Amiodarone and 
Cyclosporine-A.  This hybrid technology uncovered an unknown outcome of paracetamol 
toxicity; temporal, dose-dependent disruption of intercellular (tight) junctions and cell–
substrate adhesions, detectable even at sub-toxic APAP dose. These tight junction disruptions 
were confirmed using TEM imaging and fluorescence immunostaining of the tight junction 
protein (ZO-1). Further validating assays were conducted using phorbol-ester that is known to 
disrupt tight junctions, and NAPQI, a product of APAP metabolism.  
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The second model-on-a-chip developed in this work is for age-related macular degeneration. 
An hiPSCs-derived model of the RPE layer was developed directly on ECIS gold 
microelectrode arrays and its robustness, reproducibility and suitability was quantitatively 
addressed by real-time impedance sensing before initiating an integrated electrical wound 
healing assay. This method mimicked RPE cell loss accompanying macular degeneration and 
was used to detect variations in migration rate between a cell line derived from a patient with 
late-onset retinal macular degeneration versus a control cell line derived from an unaffected 
sibling. The migration rate of the case cell line was significantly lower than that of the healthy 
control. ECIS modelling and biochemical assays showed that this might be related to the 
stronger cell-substrate adhesion expressed by the case cell line. Further experiments with an 
immortalized RPE cell line, confirmed the relationship between higher adhesion and low 
migration rates.  
To better understand ECIS electrical wounding, keratinocytes were initially used for wounding 
assays. A wounding threshold for the HEKa cell line was determined and a formula relating 
the applied wounding parameters to wound severity was proposed. Furthermore, cell migration 
assays were conducted on the HepaRG cell line showing that this cell line does not migrate 
after wounding. 
Microelectrode arrays with high spatial resolution and different-sized, individually- addressed 
microelectrodes for ECIS measurements were designed and fabricated in-house. The fabricated 
square microelectrodes were used to electrically wound RPE using ECIS and a migration rate 
comparable to that obtained with ECIS circular electrodes was determined.  
Two therapeutic approaches have been examined in this work: antioxidants and electrical 
stimulation. The effect of the antioxidant NAC on paracetamol toxicity as well as on speeding 
up RPE migration was investigated. 10 mM NAC following the paracetamol challenge, showed 
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some signs of cell recovery with a slight increase in impedance measurements observed after 
incubating with the antioxidant for 24h. However, a similar increase in impedance was 
recorded when adding fresh culture medium. For NAC-stimulated hiPSC-RPE cultures, no 
effect on the migration of the case cell line was monitored. On the other hand, the control cell 
migration was found to decrease after incubating the cells with NAC for 2h. The effect of NAC 
on oxidatively-stressed hiPSC-RPE cells was also examined. However, no conclusive results 
were achieved. More experiments will be needed to fully understand the role of oxidative stress 
in RPE migration and to test the effect of different NAC concentrations on the recovery of 
HepaRG and RPE. 
The potential of using electrical stimulation to enhance RPE migration in degenerative diseases 
has been demonstrated.  Externally applied EFs have been shown to direct cell migration almost 
perpendicular to the EF. The cells have also been observed to elongate and to change their 
alignment due to EF application.  
Combining impedance sensing and electrical stimulation will allow for a quantitative method 
that can monitor electrically-stimulated cell migration in real-time. In an unsuccessful trial, 
ECIS impedance measurements were combined with electrical stimulation to monitor the 
directed RPE migration. However, the design of the ECIS electrodes led to the chip damage 
when subjected to the DC EF. Finally, a design that could allow electrical stimulation to be 









8.2.1. Disease models-on-a-chip: Quantifying disease kinetics 
 
The liver disease-model developed in this work has revealed unknown TJ-disruption in 
paracetamol-induced acute liver failure; whereas the age-related macular degeneration model 
pointed out towards a role for adhesion in RPE degeneration. The effect of other drugs and 
hepatotoxins on liver cells can be examined. In AMD, deriving diseased cell lines from several 
patients is required for a more thorough understanding of the genetic disorder. 
Combining stem cells with microelectrode technologies and impedance sensing, various 
diseases can be modelled. Stem cell-based disease models-on-a-chip can be developed to 
provide high throughput platforms for the quantification, characterization and evaluation of 
different aspects of the modelled diseases. These models can therefore be employed to develop 
novel drugs and therapies for incurable diseases, as well as gain more insights on kinetics and 
underlying mechanisms of curable ones. 
8.2.2. Therapeutic approaches and translational medicine 
 
Using the disease models-on-a-chip, different therapies and approaches can be examined and 
evaluated. Preliminary studies have explored the role of the antioxidant NAC in cell recovery. 
More studies examining the effects of other antioxidants with different concentrations and 
various incubation times on cell migration and recovery are needed. The effect of TJ-stabilizing 
agents in ALF, as well as that of adhesion modulating agents in AMD could help arrive at 
treatments for the two diseases. 
Electrical stimulation has been used in various clinical trials to treat different diseases, with 
varying successes, and has been reported to have a great therapeutic potential. A new design 
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has been proposed in this work to allow for radial electrical stimulation instead of applying the 
EF linearly in one direction. More experiments are required to optimize such design for cellular 
assays. Moreover the effect of electrical stimulation on different cell lines post to drug- and 
electrically-induced injuries should be examined in order to evaluate the potential role of radial 
electrical stimulation in therapy. 
8.2.3. Perspectives in MEA designs 
 
In this work, arrays with 6 and 16 microelectrodes/well were designed. MEAs with higher 
electrode densities and smaller electrode spacings are required for a higher monitoring 
resolution. Such arrays can provide more detail on the response of a cell population. In wound 
healing assays for instance, the difference in response/migration of cells around the wound 
edge as opposed to those further away from the wound can be investigated. Furthermore, small 
electrodes can be employed for these high density arrays to allow for single cell studies and 
sub-population monitoring. They could also reveal unknown kinetics that could have been 
averaged out by larger electrodes.  
8.3. Conclusions 
 
Stem cell-based disease models-on-a-chip are cutting-edge tools in disease modelling that have 
emerged as new paradigms in drug development and personalized medicine. 
The AMD disease model-on-a-chip developed in this work is a powerful platform for 
translational studies. Combining hiPSCs technology with impedance sensing, it is amenable to 
a high throughput with considerable potential to investigate novel therapies by enabling real-
time, quantitative and reproducible patient-specific RPE cell repair studies. The proposed liver-
on-a-chip approach enables non-invasive assessment of discrete structural elements, which 
maintain tissue polarity; providing a novel tool for pre-clinical drug discovery, disease 
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modelling, and therapeutic strategies. The ALF model-on-a-chip allowed for the discovery of 
a previously unknown effect of paracetamol on the liver; disruption of cell-cell tight junctions 
and cell adhesion. Finally, electrical stimulation has been shown to control and direct cell 
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The liver is the largest organ in the human body. The main function of the liver is metabolism 
and drug detoxification. The liver also synthesises essential proteins to maintain vital functions 
in the body. Hepatocytes comprise almost 78% of the liver cells. They are 10–20 µM in size 
and are characterized by having apical and basolateral poles which are directly related to their 
hepatic functionality. This is the result of their strategic location in sheets which allows them 
to perform different liver functions from drug metabolism to communication between 
parenchymal and non-parenchymal cells. Another function of hepatocytes is bile secretion into 
the bile canaliculi, which are formed between the tight junctions of hepatocytes and 
cholangiocytes (the epithelial cells of the bile duct). Other liver cell types include Kupffer cells, 
hepatic stellate cells (HSC) and the liver sinusoidal endothelial cells (LSEC). A summary of 
their functions is provided in Table A.1 [29].  
The structural and functional unit of the liver is the hepatic lobule (Figure A.1 (a)). It consists 
of hexagonal arrangement of hepatocyte plates, extending to form liver cell plates. Each plate 
is typically one cell thick by 15–25 hepatocytes in length. Blood flows between each two cell 





Liver Cells % of liver Function 
Hepatocytes 78% Detoxification 
Protein synthesis 
Biliary secretion 
Liver sinusoidal endothelial    
  cells (LSEC) 
 
2.8% Endocytosis  
Vascularization  
Migration signalling 
Blood Clearance  
 




Immune response  
 
Hepatic stellate cells (HSC) 
 Also known as Ito cells or fat-storing cells. 
1.4% Immune response          
Storage of Vitamin A  
and retinol  
ECM synthesis 
Table A.1: Liver cell functions. 
 
It has to be mentioned that for the liver to function properly, hepatic polarity has to be 
maintained. This is defined by the functional compartmentation of hepatocytes where cells 
located in different positions between the portal tract and the hepatic venule express different 























The retina is a thin layer of tissue that lines the back of the eye (Figure B.1 (a)). The retina 
converts light into neural signals and transfers these signals to the brain via the optic nerve. 
The retinal structure is shown in Figure B.1 (b).  
The main light processing function is performed through a layer of light-sensing cells known 
as the photoreceptors. There are two main types of photoreceptors: rods and cones. Rods are 
responsible for black and white vision and function mainly in dim light (at night for instance), 
while cones function in daytime and allow for coloured vision. 
The layer that is of most interest in age-related macular degeneration studies is the retinal 
pigment epithelium (RPE). RPE is located below the photoreceptors and is separated by 
Bruch’s membrane from the blood vessels of the choroid layer. RPE maintains several 
important functions from absorbing light energy to the transportation of ions, water and 
metabolites from the subretinal space to the blood. RPE also supplies the photoreceptors with 
nutrients that it transports from the blood. Another important role of RPE is in phagocytosis 
(or digestion) of damaged photoreceptor outer segments. Therefore, in diseases like age-related 
macular degeneration where RPE loss is a main feature, the light sensing cells (photoreceptors) 


















Equivalent circuits use individual components connected in series and/or in parallel to 
represent the overall impedance of a system. Figure C.1 shows simple RC circuits with their 
equivalent Nyquist and Bode plots. For a purely resistive circuit, the Nyquist plot is a fixed 
point on the x-axis (real part of the impedance), while a capacitive circuit will be plotted as a 
vertical line that coincides with the y-axis (imaginary part of the impedance). Therefore, for a 
series RC circuit (Figure C.1(a)), the overall impedance, which is the sum of the individual 
elements (equation (C.1)), is frequency dependent and its Nyquist plot is presented as shown 
in Figure C.1(c).  
𝑍(𝜔) = 𝑅 +
1
𝑗𝜔𝐶
                                                         (𝐶. 1) 
The behaviour of a parallel RC circuit is more complicated. According to equation (C.2), at 
high frequencies, the impedance is dominated by the capacitance while at low frequencies the 
circuit shows a purely resistive behaviour. The Nyquist plot for a parallel RC circuit is a semi-




















In the model of Giaever and Keese [13], cells were assumed as circular disks with a radius rc, 
hovering at a height h above the working (sensing) electrode in a medium with resistivity ρ. 
The specific impedance (the impedance for a unit area) for the cell-free electrode is defined as 
Ze(f) and represents the impedance at the electrode-electrolyte interface. The specific 
impedance for the cell is defined as Zm(f)  and is mainly the capacitance of the upper and lower 
membranes in series, according to the equation: 




                                                          (𝐷. 1) 
where, Ccl is the capacitance of the apical and the basal cell membrane capacitance in series, 
and Cm=2Ccl  (F/ cm
2). In all their calculations, Cm was set as 1 F/ cm
2. 
It was assumed that the current flew radially in the space between the electrode and the 
hovering cells, and that the current density under the cells did not change in the z-direction. 
The electrode potential was defined as Ve and the electrolyte above the cell monolayer was 
assumed to have a constant potential of Vm. 
The current flowing from the electrode can take one of two paths; either through the cell, 
passing through the cell membranes with an impedance Zm, or through the cell-cell intercellular 




 flowing from the electrode within an area defined by the radius r, while Im(r) is the current 
passing from the cell into the bulk electrolyte within the same area. Ir(r) is the current flowing 
in a radial direction within the area below the cells and is assumed to flow in an imaginary 
cylinder of a radius r and height h, so that for  0 ≤ r < rc ,    Ir(r)= Ie (r)-Im (r).
  
 
Figure D.1: Different current pathways in ECIS model [254]. 
 


































 (𝑉(𝑟) −  𝑉𝑚(𝑟))                                                   (𝐷. 5) 
These four equations were combined to yield, by differentiation of Equation (D.2), 
substitution of Equation (D.3) followed by substitution with equations (D.4) and (D.5), the 








− 𝛾2𝑉(𝑟) + 𝛽 = 0                                         (𝐷. 6) 









)                                                            (𝐷. 7) 
                          









)                                                           (𝐷. 8) 
The approximate solution of this differential equation is: 
𝑉(𝑟) = 𝐶𝐼𝑜(𝛾𝑟) +
𝛽
𝛾2
                                                          (𝐷. 9) 
Where; Io is the modified Bessel function of the first kind of zero order and C is a constant that 
can be found using suitable boundary conditions, although its value was not stated in the 
published model. 
The total impedance of the cell-covered electrode can finally be determined from: 























                                                    




If Ze is measured and Zm is given a suitable value, two unknowns remain: the intercellular 
resistance (Rb), and the term 𝑟𝑐√
𝜌
ℎ
  (referred to as the cell-substrate adhesion parameter α) that 
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1. Generation of hiPSC-RPE lines 
HiPSC lines were derived from one patient with late-onset retinal macular degeneration 
(LORMD) and one unaffected sibling, using previously established methods [334, 335]. 
Briefly, fibroblasts were expanded from 3mm punch biopsies in medium containing 10% fetal 
bovine serum (FBS), 89% DMEM and 1% penicillin/streptomycin.  Once confluent, cells were 
passaged to MEF feeder layers and reprogrammed using a Sendai reprogramming kit 
(Invitrogen).  After four weeks, morphologically identifiable cells were selected and grown on 
MEF feeder layers in hiPSC medium containing DMEM/F12 (1:1), 20% KOSR, 1% MEM 
non-essential amino acids, 100 ng/ml bFGF, 1 mM L-glutamine and 0.1 mM β-
mercaptoethanol. Long term culture was maintained feeder free in E8 (Life technologies) 
medium.  
RPE differentiation was established using a variation of a previously published protocol [53].  
Briefly, hiPSC colonies were lifted from MEF feeder layers with dispase (0.5 mg/ml) and 
collagenase (1 mg/ml) and grown as embryonic bodies (EB) for 4 days in EB medium 
containing DMEM/F12 (1:1), 20% KOSR, 1% MEM non-essential amino acids, 1 mM L-
glutamine and 0.1 mM β-ME. At Day 5, EB medium was switched to neural induction medium 




 acids and 2 µg/ml heparin. At Day 7, suspended EB aggregates were plated to allow them to 
reattach to the culture plate, where they were grown for an additional 10 days in NIM. At Day 
16, NIM medium was replaced with retinal differentiation medium (RDM) containing 
DMEM/F12 (3:1), 2% B27 supplement (without retinoic acid), MEM non-essential amino 
acids and penicillin/streptomycin. The cells were maintained as adherent cultures in RDM until 
the appearance of pigmented RPE cells. Large patches of pigmented RPE cells were micro-
dissected and then grown on laminin coated plates initially in 10% FBS/ RDM 90% for two 
days, followed by 2% FBS/ 98% RDM till confluent before switching to RDM. RPE validation 
was performed using RT-PCR and immunostaining. 
2. Quantitative Real-time PCR (RT PCR) for hiPSC-RPE 
Total RNA was extracted using the RNAeasy Mini Plus Kit (Qiagen) and treated with DNase1 
to remove any genomic DNA contamination. cDNA was synthesized using a cDNASynthesis 
Kit (Thermo Scientific), and PCR (34 cycles) was performed using gene-specific primers. PCR 
products were analyzed on 2% agarose gels. Quantitative RT PCR experiments (40 cycles) 
were carried out using SYBR® Green Supermix (Bio-Rad) and a Bio-Rad C1000 thermal 
cycler, and results were analyzed using Bio-Rad CFX software and Microsoft Excel. 
3. hiPSC-RPE biochemical Adhesion Assay 
Single cell suspensions of hiPSC-RPE were prepared by enzymatic dissociation with 0.1% 
trypsin-EDTA for 10 minutes.  Cells were resuspended in assay buffer with a concentration of 
1.0 x 106 cells/ml. 100 µL of the cell suspension was added to each well of an extra-cellular 
matrix adhesion kit (Millipore) before incubation for 1-2h at 37°C in a CO2 incubator. After 
incubation, the media was discarded and the wells were washed 3 times with 200 µL assay 




minutes at room temperature. Stain was removed and the wells were washed 5 times with de-
ionized water before air drying. 100 µL of extraction buffer was added to each well and the 
wells were incubated with shaking in an orbital shaker for 5 minutes. The absorbance of the 
wells was measured at a wavelength of 545 nm on a microplate reader.  
4. Prestoblue cell viability and ATP-depletion endpoint 
hepatotoxicity assays  
Following the 24 hour treatment with APAP or Phorbol-ester, 10% (v/v) PrestoBlue® (A-
13262; Life Technologies) was added to the cell culture medium and incubated for 30 minutes, 
before the fluorescence signal was measured on a GloMax-Multi+ Microplate Multimode 
Reader (Promega), and data processed, according to the manufacturer’s instructions. After 
performing the non-toxic PrestoBlue assay, the remaining cells were lysed to determine total 
cellular ATP levels using the CellTiter-Glo® Luminescent Cell Viability Assay (G7570; 
Promega), as per vendor’s instructions. Bioluminescent signals were detected using the above 
plate Reader. ATP levels were normalized to controls.  
5.   Immunocytochemistry  
For ZO-1 staining, HepaRG cells were grown on coverslips in a 12 well plate and treated with 
APAP (0mM, 5mM, 10mM, 20mM ). The cells were washed with PBS and then fixed by 10 
minutes treatment with methanol. Fixed cells were washed in PBS containing 0.1% Tween 20 
- PBS-T (Sigma-Aldrich). The cells were then blocked for 1 hour in 10% normal goat serum/ 
0.1% PBS-T (Life Technologies). The cells were then washed twice before being treated with 
primary antibodies overnight at 4°C. ZO-1 antibody (Santa Cruz; 1:50) was made up in 1% 
normal goat serum in 0.1% PBS-T. Following primary incubations, the cells were washed twice 




hour at room temperature. The secondary antibody was made up in PBS. Coverslips were 
washed twice in PBS-T and twice in PBS then mounted using Fluoroshield with DAPI (Sigma-
Aldrich) onto slides. Cells were imaged using a Zeiss LSM700 Confocal Microscope and Zen 
software.  
6. Morphological and ultrastructural assessment  
To examine ultrastructural features of APAP toxicity using transmission electron microscopy 
(TEM), cells were cultured in 6-well plate format and treated for 24 hours (0 mM, 5 mM, 10 
















  Appendix F 
Microfabrication Runsheet 
 
No Step Machine Parameter/Recipe Notes 
1 Wafer Cleaning       
  - Piranha Solution 
3:1 
(H2SO4:H2O2) 10mins Add Peroxide to Acid 
  - DI dump rinse Wet Bench Standard 
Ensure removal from 
surface 
  - Wafer Drying Marangoni Dryer Standard   
2 Deposit Metal       
  - Deposit Titanium 
ANS 
E-Beam Evap 10nm  
  - Deposit Platinum 
ANS 
E-Beam Evap 100nm  
3 Photolith Metal       
  - HMDS Box Prime Wet Bench 10mins   
  - Coat Photoresist SVG Track (1) Recipe 9:3:1 Manual 
  
- Expose: METAL 
(DF) 
KS Contact 
Aligner 9.0sec Prox/Spacer 
  - Develop Photoresist SVG Track (2) Recipe 9:1:1 Manual 
  - Hardbake 
Gallenkamp 
Oven 60min 
set 140degC (actual: 
110degC) 
4 Etch Metal       
  - Etch Platinum JLS RIE 80 Prog 8 - 17mins 200W (Ar - 25sccm) 
  
- Wet Etch 






5 Resist Strip       
  - Plasma strip Barrel Ash 75mins   
  - ACT rinse (1) Water Bath 15mins  50 degC 
  - ACT rinse (2) Water Bath 15mins 50 degC 
  - IPA rinse Wet Deck 10mins DI rinse and N2 dry 
6 Coat Passivation       
  - Parylene C Labcoter 1000nm   
7 Photolith Contact       
  - HMDS Box Prime Wet Bench 10mins   
  - Coat Photoresist SVG Track (1) Recipe 9:2:1 Manual 
  
- Expose: METAL 
(DF) 
KS Contact 
Aligner 9.0sec Prox/Spacer 
  - Develop Photoresist SVG Track (2) Recipe 9:1:1 Manual 
  - Hardbake 
Gallenkamp 
Oven 60min 
set 140degC (actual: 
110degC) 
8 Etch Contact       
  - Etch Parylene JLS RIE 80     
8 Resist Strip       
  - Plasma strip Barrel Ash 75mins   
  - ACT rinse (1) Water Bath 15mins  50 degC 
  - ACT rinse (2) Water Bath 15mins 50 degC 
  - IPA rinse Wet Deck 10mins DI rinse and N2 dry 
9 Completion       
  - HMDS Box Prime Wet Bench 10mins   
  - Coat Photoresist SVG Track (1) Recipe 9:1:1 Manual 
  - Dice wafers Disco Saw prog 362   
 - Deliver Package   COMPLETED 
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